col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


2291 Results       Page 1

 [1]  [2] [ Next > ]
Wiley: Journal of Medical Virology
  original article Date Title Authors   All Authors
1 [GO] 2024―Jul―05 Prophylactic antibodies inhibit spike-specific T and B cell responses after COVID-19 vaccination Henrik E. Mei, Axel Ronald Schulz, Heike Hirseland, Lisa-Marie Diekmann, Elisa Habermann, Alexander ten Hagen, et al. (+4)
2 [GO] 2024―Jul―05 Attenuated replication and damaging effects of SARS-CoV-2 Omicron variants in an intestinal epithelial barrier model Meta Volcic, Rayhane Nchioua, Chiara Pastorio, Fabian Zech, Isabell Haußmann, Daniel Sauter, et al. (+3)
3 [GO] 2024―Jul―02 Comment on “A systematic review and meta-analysis of herpes zoster occurrence/recurrence after COVID-19 infection and vaccination” Chia-Li Kao, Ping-Hsin Liu
4 [GO] 2024―Jul―01 Metabolic and mitochondria alterations induced by SARS-CoV-2 accessory proteins ORF3a, ORF9b, ORF9c and ORF10 Blanca D. López-Ayllón, Silvia Marin, Marco Fariñas Fernández, Tránsito García-García, Raúl Fernández-Rodríguez, Ana de Lucas-Rius, et al. (+17)
5 [GO] 2024―Jun―28 Dispersal history of SARS-CoV-2 in Galicia, Spain Pilar Gallego-García, Nuria Estévez-Gómez, Loretta De Chiara, Pilar Alvariño, Pedro M. Juiz-González, Isabel Torres-Beceiro, et al. (+45)
6 [GO] 2024―Jun―20 Hybrid immunity by two COVID-19 mRNA vaccinations and one breakthrough infection provides a robust and balanced cellular immune response as basic immunity against severe acute respiratory syndrome coronavirus 2 Giovanni Almanzar, Kimia Koosha, Tim Vogt, Astrid Stein, Lars Ziegler, Claudia Asam, et al. (+15)
7 [GO] 2024―Jun―20 Value of a secretomic approach for distinguishing patients with COVID-19 viral pneumonia among patients with respiratory distress admitted to intensive care unit Angélique Blangy-Letheule, Amandine Vergnaud, Thomas Dupas, Damien Habert, Jérôme Montnach, Walid Oulehri, et al. (+12)
8 [GO] 2024―Jun―20 Human umbilical cord-derived mesenchymal stem cell transplantation improves the long COVID Yuling Tang, Xiao Zou, Ping Liu, Yanni Dai, Siqi Wang, Xian Su, et al. (+11)
9 [GO] 2024―Jun―17 Clinical efficacy of SARS-CoV-2 Omicron-neutralizing antibodies in immunoglobulin preparations for the treatment of agammaglobulinemia in patients with primary antibody deficiency Michael Karbiener, Gerhard Kindle, Isabelle Meyts, Mikko R. J. Seppänen, Fabio Candotti, Marta Kamieniak, et al. (+3)
10 [GO] 2024―Jun―14 Malaria and other infections induce polyreactive antibodies that impact SARS-CoV-2 seropositivity estimations in endemic settings Ruth Aguilar, Alfons Jiménez, Rebeca Santano, Marta Vidal, Oumou Maiga-Ascofare, Ricardo Strauss, et al. (+21)
11 [GO] 2024―Jun―14 Risks of cutaneous immune-related adverse events in long COVID: Multinational cohort studies in South Korea, Japan, and the UK Hyejun Kim, Seoyeon Kyung, Jaeyu Park, Hojae Lee, Myeongcheol Lee, Lee Smith, et al. (+10)
12 [GO] 2024―Jun―05 Unveiling the metabolic and coagulation disruptions in SARS-CoV-2-associated acute macular neuroretinopathy: A case-control study Xiaojing Xiong, Zheng Zheng, Chunlin Liu, Xinyu Wang, Shuai Luo, Qinqin Xie, et al. (+3)
13 [GO] 2024―May―30 Effectiveness of nirmatrelvir-ritonavir on severe outcomes of COVID-19: A meta-regression analysis I-Wen Chen, Ting-Sian Yu, Chien-Hung Lin, Kuo-Chuan Hung
14 [GO] 2024―May―30 Antibiotics in COVID-19: Unveiling disturbing truths through critical scrutiny Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan, Kaeshaelya Thiruchelvam
15 [GO] 2024―May―29 TMPRSS13 promotes the cell entry of swine acute diarrhea syndrome coronavirus Yutong Han, Yanlong Ma, Ziqiao Wang, Fei Feng, Ling Zhou, Hui Feng, et al. (+3)
16 [GO] 2024―May―28 Persistence of SARS-CoV-2 infection and viral intra- and inter-host evolution in COVID-19 hospitalized patients Grazia Pavia, Angela Quirino, Nadia Marascio, Claudia Veneziano, Federico Longhini, Andrea Bruni, et al. (+23)
17 [GO] 2024―May―28 A prospective humoral immune monitoring study of kidney transplant recipients receiving three doses of SARS-CoV-2 mRNA vaccine Cinzia Borgogna, Daniela Ferrante, Greta Rosso, Gabriele Guglielmetti, Irene Lo Cigno, Stefano Raviola, et al. (+4)
18 [GO] 2024―May―22 Rotavirus trends and distribution of genotypes before and during COVID-19 pandemic era: Bangladesh, 2017-2021 Warda Haque, Muhammad Talha, Sezanur Rahman, Mehedi Hasan, Shaheen Alam, Zahid Hassan, et al. (+9)
19 [GO] 2024―May―20 Elevated pretreatment serum apolipoprotein E level associated with poor prognosis of patients with COVID-19 during the omicron BA.5 and BF.7 wave Shengping Gong, Chao Ma, Ruishuang Ma, Ting Zhu, Xiaoqin Ge, Rongrong Xie, et al. (+3)
20 [GO] 2024―May―20 Ten different viral agents infecting and co-infecting children with acute gastroenteritis in Southern Italy: Role of known pathogens and emerging viruses during and after COVID-19 pandemic Maria Grazia Amoroso, Alessia Pucciarelli, Francesco Serra, Giovanni Ianiro, Michele Iafusco, Filomena Fiorito, et al. (+8)
21 [GO] 2024―May―20 Nanomedicine-mediated recovery of antioxidant glutathione peroxidase activity after oxidative-stress cellular damage: Insights for neurological long COVID Thelma Akanchise, Borislav Angelov, Angelina Angelova
22 [GO] 2024―May―17 Risks of alopecia areata in long COVID: Binational population-based cohort studies from South Korea and Japan Seoyeon Kyung, Yejun Son, Minji Kim, Jiseung Kang, Lee Smith, Hayeon Lee, Dong Keon Yon
23 [GO] 2024―May―15 Presence of SARS-CoV-2 RNA in COVID-19 survivors with post-COVID symptoms 2 years after hospitalization: The VIPER study César Fernández-de-las-Peñas, Juan Torres-Macho, Maria Ruiz-Ruigómez, Estibaliz Arrieta-Ortubay, Carolina Rodríguez-Rebollo, Míriam Akasbi-Moltalvo, et al. (+7)
24 [GO] 2024―May―15 SARS-CoV-2 induces blood-brain barrier and choroid plexus barrier impairments and vascular inflammation in mice Haowen Qiao, Xiangxue Deng, Lingxi Qiu, Yafei Qu, Yuanpu Chiu, Feixiang Chen, et al. (+8)
25 [GO] 2024―May―10 Clinical effectiveness of nirmatrelvir plus ritonavir on the short- and long-term outcome in high-risk children with COVID-19 Jheng-Yan Wu, Chia-Chen Chen, Mei-Yuan Liu, Wan-Hsuan Hsu, Ya-Wen Tsai, Ting-Hui Liu, et al. (+7)
26 [GO] 2024―May―10 Exploring viral infections' role in Kawasaki disease onset: A study during the COVID-19 pandemic Taku Ishii, Nobutoshi Nawa, Susumu Hosokawa, Tomohiro Morio, Takeo Fujiwara
27 [GO] 2024―May―10 Prior COVID-19 vaccination and reduced risk of cerebrovascular diseases among COVID-19 survivors Sheng-Yin Chen, Tina Yi Jin Hsieh, Yao-Min Hung, Jae Won Oh, Shen-Kai Chen, Shiow-Ing Wang, et al. (+2)
28 [GO] 2024―May―10 Prevalence and diversity of imported severe acute respiratory syndrome coronavirus 2 variants in China, 2021-2022 Yenan Feng, Xiang Zhao, Zhixiao Chen, Yuchao Wu, Lili Li, Changcheng Wu, et al. (+6)
29 [GO] 2024―May―10 Human coronavirus 229E inactivation on porous and nonporous materials using dielectric barrier discharge (DBD) plasma Sekar Ashokkumar, Jun Sup Lim, Nagendra Kumar Kaushik, Ihn Han, Han Sup Uhm, Yung Oh Shin, Eun Ha Choi
30 [GO] 2024―May―10 Characterizing the antigenic evolution of pandemic influenza A (H1N1) pdm09 from 2009 to 2023 Peiwen Cheng, Ke Zhai, Wenjie Han, Jinfeng Zeng, Zekai Qiu, Yilin Chen, et al. (+5)
31 [GO] 2024―May―07 The burden of infectious diseases throughout and after the COVID-19 pandemic (2020-2023) and Russo-Ukrainian war migration Piotr Rzymski, Dorota Zarębska-Michaluk, Miłosz Parczewski, Agnieszka Genowska, Barbara Poniedziałek, Birute Strukcinskiene, et al. (+2)
32 [GO] 2024―May―06 Molnupiravir increases SARS-CoV-2 genome diversity and complexity: A case-control cohort study Cesare Ernesto Maria Gruber, Fabio Giovanni Tucci, Emanuela Giombini, Valentina Mazzotta, Pietro Giorgio Spezia, Martina Rueca, et al. (+12)
33 [GO] 2024―Apr―29 A systematic review and meta-analysis of herpes zoster occurrence/recurrence after COVID-19 infection and vaccination Fengge Wang, Yidan Gao, Abram L. Wagner, Yihan Lu
34 [GO] 2024―Apr―29 Research progress in Fc-effector functions against SARS-CoV-2 Rongyuan Gao, Chenchen Feng, Zizhang Sheng, Feng Li, Dan Wang
35 [GO] 2024―Apr―29 Antibody-dependent enhancement (ADE) of SARS-CoV-2 in patients exposed to MERS-CoV and SARS-CoV-2 antigens Swapna Thomas, Maria K. Smatti, Haya Alsulaiti, Hadeel T. Zedan, Ali H. Eid, Ali A. Hssain, et al. (+7)
36 [GO] 2024―Apr―25 Reply to comment on “The risk assessment of uveitis after COVID-19 diagnosis by Wu et al. 2024” Alan Y. Hsu, Chun-Ju Lin, Ning-Yi Hsia, Yu-Hsun Wang, Jing-Xing Li, Huan-Sheng Chen, et al. (+2)
37 [GO] 2024―Apr―23 Safety, immunogenicity, and protective effective of inhaled COVID-19 vaccines: A systematic review and meta-analysis Gao Song, Rong Li, Meng-qun Cheng
38 [GO] 2024―Apr―19 COVID-19 vaccination and autoimmunity: Do we need more evidence? Ranjeet Singh Mahla, Lynn B. Dustin
39 [GO] 2024―Apr―19 Unveiling the micronutrient-immunity puzzle in inactivated COVID-19 vaccination: A comprehensive analysis of circulating micronutrient levels and humoral responses in healthy adults Huicui Meng, Yin Wang, Yanmei Zhai, Wanyu Luo, Yuanyuan Wang, Yunqi Hu, et al. (+7)
40 [GO] 2024―Apr―18 Changing respiratory pathogens infection patterns after COVID-19 pandemic in Shanghai, China Muyun Wei, Shuangshuang Li, Xinhua Lu, Kaiming Hu, Zhilan Li, Min Li
41 [GO] 2024―Apr―16 Poor durability of the neutralizing response against XBB sublineages after a bivalent mRNA COVID-19 booster dose in persons with HIV Giulia Matusali, Alessandra Vergori, Eleonora Cimini, Davide Mariotti, Valentina Mazzotta, Alessandro Cozzi Lepri, et al. (+9)
42 [GO] 2024―Apr―16 Incidence of fatigue 2 years after SARS-CoV-2 infection: An updated meta-analysis and subgroup analysis I-Wen Chen, Hsiu-Lan Weng, Yi-Chen Lai, Kuo-Chuan Hung
43 [GO] 2024―Apr―15 Probing molecular pathways: Illuminating the connection between COVID-19 and Alzheimer's disease through the endocannabinoid system dynamics Qingyuan Sun, Jinyang Gao, Ran An, Menggeer Wang, Yanqing Wang
44 [GO] 2024―Apr―15 Convalescent plasma transfusion for immunocompromised viremic patients with COVID-19: A retrospective multicenter study Marjolaine Destremau, Hélène Chaussade, Victor Hemar, Mathilde Beguet, Pantxika Bellecave, Elodie Blanchard, et al. (+11)
45 [GO] 2024―Apr―10 Metagenomic insights into fungal community composition of the nasopharyngeal region of COVID-19 associated mucormycosis patients from India Bharathi Arunan, Daizee Talukdar, Satish Swain, Ashwin Varadarajan, Radhika Sarda, Gagandeep Singh, et al. (+12)
46 [GO] 2024―Apr―08 Obesity fosters severe disease outcomes in a mouse model of coronavirus infection associated with transcriptomic abnormalities Pallavi Rai, Jeffrey M. Marano, Lin Kang, Sheryl Coutermarsh-Ott, Andrea R. Daamen, Peter E. Lipsky, James Weger-Lucarelli
47 [GO] 2024―Apr―08 The abortive SARS-CoV-2 infection of osteoclast precursors promotes their differentiation into osteoclasts Franco Sviercz, Patricio Jarmoluk, Joshua Godoy Coto, Cintia Cevallos, Rosa Nicole Freiberger, Cinthya Alicia Marcela López, et al. (+3)
48 [GO] 2024―Apr―08 A peptide derived from SARS-CoV-2 nucleocapsid protein with broad-spectrum anti-coronavirus activity Guoguo Ye, Yimin Tang, Qin Yang, Chenhui Zhang, Huiping Shi, Jun Wang, et al. (+7)
49 [GO] 2024―Apr―04 Two- and 3-year outcomes in convalescent individuals with COVID-19: A prospective cohort study Huqin Yang, Lujia Guan, Tingyu Yang, Haomiao Ma, Xuefeng Liu, Xuyan Li, et al. (+2)
50 [GO] 2024―Apr―04 Comparative single-cell RNA sequencing analysis of immune response to inactivated vaccine and natural SARS-CoV-2 infection Shuai He, Shu-Qiang Liu, Xiang-Yun Teng, Jin-Yong He, Yang Liu, Jia-Hui Gao, et al. (+5)
51 [GO] 2024―Apr―04 The use of human iPSC-derived alveolar organoids to explore SARS-CoV-2 variant infections and host responses Chaitanya Gandikota, Kishore Vaddadi, Pulavendran Sivasami, Chaoqun Huang, Yurong Liang, Samuel Pushparaj, et al. (+4)
52 [GO] 2024―Apr―03 Immune features revealed by single-cell RNA and single-cell TCR/BCR sequencing in patients with rheumatoid arthritis receiving COVID-19 booster vaccination Yong Fan, Siyuan Huang, Duo Wu, Ming Chu, Juan Zhao, Jiaying Zhang, et al. (+7)
53 [GO] 2024―Apr―03 Long-term dynamics of natural killer cells in response to SARS-CoV-2 vaccination: Persistently enhanced activity postvaccination Dalila Mele, Sabrina Ottolini, Andrea Lombardi, Daniela Conteianni, Alessandra Bandera, Barbara Oliviero, et al. (+6)
54 [GO] 2024―Apr―01 Influenza vaccination on SARS-CoV-2 infection risk: A subgroup analysis on geographic factor Kuo-Chuan Hung, Ting-Sian Yu, Kuei-Fen Wang, I-Wen Chen
55 [GO] 2024―Mar―26 The antiviral potential of the antiandrogen enzalutamide and the viral-androgen signaling interplay in seasonal coronaviruses Oluwadamilola D. Ogunjinmi, Tukur Abdullahi, Riaz-Ali Somji, Charlotte L. Bevan, Wendy S. Barclay, Nigel Temperton, et al. (+2)
56 [GO] 2024―Mar―26 Neutralizing antibody response to SARS-CoV-2 bivalent mRNA vaccine in SIV-infected rhesus macaques: Enhanced immunity to XBB subvariants by two-dose vaccination Julia N. Faraone, Xiaolwei Wang, Panke Qu, Yi-Min Zheng, Eunice Vincent, Huanbin Xu, Shan-Lu Liu
57 [GO] 2024―Mar―26 Evaluation of the effectiveness and safety of sequential vaccination with inactivated SARS-CoV-2 vaccine and Ad5-nCoV booster in pediatric liver transplant recipients Zhigang Zheng, Huimin Wu, Xiaowei Sun, Yefeng Lu, Yanyan Song, Yi Luo, et al. (+9)
58 [GO] 2024―Mar―22 Association between monoclonal antibody therapy, vaccination, and longer-term symptom resolution after acute COVID-19 Samantha C. Roberts, Sarah E. Jolley, Laurel E. Beaty, Neil R. Aggarwal, Tellen D. Bennett, Nichole E. Carlson, et al. (+6)
59 [GO] 2024―Mar―22 High pre-Delta and early-Omicron SARS-CoV-2 seroprevalence detected in dried blood samples from Kinshasa (D.R. Congo) Paula Martínez de Aguirre, Silvia Carlos, Manuel Pina-Sánchez, Samclide Mbikayi, Eduardo Burgueño, Céline Tendobi, et al. (+3)
60 [GO] 2024―Mar―22 Comparable CD8+ T-cell responses to SARS-CoV-2 vaccination in single-cell transcriptomics of recently allogeneic transplanted patients and healthy individuals Eva Tranter, Marco Frentsch, Marie Luise Hütter-Krönke, Giang Lam Vuong, David Busch, Lucie Loyal, et al. (+8)
61 [GO] 2024―Mar―22 TRIM6 facilitates SARS-CoV-2 proliferation by catalyzing the K29-typed ubiquitination of NP to enhance the ability to bind viral genomes Jian Zhou, Yuzheng Zhou, Xia-Fei Wei, Lujie Fan, Xiang Gao, Yunfei Li, et al. (+6)
62 [GO] 2024―Mar―21 Temporal changes in biomarkers of neutrophil extracellular traps and NET-promoting autoantibodies following adenovirus-vectored, mRNA, and recombinant protein COVID-19 vaccination Yu-Min Kuo, Chun-Min Kang, Zhi-Yun Lai, Ting-Yu Huang, Shiang-Jong Tzeng, Chih-Chieh Hsu, et al. (+5)
63 [GO] 2024―Mar―21 SARS-CoV-2 infection triggers more potent antibody-dependent cellular cytotoxicity (ADCC) responses than mRNA-, vector-, and inactivated virus-based COVID-19 vaccines Hadeel T. Zedan, Maria K. Smatti, Duaa W. Al-Sadeq, Hebah A. Al Khatib, Eleonora Nicolai, Massimo Pieri, et al. (+9)
64 [GO] 2024―Mar―21 Optimization of a DNA-launched SARS-CoV-2 replicon with RNA splicing inhibitor Isoginkgetin Hu Zhang, Haitao Guo
65 [GO] 2024―Mar―20 Resurgence of human respiratory syncytial virus during COVID-19 pandemic in Southern Brazil Guilherme C. Fröhlich, Tatiana S. Gregianini, Felipe G. Pinheiro, Rodrigo Nascimento, Thiago M. Cezar, Veridiane M. Pscheidt, et al. (+10)
66 [GO] 2024―Mar―20 A retrospective cohort study on early antibiotic use in vaccinated and unvaccinated COVID-19 patients Carlo Brogna, Luigi Montano, Maria Elisabetta Zanolin, Domenico Rocco Bisaccia, Gianluca Ciammetti, Valentina Viduto, et al. (+9)
67 [GO] 2024―Mar―20 Integrating Fréchet distance and AI reveals the evolutionary trajectory and origin of SARS-CoV-2 Anyou Wang
68 [GO] 2024―Mar―20 New-onset neurodegenerative diseases following SARS-CoV-2 infection: An analysis of prediction interval Kuo-Chuan Hung, Hsiu-Jung Lin, I-Wen Chen
69 [GO] 2024―Mar―20 Long-term immunogenicity and safety of heterologous boosting with a SARS-CoV-2 mRNA vaccine (SYS6006) in Chinese participants who had received two or three doses of inactivated vaccine Jianying Huang, Yuanzheng Qiu, Lin Luo, Jianyuan Wu, Di Hu, Xiang Zhong, et al. (+5)
70 [GO] 2024―Mar―20 Detection of SARS-CoV-2 virus in middle ear effusions and its association with otitis media with effusion Xiao Fu, Zhujian Wang, Binjun Chen, Haojie Sun, Jihan Lyu, Jing Shao, et al. (+6)
71 [GO] 2024―Mar―16 Correction to “Exploring the impact of ursodeoxycholic acid therapy on COVID-19 in a real-word setting”
72 [GO] 2024―Mar―12 Respiratory syncytial virus incidence and typing in the last six seasons in the north of Spain (Asturias). Genetic characterization during the SARS-CoV-2 pandemic Susana Rojo-Alba, Zulema Pérez Martínez, José María González-Alba, José Antonio Boga, Cristina Ochoa Varela, Maria Agustina Alonso Álvarez, et al. (+7)
73 [GO] 2024―Mar―11 Exploring the incidence of peripheral arterial occlusive disease following COVID-19 infection: A retrospective cohort study Liang-Tsai Yeh, Chi-Ho Chan, Yu-Hsun Wang, Chia-Yi Lee, Shun-Fa Yang, Chao-Bin Yeh
74 [GO] 2024―Mar―11 Low antibody levels associated with significantly increased rate of SARS-CoV-2 infection in a highly vaccinated population from the US National Basketball Association Caroline G. Tai, Miriam J. Haviland, Steven M. Kissler, Rachel M. Lucia, Michael Merson, Lisa L. Maragakis, et al. (+6)
75 [GO] 2024―Mar―08 Prevalence of orthostatic intolerance in long covid clinic patients and healthy volunteers: A multicenter study Cassie Lee, Darren C. Greenwood, Harsha Master, Kumaran Balasundaram, Paul Williams, Janet T. Scott, et al. (+12)
76 [GO] 2024―Mar―06 Comment on “The association of sickle cell disorder with adverse outcomes in COVID-19 patients: A meta-analysis” I-Wen Chen, Hsiu-Jung Lin, Yao-Tsung Lin, Kuo-Chuan Hung
77 [GO] 2024―Mar―06 A superior heterologous prime-boost vaccination strategy against COVID-19: A bivalent vaccine based on yeast-derived RBD proteins followed by a heterologous vaccine Yu Liu, Miao Li, Tingting Cui, Zhian Chen, Liangting Xu, Wenjuan Li, et al. (+8)
78 [GO] 2024―Mar―06 Empowering SARS-CoV-2 variant neutralization with a bifunctional antibody engineered with tandem heptad repeat 2 peptides Ji Woong Kim, Ji Hyun Lee, Hyun Jung Kim, Kyun Heo, Yoonwoo Lee, Hui Jeong Jang, et al. (+8)
79 [GO] 2024―Mar―04 Clinical and immunological features of COVID-19 in patients with anti-MDA5 dermatomyositis during the omicron wave in Chongqing, China Na Wu, Zhiwei Chen, Guanhua Zha, Zhiling Deng, Wenhan Huang, Dachuan Cai, et al. (+4)
80 [GO] 2024―Mar―04 Identifying COVID-19 subtypes by single-sample gene set enrichemnt analysis and providing guidance for sensitive drug selection Nan Xiong, Qiangming Sun
81 [GO] 2024―Mar―04 Improved fluorescence-based assay for rapid screening and evaluation of SARS-CoV-2 main protease inhibitors Rui Zhang, Haohao Yan, Jiahao Zhou, Gangan Yan, Xiaoping Liu, Chao Shang, Yunyu Chen
82 [GO] 2024―Mar―02 Retraction: “Safety and immunogenicity of a recombinant receptor-binding domain-based protein subunit vaccine (Noora vaccine™) against COVID-19 in adults: A randomized, double-blind, placebo-controlled, Phase 1 trial”
83 [GO] 2024―Feb―28 The characteristics of BCR-CDR3 repertoire in COVID-19 patients and SARS-CoV-2 vaccinated volunteers Jiaping Xiao, Yan Luo, Yangyang Li, Xinsheng Yao
84 [GO] 2024―Feb―25 Comment on “The risk assessment of uveitis after COVID-19 diagnosis” Patrick Wu, Chin-Yuan Yii, Su-Boon Yong
85 [GO] 2024―Feb―21 Effect of inactivated vaccine boosters against severe and critical COVID-19 during the Omicron BA.5 wave: A retrospective analysis of hospitalized patients in China Jiadi Gan, Huohuo Zhang, Jiaxuan Wu, Yi Liu, Pingping Liu, Ruixin Cheng, et al. (+4)
86 [GO] 2024―Feb―20 On coming back, the scaring COVID-19 concern. Addressing indoor microclimates with innovative and straightforward solutions to prevent SARS-CoV2 spreading Salvatore Chirumbolo, Umberto Tirelli
87 [GO] 2024―Feb―20 Effectiveness of nirmatrelvir-ritonavir on severe outcomes of COVID-19 in the era of vaccination and Omicron: An updated meta-analysis Sien Ombelet, Diego Castanares-Zapatero, Fabian Desimpel, Frank Hulstaert, Sabine Stordeur, Dominique Roberfroid
88 [GO] 2024―Feb―19 Type-II IFN inhibits SARS-CoV-2 replication in human lung epithelial cells and ex vivo human lung tissues through indoleamine 2,3-dioxygenase-mediated pathways Dong Yang, Jasper Fuk-Woo Chan, Chaemin Yoon, Tsz-Yat Luk, Huiping Shuai, Yuxin Hou, et al. (+17)
89 [GO] 2024―Feb―14 The impact of ABO blood types on humoral immunity responses and antibody persistency after different COVID-19 vaccine regimens Mona Sadat Larijani, Amir Javadi, Seyed Ebrahim Eskandari, Delaram Doroud, Fatemeh Ashrafian, Mohammad Banifazl, et al. (+3)
90 [GO] 2024―Feb―13 COVID-19 vaccine uptake, conspiracy theories, and health literacy among Black individuals in Canada: Racial discrimination, confidence in health, and COVID-19 stress as mediators Jude Mary Cénat, Seyed Mohammad Mahdi Moshirian Farahi, Rose Darly Dalexis, Sanni Yaya, Lisa Caulley, Marie-Hélène Chomienne
91 [GO] 2024―Feb―12 Comparative analysis of symptom profile and risk of death associated with infection by SARS-CoV-2 and its variants in Hong Kong Kin On Kwok, Wan In Wei, Edward B. Mcneil, Arthur Tang, Julian W.-T. Tang, Samuel Y. S. Wong, Eng Kiong Yeoh
92 [GO] 2024―Feb―12 A mouse xenograft long-term replication yields a SARS-CoV-2 Delta mutant with increased lethality Dongbum Kim, Minyoung Kim, Jinsoo Kim, Kyeongbin Baek, Heedo Park, Sangkyu Park, et al. (+13)
93 [GO] 2024―Feb―08 Additional analyses support superior efficacy of nirmatrelvir/ritonavir over molnupiravir for COVID-19 Li-Chen Chang, I-Wen Chen, Kuo-Chuan Hung
94 [GO] 2024―Feb―08 Genomic surveillance of omicron B.1.1.529 SARS-CoV-2 and its variants between December 2021 and March 2023 in Tamil Nadu, India-A state-wide prospective longitudinal study Sivaprakasam T. Selvavinayagam, Suvaiyarasan Suvaithenamudhan, Yean K. Yong, Kannan Hemashree, Manivannan Rajeshkumar, Anandhazhvar Kumaresan, et al. (+22)
95 [GO] 2024―Feb―07 Innate immune response to SARS-CoV-2 infection contributes to neuronal damage in human iPSC-derived peripheral neurons Vania Passos, Lisa M. Henkel, Jiayi Wang, Francisco J. Zapatero-Belinchón, Rebecca Möller, Guorong Sun, et al. (+13)
96 [GO] 2024―Feb―07 Dynamics of serum cross-neutralization capacity against SARS-CoV-2 Delta variant in convalescent COVID-19 patients Iulia Nedelcu, Paula Florian, Daniel Ion, Eliza Militaru, Anca Damalan, Costin-Ioan Popescu, Adriana Hristea
97 [GO] 2024―Feb―07 Landscape of T cell epitopes displays hot mutations of SARS-CoV-2 variant spikes evading cellular immunity Mengze Gan, Jinge Cao, Yandi Zhang, Hui Fu, Xiaosong Lin, Qi Ouyang, et al. (+3)
98 [GO] 2024―Feb―02 Machine learning versus multivariate logistic regression for predicting severe COVID-19 in hospitalized children with Omicron variant infection Pan Liu, Zixuan Xing, Xiaokang Peng, Mengyi Zhang, Chang Shu, Ce Wang, et al. (+9)
99 [GO] 2024―Feb―02 Reply to: Inspiratory muscle training for COVID-19: Benefits appear promising but findings remain uncertain Yusha Chen, Xuefeng Liu, Tong Zhaohui
100 [GO] 2024―Jan―31 Genetic characteristics involved in COVID-19 severity. The CARGENCORS case-control study and meta-analysis Anna Camps-Vilaró, Mel·lina Pinsach-Abuin, Irene R. Degano, Rafel Ramos, Ruth Martí-Lluch, Roberto Elosua, et al. (+15)
101 [GO] 2024―Jan―31 SARS-CoV-2 infections among pregnant women, 2020, Finland-Cross-testing of neutralization assays Jenni Virtanen, Essi M. Korhonen, Sami Salonen, Olli Vapalahti, Tarja Sironen, Anne J. Jääskeläinen
102 [GO] 2024―Jan―29 Neutralizing antibody response after immunization with a COVID-19 bivalent vaccine: Insights to the future Milena Silva Souza, Jéssica Pires Farias, Robert Andreata-Santos, Marianne Pereira Silva, Ruth Dálety da Silva Brito, Marcia Duarte Barbosa da Silva, et al. (+19)
103 [GO] 2024―Jan―29 Reconstitution of RNA cap methylation reveals different features of SARS-CoV-2 and SARS-CoV methyltransferases Miao He, Liu Cao, Lihong Liu, Xu Jin, Birong Zheng, Xue Liu, et al. (+13)
104 [GO] 2024―Jan―23 Study on the epidemiological characteristics of enterovirus among pediatric patients in Hangzhou, China: A comparison between the pre-COVID-19, COVID-19 pandemic, and post-COVID-19 periods Yanhong Sun, Jianming Zhou, Wenjian Nie, Dandan Tian, Qing Ye
105 [GO] 2024―Jan―23 Th2 and Th17-associated immunopathology following SARS-CoV-2 breakthrough infection in Spike-vaccinated ACE2-humanized mice Tianyi Zhang, Nicholas Magazine, Michael C. McGee, Mariano Carossino, Gianluca Veggiani, Konstantin G. Kousoulas, et al. (+2)
106 [GO] 2024―Jan―23 Generation of SARS-CoV-2 spike receptor binding domain mutants and functional screening for immune evaders using a novel lentivirus-based system Junli Jia, Emanuela Garbarino, Yuhang Wang, Jiaming Li, Minmin Song, Xin Zhang, et al. (+5)
107 [GO] 2024―Jan―19 Exploring the impact of ursodeoxycholic acid therapy on COVID-19 in a real-word setting Christophe Corpechot, Marie Verdoux, Marie Frank-Soltysiak, Jean-Charles Duclos-Vallée, Lamiae Grimaldi
108 [GO] 2024―Jan―19 Corrigendum to “A pilot study of the antiviral activity of anionic and cationic polyamidoamine dendrimers against the Middle East respiratory syndrome coronavirus
109 [GO] 2024―Jan―18 SuPAR, biomarkers of inflammation, and severe outcomes in patients hospitalized for COVID-19: The International Study of Inflammation in COVID-19 Alexi Vasbinder, Kishan Padalia, Ian Pizzo, Kristen Machado, Tonimarie Catalan, Feriel Presswalla, et al. (+27)
110 [GO] 2024―Jan―18 Unusual TSCM-like cells with poly-chemokine-receptor expression in a B-cell-depleted survivor of severe COVID-19 Addi Josua Romero-Olmedo, Axel Ronald Schulz, Dennis Das Gupta, Daniel Staudenraus, Heike Hirseland, Bärbel Camara, et al. (+6)
111 [GO] 2024―Jan―18 Pregnancy outcomes after frozen-thawed embryo transfer in women with COVID-19 history: A prospective cohort study Jialyu Huang, Yuxin Liu, Jiawei Wang, Dingfei Xu, Zhihui Huang, Mengxi Li, et al. (+9)
112 [GO] 2024―Jan―18 The prevalence of obstructive sleep apnea syndrome after COVID-19 infection Wen-Chun Lin, Meng-Che Wu, Yu-Hsun Wang, Che-Hsuan Lin, James Cheng-Chung Wei
113 [GO] 2024―Jan―18 Mucosal antibody response and SARS-CoV-2 shedding in patients with COVID-19 related olfactory dysfunction Shilpee Sharma, Anaïs Thiriard, Véronique Olislagers, Jerome R. Lechien, Marie-Hélène Jurion, Marie-Luce Delforge, et al. (+2)
114 [GO] 2024―Jan―18 One dose versus two doses of COVID-19 vaccine for the prevention of breakthrough infections among people previously infected with SARS-Cov-2 Fangjian Guo, Victor Adekanmbi, Christine D. Hsu, Efstathia Polychronopoulou, Abbey B. Berenson
115 [GO] 2024―Jan―18 Inspiratory muscle training for COVID-19: Benefits appear promising but findings remain uncertain Wei-Ting Wang, I-Wen Chen, Kuo-Chuan Hung
116 [GO] 2024―Jan―18 The swab site of the upper airways influences the diagnostic sensitivity for the omicron variant of SARS-CoV-2 Fynn Atzler, Florian Dahms, Gregor Paul, Stojan Perisic
117 [GO] 2024―Jan―18 SARS-CoV-2 NSP12 utilizes various host splicing factors for replication and splicing regulation Li Yang, Xiao-Tao Zeng, Rong-Hua Luo, Si-Xue Ren, Lin-Lin Liang, Qiu-Xia Huang, et al. (+6)
118 [GO] 2024―Jan―18 Differential pathogenic and molecular features in neurological infection of SARS-CoV-2 Omicron BA.5.2 and BA.2.75 and Delta Erlin Wang, Qiao-Jiang Yang, Xiang-Xiong Xu, Qing-Cui Zou, Yanghaopeng Long, Guanqin Ma, et al. (+4)
119 [GO] 2024―Jan―16 Correction to “Evaluation of the relationship between pentraxin 3 (PTX3) rs2305619 (281A/G) and rs1840680 (1449A/G) polymorphisms and the clinical course of COVID-19
120 [GO] 2024―Jan―10 Epidemiological characteristics of respiratory syncytial virus infection in pediatric patients before, during the COVID-19 pandemic and after easing of COVID-19 restrictive measures in China Lidan Hu, Yang Yang, Jianyu Lin, Qingtao Yan, Changxuan Sun, Ziqiao Li, et al. (+4)
121 [GO] 2024―Jan―09 Exploring gut-lung axis crosstalk in SARS-CoV-2 infection: Insights from a hACE2 mouse model Yu Zhang, Yifang Ma, Weiyang Sun, Xiaoyang Zhou, Ruixuan Wang, Peng Xie, et al. (+3)
122 [GO] 2024―Jan―08 Generation and characterization of a humanized ACE2 mouse model to study long-term impacts of SARS-CoV-2 infection Chang-Yong Choi, Kundlik Gadhave, Jason Villano, Andrew Pekosz, Xiaobo Mao, Hongpeng Jia
123 [GO] 2024―Jan―05 SARS-CoV-2 nucleocapsid antigen in plasma of children hospitalized for COVID-19 or with incidental detection of SARS-CoV-2 infection Nicolas Capelli, Léa Domitien Payet, Carmen Alcocer Cordellat, Amandine Pisoni, Ilka Engelmann, Philippe Van de Perre, et al. (+2)
124 [GO] 2024―Jan―05 Comment on Shao et al.'s “Risk factors associated with COVID-19 pneumonia in Chinese patients with pre-existing interstitial lung disease during the SARS-CoV-2 pandemic Hsiu-Ming Lee, Po-Cheng Shih, James Cheng-Chung Wei
125 [GO] 2024―Jan―05 Saliva-based Proteinase K method: A rapid and reliable diagnostic tool for the detection of SARS-COV-2 in children Min Jung Kim, Pil-gu Park, Su Jin Hwang, Seung Jun Bang, Jae Hwa Jung, Eun Bin Kown, et al. (+7)
126 [GO] 2024―Jan―05 CRISPR-Cas system: A promising tool for rapid detection of SARS-CoV-2 variants Jing Li, Kuo Zhang, Guigao Lin, Jinming Li
127 [GO] 2024―Jan―04 Association of nirmatrelvir for acute SARS-CoV-2 infection with subsequent Long COVID symptoms in an observational cohort study Matthew S. Durstenfeld, Michael J. Peluso, Feng Lin, Noah D. Peyser, Carmen Isasi, Thomas W. Carton, et al. (+7)
128 [GO] 2024―Jan―02 The mutation point of view of the SARS-CoV-2 HV.1 lineage Alessandra Ciccozzi, Pier Luigi Fiori, Marco Casu, Daria Sanna, Massimo Ciccozzi, Fabio Scarpa
129 [GO] 2024―Jan―01 Vaccination against influenza viruses reduces infection, not hospitalization or death, from respiratory COVID-19: A systematic review and meta-analysis Antonio E. Pontiroli, Francesco Scovenna, Valentina Carlini, Elena Tagliabue, Jimmy Martin-Delgado, Lucia La Sala, et al. (+2)
130 [GO] 2024―Jan―01 Rational prediction of immunogenicity clustering through cross-reactivity analysis of thirteen SARS-CoV-2 variants Ziteng Liang, Jincheng Tong, Ziqi Sun, Shuo Liu, Jiajing Wu, Xi Wu, et al. (+8)
131 [GO] 2023―Dec―27 Early recognition of a superinfection: This is the problem in the critically ill COVID-19 patients Francesco Alessandri, Gabriella d'Ettorre, Massimo Ciccozzi, Giuseppe Migliara, Valentina Baccolini, Francesco Pugliese, Giancarlo Ceccarelli
132 [GO] 2023―Dec―27 No emergence of resistance mutations in COVID-19 patients receiving nirmatrelvir/ritonavir Rosalía Palomino-Cabrera, Francisco Tejerina, Andrea Molero-Salinas, Cristina Veintimilla, Pilar Catalán, María Ferris, et al. (+5)
133 [GO] 2023―Dec―26 Nasopharyngeal neutrophilic-retention signatures could predict disease progression in early SARS-CoV-2 infection Furong Qi, Yingyin Cao, Yunyun Shen, Haiyan Wang, Dapeng Li, Qianting Yang, et al. (+2)
134 [GO] 2023―Dec―23 Clinical utility of quantitative immunoassays and surrogate virus neutralization tests for predicting neutralizing activity against the SARS-CoV-2 Omicron BA.1 and BA.5 variants Beomki Lee, Jae-Hoon Ko, Yong Chan Kim, Jin Yang Baek, Yoon Soo Park, Kyoung-Ho Song, et al. (+17)
135 [GO] 2023―Dec―23 Immunogenicity and safety of inactivated SARS-CoV-2 vaccines in people living with HIV: A longitudinal cohort study Jie Li, Ling Nie, Caiping Guo, Yuchuan Deng, Qiong Guo, Can Pang, et al. (+4)
136 [GO] 2023―Dec―22 Factors associated with prolonged viral shedding of SARS-CoV-2 Omicron variant infection in Shanghai: A multicenter, retrospective, observational study Wenbin Liu, Fangchen Gong, Xiangtao Zheng, Lei Pei, Xiaofeng Wang, Song Yang, et al. (+9)
137 [GO] 2023―Dec―20 Clinical performance of the STANDARD M10 SARS-CoV-2 rapid RT-PCR assay in patients visiting an emergency department Dong-hyun Lee, Eunhee Han, Soorack Ryu, Hyuk joong Choi, Jieun Kim, Jinyeong Kim, Mi Hyun Bae
138 [GO] 2023―Dec―19 Clinical and electrocardiographic correlates of myocardial dysfunction after COVID-19 in nonhospitalised patients in long-term follow-up. Data from the polish long-covid cardiovascular study Joanna Kapusta, Mateusz Babicki, Karolina Pieniawska-Śmiech, Żaneta Kałuzińska-Kołat, Damian Kołat, Piotr Jankowski, et al. (+4)
139 [GO] 2023―Dec―19 Azvudine and nirmatrelvir-ritonavir in hospitalized patients with moderate-to-severe COVID-19: Emulation of a randomized target trial Yiling Zhou, Yi Liu, Li Jiang, Renqing Zhang, Huohuo Zhang, Qingyang Shi, et al. (+12)
140 [GO] 2023―Dec―18 Outpatient randomized controlled trials to reduce COVID-19 hospitalization: Systematic review and meta-analysis David J. Sullivan, Daniele Focosi, Daniel F. Hanley, Mario Cruciani, Massimo Franchini, Jiangda Ou, et al. (+2)
141 [GO] 2023―Dec―16 Respiratory torque teno virus load at emergency department visit predicts intensive care unit admission of SARS-CoV-2 infected patients Linda Feghoul, Amandine Caillault, Olivier Peyrony, Maud Salmona, Marie-Laure Nere, Constance Delaugerre, et al. (+3)
142 [GO] 2023―Dec―16 Long COVID during the Omicron predominant waves among Japanese healthcare workers Yunfei Li, Shohei Yamamoto, Kumi Horii, Tetsuya Mizoue, Maki Konishi, Haruhito Sugiyama, et al. (+2)
143 [GO] 2023―Dec―15 Autoantibodies against angiotensin-converting enzyme 2 (ACE2) after COVID-19 infection or vaccination James Yiu Hung Tsoi, Jianpiao Cai, Jianwen Situ, Winston Jim Lam, Estie Hon Kiu Shun, Joy Ka Yi Leung, et al. (+10)
144 [GO] 2023―Dec―13 Dynamically adjustable SVEIR(MH) model of multiwave epidemics: Estimating the effects of public health measures against COVID-19 Zuo-jing Yin, Han Xiao, Stuart McDonald, Vladimir Brusic, Tian-yi Qiu
145 [GO] 2023―Dec―13 Competitive fitness and homologous recombination of SARS-CoV-2 variants of concern Qi Chen, Si Qin, Hang-Yu Zhou, Yong-Qiang Deng, Pan-Deng Shi, Hui Zhao, et al. (+11)
146 [GO] 2023―Dec―12 Live-virus serum neutralization after bivalent SARS-CoV-2 mRNA vaccination in hemodialysis patients Louise Benning, Marie Bartenschlager, Heeyoung Kim, Florian Kälble, Christian Nusshag, Mirabel Buylaert, et al. (+7)
147 [GO] 2023―Dec―12 Low neutralization of SARS-CoV-2 Omicron BA.5.2.48, BF.7.14, XBB.1 subvariants by homologous or heterologous booster Jianhua Li, Haiyan Mao, Wanchen Song, Yin Chen, Yan Feng, Jiaxuan Li, et al. (+7)
148 [GO] 2023―Dec―08 Posttranslational modifications of ACE2 protein: Implications for SARS-CoV-2 infection and beyond Yingzi Xiao, Le Chang, Huimin Ji, Huizhen Sun, Shi Song, Kaihao Feng, et al. (+6)
149 [GO] 2023―Dec―08 Antibody responses to SARS-CoV-2 Omicron infection in patients with hematological malignancies: A multicenter, prospective cohort study Jun Li, Yi Liu, Xia Wei, Zhanshu Liu, Zailiang Yang, Ling Liu, et al. (+41)
150 [GO] 2023―Dec―06 Eliminating COVID-19 as the immediate culprit for igniting pancreatitis Peng Ge, Yalan Luo, Jie Liu, Jin Liu, Haiyun Wen, Guixin Zhang, Hailong Chen
151 [GO] 2023―Dec―06 Evolution of neutralizing antibodies through vaccination and breakthrough infections in the era of COVID-19 endemicity Jinyoung Yang, Hye-Jin Kim, Jun-Won Kim, Jin Yang Baek, Young Jae Lee, Ju-yeon Choi, et al. (+9)
152 [GO] 2023―Dec―06 Metabolic alterations unravel the maternofetal immune responses with disease severity in pregnant women infected with SARS-CoV-2 Sandhya Hora, Prabhjyoti Pahwa, Hamda Siddiqui, Anoushka Saxena, Minal Kashyap, Jayesh K. Sevak, et al. (+11)
153 [GO] 2023―Dec―06 Nasal spray of an IgM-like ACE2 fusion protein HH-120 prevents SARS-CoV-2 infection: Two investigator-initiated postexposure prophylaxis trials Rui Song, Xiaoyou Chen, Baoliang Li, Jun Ni, Yunao Zhou, Hongbin Zhang, et al. (+12)
154 [GO] 2023―Dec―05 Omicron induced distinct immune respiratory transcriptomics signatures compared to pre-existing variants in critically ill COVID-19 patients Pierre Bay, Christophe Rodriguez, Stefano Caruso, Vanessa Demontant, Laure Boizeau, Alexandre Soulier, et al. (+5)
155 [GO] 2023―Dec―04 SARS-CoV-2 nucleocapsid protein enhances the level of mitochondrial reactive oxygen species Haiyun Yu, Lu Yang, Zhennan Han, Xiaoyu Zhou, Zihan Zhang, Tianli Sun, et al. (+5)
156 [GO] 2023―Dec―01 Assessing risk factors for COVID-19 pneumonia in Chinese patients with pre-existing interstitial lung disease Po-Yu Huang, Chih-Cheng Lai, Chi-Kuei Hsu
157 [GO] 2023―Nov―28 Nutritional deficiency anemia and post-acute sequelae in patients with severe acute respiratory syndrome coronavirus 2 infection: A six-month retrospective cohort analysis of 30 892 patients Jheng-Yan Wu, Mei-Yuan Liu, Kuo-Chuan Hung, Wan-Hsuan Hsu, Ya-Wen Tsai, Ting-Hui Liu, et al. (+5)
158 [GO] 2023―Nov―28 Resurgence of influenza during COVID-19 in Chongqing, China: A retrospective analysis Zhourong Li, Yu Xiong, Jiang Long, Tingting Li, Xiaoqing Fu, Shuang Yang, et al. (+3)
159 [GO] 2023―Nov―28 Virological characteristics and the rapid antigen test as deisolation criteria in immunocompromised patients with COVID-19: A prospective cohort study Sung-Woon Kang, Jun-Won Kim, Ji Yeun Kim, So Yun Lim, Choi-Young Jang, Euijin Chang, et al. (+7)
160 [GO] 2023―Nov―27 High sera levels of SARS-CoV-2 N antigen are associated with death in hospitalized COVID-19 patients Houssem Redha Chenane, Guillaume Lingas, Reyene Menidjel, Cédric Laouenan, Sarah Tubiana, Diane Descamps, et al. (+9)
161 [GO] 2023―Nov―27 Acne and COVID-19 susceptibility, hospitalization, and severity: A genetic correlation study Rui Mao, Zhihua Fan, Meihui He, Ji Li
162 [GO] 2023―Nov―27 Serological analysis of severe acute respiratory syndrome coronavirus 2 infection in children with Kawasaki disease Yotaro Kondo, Yoshiki Kawamura, Fumihiko Hattori, Hidetaka Nakai, Kazuyoshi Saito, Daijiro Suzuki, et al. (+2)
163 [GO] 2023―Nov―27 Unraveling the evolutionary patterns and phylogenomics of coronaviruses: A consensus network approach Geng-Ming Hu, Yu-Chen Tai, Chi-Ming Chen
164 [GO] 2023―Nov―27 Molecular PET/CT mapping of rhACE2 distribution and quantification in organs to aid in SARS-CoV-2 targeted therapy Zilei Wang, Chuanke Zhao, Chuangui Li, Song Liu, Jin Ding, Chengxue He, et al. (+6)
165 [GO] 2023―Nov―22 The breadth of the neutralizing antibody response to original SARS-CoV-2 infection is linked to the presence of Long COVID symptoms Amanda M. Buck, Amelia N. Deitchman, Saki Takahashi, Scott Lu, Sarah A. Goldberg, Aaron Bodansky, et al. (+18)
166 [GO] 2023―Nov―16 Superior neutralizing response after first versus second SARS-CoV-2 infection in fully vaccinated individuals Gonzalo Rivas, Nuria Labiod, Joanna Luczkowiak, Fátima Lasala, Marta Rolo, Mikel Mancheño-Losa, et al. (+5)
167 [GO] 2023―Nov―15 Integrative proteomics and metabolomics study reveal enhanced immune responses by COVID-19 vaccine booster shot against Omicron SARS-CoV-2 infection Beili Wang, Wenjing Yang, Yexin Tong, Mingjun Sun, Sheng Quan, Jing Zhu, et al. (+14)
168 [GO] 2023―Nov―15 Application of whole-genome tiling array at Shanghai port, China: An alternative method for SARS-CoV-2 surveillance Danlei Liu, Zhiyi Wang, Mao Mao, Zilei Zhang, Xun Ding, Huajun Zheng, et al. (+3)
169 [GO] 2023―Nov―10 Discovery of the covalent SARS-CoV-2 Mpro inhibitors from antiviral herbs via integrating target-based high-throughput screening and chemoproteomic approaches Ya-Ni Zhang, Guang-Hao Zhu, Wei Liu, Xi-Xiang Chen, Yuan-Yuan Xie, Jian-Rong Xu, et al. (+5)
170 [GO] 2023―Nov―08 Predictors of disease severity in SARS-CoV-2 omicron variant XBB sublineages and variants of interest Jinghao Nicholas Ngiam, Oon Tek Ng, Matthias Paul Han Sim Toh, Qi Gao, Ai Jia Soong, Joel Han Wen Teo, et al. (+10)
171 [GO] 2023―Nov―07 Development of a rapid, sensitive detection method for SARS-CoV-2 and influenza virus based on recombinase polymerase amplification combined with CRISPR-Cas12a assay Yuning Wang, Liqiang Wu, Xiaomei Yu, Gang Wang, Ting Pan, Zhao Huang, et al. (+5)
172 [GO] 2023―Nov―06 Genomic epidemiology of the main SARS-CoV-2 variants in Italy between summer 2020 and winter 2021 Annalisa Bergna, Alessia Lai, Carla Della Ventura, Bianca Bruzzone, Alessandro Weisz, Morena d'Avenia, et al. (+28)
173 [GO] 2023―Nov―06 Risk factors of long COVID 6-12 months after infection with the Omicron variant among nonhospitalized patients Guangting Zeng, Zanling Zhang, Linlin Wang, Jianqiang Li
174 [GO] 2023―Nov―03 Investigating the Impact of Sinopharm COVID-19 Vaccination on Antibody Response in Pregnant Women and Their Newborns Tahoora Abdolahi, Gholamali Maamouri, Maryam Behmadi, Sara Mirzaeian, Hassan Boskabadi, Raheleh Faramarzi
175 [GO] 2023―Nov―03 Comparison of anti-nucleocapsid antibody assays for the detection of SARS-CoV-2 Omicron vaccine breakthroughs after various intervals since the infection David Niklas Springer, Elisabeth Reuberger, Christian Borsodi, Elisabeth Puchhammer-Stöckl, Lukas Weseslindtner
176 [GO] 2023―Nov―02 Interstitial lung diseases and COVID-19 pneumonia Ranjeet S. Mahla
177 [GO] 2023―Nov―02 Tracking antigen-specific TCR clonotypes in SARS-CoV-2 infection reveals distinct severity trajectories Ik Soo Kim, Chang Kyung Kang, Seung Jae Lee, Chang-Han Lee, Minji Kim, Chaehwa Seo, et al. (+15)
178 [GO] 2023―Nov―02 SARS-CoV-2 ORF7a blocked autophagy flux by intervening in the fusion between autophagosome and lysosome to promote viral infection and pathogenesis Shun Li, Xiaobo Li, Haowei Liang, Kuike Yu, Jingbo Zhai, Mengzhou Xue, et al. (+3)
179 [GO] 2023―Oct―26 The risk assessment of uveitis after COVID-19 diagnosis: A multicenter population-based study Ning-Yi Hsia, Alan Y. Hsu, Yu-Hsun Wang, Jing-Xing Li, Huan-Sheng Chen, James Cheng-Chung Wei, et al. (+2)
180 [GO] 2023―Oct―26 Clinical and pathological features of omicron variant of SARS-CoV-2-associated kidney injury Zhiwen Qi, Shuguang Yuan, Jinying Wei, Shiyu Xia, Yao Huang, Xiaojun Chen, et al. (+8)
181 [GO] 2023―Oct―25 Characterization of B-cell receptor clonality and immunoglobulin gene usage at multiple time points during active SARS-CoV-2 infection Evgeny Arons, Kiersten Henry, Christopher Haas, Mory Gould, Jack Tsintolas, Jack Mauter, et al. (+4)
182 [GO] 2023―Oct―20 Viral codon optimization on SARS-CoV-2 Spike boosts immunity in the development of COVID-19 mRNA vaccines Chih-Jen Lai, Dokyun Kim, Seokmin Kang, Kun Li, Inho Cha, Akimi Sasaki, et al. (+3)
183 [GO] 2023―Oct―19 Increased population susceptibility to seasonal influenza during the COVID-19 pandemic in China and the United States Qing Wang, Mengmeng Jia, Mingyue Jiang, Yanlin Cao, Peixi Dai, Jiao Yang, et al. (+4)
184 [GO] 2023―Oct―19 Response to the Letter to the Editor on “Bacterial and fungal superinfections are detected at higher frequency in critically ill patients affected by SARS-CoV-2 infection than negative patients and are associated to a worse outcome” Maria Antonia De Francesco, Simone Piva, Simone Pellizzeri, Liana Signorini, Benedetta Fumarola, Silvia Corbellini, et al. (+9)
185 [GO] 2023―Oct―18 Regarding the article Causal effect of COVID-19 on Alzheimer's disease: A Mendelian randomization study by Baranova et al. Hanieh Mohammadi-Pilehdarboni, Mohammad Shenagari
186 [GO] 2023―Oct―16 Epidemiology of influenza A outbreak among children after COVID-19: A single-center retrospective observational study Tiewei Li, Ning Chen, Xuchen Wang, Nan Chen, Zhipeng Jin, Panpan Fang, et al. (+4)
187 [GO] 2023―Oct―16 Structural basis of the American mink ACE2 binding by Y453F trimeric spike glycoproteins of SARS-CoV-2 Hyunjun Ahn, Brenda M. Calderon, Xiaoyu Fan, Yunrong Gao, Natalie L. Horgan, Nannan Jiang, et al. (+10)
188 [GO] 2023―Oct―16 Evaluation of a smartphone-operated point-of-care device using loop-mediated isothermal amplification technology for rapid and remote detection of SARS-CoV-2 Eline Meyers, JeongHo Park, Anja Coen, Leen Raman, Stefan Heytens, Joowon Rhee, et al. (+2)
189 [GO] 2023―Oct―16 First detection of SARS-CoV-2 BA.2.86.1 in Italy Francesca Caccuri, Serena Messali, Fabio Scarpa, Marta Giovanetti, Massimo Ciccozzi, Arnaldo Caruso
190 [GO] 2023―Oct―12 The impact of the COVID-19 pandemic on the prevalence and genotype distribution of HPV infection in Beijing, China Jie Yi, Xu Li, Rui Zhang, Lingjun Kong, Ziyi Wang, Qi Yu, et al. (+5)
191 [GO] 2023―Oct―12 Its all about IFN-λ4: Protective role of IFNL4 polymorphism against COVID-19-related pneumonia in females Sanja Matic, Dragan Milovanovic, Zeljko Mijailovic, Predrag Djurdjevic, Predrag Sazdanovic, Srdjan Stefanovic, et al. (+12)
192 [GO] 2023―Oct―12 Comprehensive evaluation of the effect of inactivated SARS-CoV-2 vaccination on female fertility: A retrospective cohort study Zaihua Ba, Aijun Yang, Shiheng Zhu, Yuqi Li, Jiao Ma, Yingze Zhang, et al. (+2)
193 [GO] 2023―Oct―12 Emergence of a second SARS-CoV-2 variant with a tremendous genetic leap from its ancestors Philippe Colson, Bernard La Scola, Mamadou Beye, Jérémy Delerce, Didier Raoult, Jacques Fantini
194 [GO] 2023―Oct―12 Early humoral and cellular responses after bivalent SARS-CoV-2 mRNA-1273.214 vaccination in long-term care and retirement home residents in Ontario, Canada: An observational cohort study Jessica A. Breznik, Ahmad Rahim, Hina Bhakta, Rumi Clare, Ali Zhang, Jann Ang, et al. (+11)
195 [GO] 2023―Oct―12 Alleviated symptoms of SARS-CoV-2 Omicron variant infection in chronic hepatitis B patients with immune control Jing Liu, Huiqing Zhang, Jianing Kong, Shiyi Liu, Liping Chen, Yanming Jiang, et al. (+10)
196 [GO] 2023―Oct―12 Subunit vaccine raised against the SARS-CoV-2 spike of Delta and Omicron variants Sheng Feng, Zechang Fan, Keyue Zhou, Shanshan Ma, Mingzheng Liang, He Zhang, et al. (+4)
197 [GO] 2023―Oct―10 CoronaVac and BBIBP-CorV vaccines against SARS-CoV-2 during predominant circulation of Omicron BA.5.2 and BF.7 in China, a retrospective cohort study Zhanwei Hu, Zhou Jin, Mengyun Zhou, Chunbo Zhang, Yingcong Bao, Xinran Gao, Guangfa Wang
198 [GO] 2023―Oct―08 Reduced neutralization and Fc effector function to Omicron subvariants in sera from SARS-CoV-1 survivors after two doses of CoronaVac plus one dose subunit vaccine Danying Chen, Xinglin Li, Xiaohua Hao, Yaruo Qiu, Yanjun Song, Hui Sun, et al. (+10)
199 [GO] 2023―Oct―08 Repurposing Navitoclax to block SARS-CoV-2 fusion and entry by targeting heptapeptide repeat sequence 1 in S2 protein Fanke Jiao, Alexander M. Andrianov, Lijue Wang, Konstantin V. Furs, Anna V. Gonchar, Qian Wang, et al. (+5)
200 [GO] 2023―Oct―07 Maternal antibody transfer rate of vaccination against SARS-CoV-2 before or during early pregnancy and its protective effectiveness on offspring Shuang Liu, Ping Wang, Xiaolu Shi, Tingsong Weng, Jiayi Zhong, Xiaomin Zhang, et al. (+9)
201 [GO] 2023―Oct―06 The return of the “Mistigri” (virus adaptative gain by gene loss) through the SARS-CoV-2 XBB.1.5 chimera that predominated in 2023 Philippe Colson, Jérémy Delerce, Jacques Fantini, Pierre Pontarotti, Bernard La Scola, Didier Raoult
202 [GO] 2023―Oct―04 COVID-19 mRNA vaccine, but not a viral vector-based vaccine, promotes neutralizing anti-type I interferon autoantibody production in a small group of healthy individuals Wanli Xu, Xiaoting Wen, Xiaomei Cong, Wei Jiang
203 [GO] 2023―Oct―04 Humoral and cellular immune responses in fully vaccinated individuals with or without SARS-CoV-2 breakthrough infection: Results from the CoV-ADAPT cohort Moritz M. Hollstein, Sascha Dierks, Michael P. Schön, Armin Bergmann, Anna Abratis, Abass Eidizadeh, et al. (+10)
204 [GO] 2023―Oct―03 Associations between COVID-19 therapies and inpatient gastrointestinal bleeding: A multisite retrospective study Noah A. Wiedel, Harlan Sayles, Jessica Larson, Jana L. Wardian, Alexander Hewlett, James McClay, et al. (+2)
205 [GO] 2023―Sep―29 The association of sickle cell disorder with adverse outcomes in COVID-19 patients: A meta-analysis Tianyi Liang, Kaixin Guo, Peng Ni, Guangcai Duan, Rongguang Zhang
206 [GO] 2023―Sep―29 Long-term dynamic shifts in genomic base content and evolutionary trajectories of SARS-CoV-2 variants Xinjie Li, Yuqi Zhang, Jie Wang, Jun Han, Tao Shen
207 [GO] 2023―Sep―29 Fitness evaluation of SARS-CoV-2 variants: A retrospective study Mingda Hu, Xin Wang, Beiping Li, Boqian Wang, Yunxiang Zhao, Zili Chai, et al. (+3)
208 [GO] 2023―Sep―28 Considerations regarding the long-term risk of herpes zoster following COVID-19 Han-Lin Shih, Yi-Ting Lee, Cheuk-Kwan Sun, Renin Chang
209 [GO] 2023―Sep―26 A conserved N protein nano-vaccine of COVID-19 exerts potent and cross-reactive humoral and cellular immune responses in mice Bing Li, Jing Zhang, Yang Huang, Xinrui Li, Jing Feng, Yan Li, Rongxin Zhang
210 [GO] 2023―Sep―26 The binding profile of SARS-CoV-2 with human leukocyte antigen polymorphisms reveals critical alleles involved in immune evasion Yan Zhan, Ling Ye, Qianying Ouyang, Jiye Yin, Jiajia Cui, Ke Liu, et al. (+6)
211 [GO] 2023―Sep―21 Association of seizure with COVID-19 vaccines in persons with epilepsy: A systematic review and meta-analysis Ali Rafati, Melika Jameie, Mobina Amanollahi, Mana Jameie, Yeganeh Pasebani, Delaram Sakhaei, et al. (+6)
212 [GO] 2023―Sep―19 Infection with COVID-19 is no longer a public emergency: But what about degenerative dementia? Burak Yulug, Behçet Ayyıldız, Sevilay Ayyıldız, Dila Sayman, Ali Behram Salar, Seyda Cankaya, et al. (+9)
213 [GO] 2023―Sep―19 Molecular epidemiology of SARS-CoV-2 variants in circulation in the state of Maranhão, Brazil Luis Artur Ferreira de Sousa, Lucas Salomão de Sousa Ferreira, Luis Felipe Lima Lobato, Hivylla Lorrana dos Santos Ferreira, Lucas Henrique dos Santos Sousa, Valdenice Ferreira dos Santos, et al. (+9)
214 [GO] 2023―Sep―18 Clinical effectiveness of oral antiviral agents in older patients with COVID-19 based on real-world data Ya-Wen Tsai, Jheng-Yan Wu, Ting-Hui Liu, Min-Hsiang Chuang, Wan-Hsuan Hsu, Po-Yu Huang, et al. (+3)
215 [GO] 2023―Sep―14 Risk factors associated with COVID-19 pneumonia in Chinese patients with pre-existing interstitial lung disease during the SARS-CoV-2 pandemic Chi Shao, Yujie Shi, Ruxuan Chen, Xiangning Liu, Hui Huang, Yang Zhao, et al. (+4)
216 [GO] 2023―Sep―14 Risk of cytomegalovirus diseases among coronavirus disease survivors: A retrospective cohort study Bin Zhang, Ya-Wen Tsai, Jheng-Yan Wu, Ting-Hui Liu, Min-Hsiang Chuang, Wan-Hsuan Hsu, et al. (+2)
217 [GO] 2023―Sep―14 Whole genome CRISPR screening strategy to identify genes contributing to SARS-CoV-2 spike and VSV-G mediated entry Md. Saddam Hossain, Jason G. Kerkvliet, Adam D. Hoppe
218 [GO] 2023―Sep―12 Baseline gut microbiome features prior to SARS-CoV-2 infection are associated with host symptoms in and post COVID-19 Tao Zuo, Guanzhan Liang, Ziyu Huang, Zhirui Cao, Feiyu Bai, Yingqian Zhou, et al. (+6)
219 [GO] 2023―Sep―12 Long-term risk of herpes zoster following COVID-19: A retrospective cohort study of 2 442 686 patients Shih-Wei Huang, Wen-Bin Yeh, Hui-Yuan Chen, Su-Boon Yong
220 [GO] 2023―Sep―12 Response to the Letter to the Editor on “Clinical characteristics of unvaccinated or incompletely vaccinated children with neurological manifestations due to SARS-CoV-2 Omicron infection” Winnie W.-Y. Tso, Mike Y.-W. Kwan, Patrick Ip, Jasper F.-W. Chan
221 [GO] 2023―Sep―12 Examination of autoantibodies to type I interferon in patients suffering from long COVID Kristoffer Skaalum Hansen, Sofie Eg Jørgensen, Morten Kelder Skouboe, Jane Agergaard, Berit Schiøttz-Christensen, Line Khalidan Vibholm, et al. (+4)
222 [GO] 2023―Sep―11 Comment on Tsai et al.'s “clinical effectiveness of oral antiviral agents in older patients with COVID-19 based on real-world data” Wei-Min Chu, Tsung-Hsueh Hsieh, James Cheng-Chung Wei
223 [GO] 2023―Sep―11 Comparison of semen parameters in the same patients before and after diagnosis of COVID-19 Cihan Cakir, Goktan Kuspinar, Gizem Kurt, Miray Berber, Kiper Aslan, Isil Kasapoglu, et al. (+2)
224 [GO] 2023―Sep―11 CRISPR dual enzyme cleavage triggers DNA and RNA substrate cleavage for SARS-CoV-2 dual gene detection Tong Jiang, Runde Liu, Jilu Shen
225 [GO] 2023―Sep―07 Infection with critically ill COVID-19 increases the risk of cardioembolic stroke Jin Ma, Shizheng Qiu
226 [GO] 2023―Sep―07 Ethno-demographic disparities in humoral responses to the COVID-19 vaccine among healthcare workers Pankaj Ahluwalia, Ashutosh Vashisht, Harmanpreet Singh, Nikhil Shri Sahajpal, Ashis K. Mondal, Kimya Jones, et al. (+18)
227 [GO] 2023―Sep―07 Exploring the mechanisms of long COVID: Insights from computational analysis of SARS-CoV-2 gene expression and symptom associations Sanisha Das, Suresh Kumar
228 [GO] 2023―Sep―06 Nirmatrelvir/ritonavir for the treatment of immunocompromised adult patients with early-stage symptomatic COVID-19: A real-life experience José María Caso, Mario Fernández-Ruiz, Francisco López-Medrano, José Manuel Caro-Teller, Manuel Lizasoain, Rafael San-Juan, et al. (+4)
229 [GO] 2023―Sep―06 SARS-CoV-2 infection of polarized human airway epithelium induces necroptosis that causes airway epithelial barrier dysfunction Siyuan Hao, Kang Ning, Cagla A. Kuz, Min Xiong, Wei Zou, Soo Y. Park, et al. (+3)
230 [GO] 2023―Sep―05 On the SARS-CoV-2 BA.2.86 lineage: a mutation point of view Fabio Scarpa, Massimo Ciccozzi
231 [GO] 2023―Sep―04 Genetic and structural analyses reveal the low potential of the SARS-CoV-2 EG.5 variant Fabio Scarpa, Stefano Pascarella, Alessandra Ciccozzi, Marta Giovanetti, Ilenia Azzena, Chiara Locci, et al. (+6)
232 [GO] 2023―Aug―31 Correction to “Safety and immunogenicity of COVID-19 vaccination in patients with hepatocellular carcinoma (CHESS-NMCID 2101): A multicenter prospective study”
233 [GO] 2023―Aug―31 Arbidol increases the survival rate by mitigating inflammation in suckling mice infected with human coronavirus OC43 virus Hongxia Zhou, Peifang Xie, Minshan Qiu, Shuwei Dong, Xueshan Xia, Zifeng Yang, et al. (+2)
234 [GO] 2023―Aug―31 Perturbations in spike-specific peripheral T follicular helper cells in SARS-CoV2 breakthrough convalescent individuals immunized by BBV152 vaccine Soumya Sengupta, Shubham K. Shaw, Sanchari Chatterjee, Gargee Bhattacharya, Prakash K. Barik, Soma Chattopadhyay, Satish Devadas
235 [GO] 2023―Aug―29 Antibody response following the fourth SARS-CoV-2 vaccine dose during the Omicron wave in Brazil Maria Francilene Souza Silva, Fátima de Cássia Evangelista de Oliveira, Ana Carolina M. Dinelly Pinto, Maria Claudia dos S. Luciano, Max Moreira Lizano Garcia, Fernanda Montenegro de C. Araújo, Marcela H. Gambim Fonseca
236 [GO] 2023―Aug―28 Co-delivery of a trimeric spike DNA and protein vaccine with aluminum hydroxide enhanced Th1-dominant humoral and cellular immunity against SARS-CoV-2 Hung-Chun Liao, Min-Syuan Huang, Fang-Feng Chiu, Kit Man Chai, Ching-Len Liao, Suh-Chin Wu, et al. (+2)
237 [GO] 2023―Aug―25 Association of inactivated COVID-19 vaccination with maternal coagulation function in early pregnancy Yan Zhao, Yongbo Zhao, Jianlong Zhu, Lei Lei, Baohua Zhang, Xianghong Xu, Liping Jin
238 [GO] 2023―Aug―25 Long-term SARS-CoV-2 neutralizing antibody level prediction using multimodal deep learning: A prospective cohort study on longitudinal data in Wuhan, China Cong Fang, Weiming Yan, Yuying Chen, Zhiyong Dou, Tingting Liu, Fengning Luo, et al. (+13)
239 [GO] 2023―Aug―24 COVID-19 infection after oocyte retrieval did not have detrimental effects on embryo implantation for frozen embryo transfer Haiyan Guo, Mingru Yin, Yali Liu, Bian Wang, Jiaying Lin, Qianqian Zhu
240 [GO] 2023―Aug―24 SARS-CoV-2 seroprevalence and vaccine coverage from August to November 2021: A nationally representative survey in Mexico Ana Basto-Abreu, Martha Carnalla, Leticia Torres-Ibarra, Andres Sanchez-Pájaro, Martin Romero-Martínez, Jesus Martínez-Barnetche, et al. (+6)
241 [GO] 2023―Aug―22 Cytokines, chemokines, and cells growth factors in patients with mild to moderate SARS-CoV-2 infection: A case-control study Rafhaella N. D. G. Gondim, Erico Antônio Gomes de Arruda, Roberto da Justa Pires Neto, Melissa Soares Medeiros, José Quirino-Filho, Marco A. Clementino, et al. (+7)
242 [GO] 2023―Aug―22 Efficacy and safety of Oral LL-37 against the Omicron BA.5.1.3 variant of SARS-COV-2: A randomized trial Yiming Zhao, Hanlin Zhang, Zhizhuang Zhao, Fangfang Liu, Meng Dong, Li Chen, et al. (+14)
243 [GO] 2023―Aug―19 Reinfection with SARS-CoV-2 Omicron BA.4 and BA.5 variants Nhu Ngoc Nguyen, Linda Houhamdi, Line Meddeb, Philippe Colson, Philippe Gautret
244 [GO] 2023―Aug―17 COVID-19 has causal effects on cancer risk? Something we might ignore Zhen Sun, Siying Wang, Xiaoxiao Sun, Yaoping Shi, Haojie Jin
245 [GO] 2023―Aug―16 Impaired systemic nucleocapsid antigen clearance in severe COVID-19 Christian Bauer, Elisabeth Mack, Véronique Hefter, Alexandra Fischer, Kirsten Volland, Chrysanthi Skevaki, et al. (+4)
246 [GO] 2023―Aug―11 Molecular and immune signatures, and pathological trajectories of fatal COVID-19 lungs defined by in situ spatial single-cell transcriptome analysis Arun Das, Wen Meng, Zhentao Liu, Md Musaddaqul Hasib, Hugh Galloway, Suzane Ramos da Silva, et al. (+12)
247 [GO] 2023―Aug―10 Omicron breakthrough infections in wild-type SARS-CoV-2 vaccinees elicit high levels of neutralizing antibodies against pangolin coronavirus GX_P2V Shanshan Lu, Shengdong Luo, Bingke Bai, Zhenping Fan, Bixia Hong, Wen Xu, et al. (+5)
248 [GO] 2023―Aug―10 Ancestral SARS-CoV-2 and Omicron BA.5-specific neutralizing antibody and T-cell responses after Omicron bivalent booster vaccination in previously infected and infection-naive individuals Willem A. Mak, Wendy Visser, Marijke van der Vliet, Hilde Y. Markus, Johannes G. M. Koeleman, David S. Y. Ong
249 [GO] 2023―Aug―09 Factors associated with antibody titer levels among an occupational cohort of fully vaccinated individuals and subsequent risk of COVID-19 infection: A cohort study Erin B. Wasserman, Allen K. Sills, Damion Martins, Anthony Casolaro, Patti Walton, Deverick Anderson, et al. (+6)
250 [GO] 2023―Aug―07 Role of tixagevimab-cilgavimab in preventing SARS-CoV-2 in hematopoietic stem cell transplant and chimeric antigen receptor T-cell therapy recipients Aswani Thurlapati, Mary McGann, James A. Davis, Katelynn Granger, Kiera Roubal, Deidra Smith, et al. (+6)
251 [GO] 2023―Aug―07 Epidemic history and evolution of an emerging threat of international concern, the severe acute respiratory syndrome coronavirus 2 Marta Giovanetti, Francesco Branda, Eleonora Cella, Fabio Scarpa, Liliana Bazzani, Alessandra Ciccozzi, et al. (+14)
252 [GO] 2023―Aug―07 The short and long-term impact of nonpharmaceutical interventions on the prevalence of varicella in Xi'an during the COVID-19 pandemic Yao Bai, Li Shen, Minghao Sun, Zurong Yang, Zhijun Chen, Jingbo Zhai, et al. (+4)
253 [GO] 2023―Aug―07 Inactivated vaccine fueled adaptive immune responses to Omicron in 2-year COVID-19 convalescents Maoshun Liu, Jie Zhang, Lei Li, Jinmin Tian, Mengjie Yang, Bingli Shang, et al. (+16)
254 [GO] 2023―Aug―06 Sapovirus infections in Japan before and after the emergence of the COVID-19 pandemic: An alarming update Sheikh Ariful Hoque, Ngan Thi Kim Pham, Yuko Onda-Shimizu, Shuichi Nishimura, Kumiko Sugita, Masaaki Kobayashi, et al. (+6)
255 [GO] 2023―Aug―04 Genomic analysis of SARS-CoV-2 in forensic autopsy cases of COVID-19 Yuichiro Hirata, Harutaka Katano, Shun Iida, Sohtaro Mine, Sayaka Nagasawa, Yohsuke Makino, et al. (+13)
256 [GO] 2023―Aug―04 Epidemiology of respiratory syncytial virus outbreak among children after the COVID-19 pandemic Xiaojuan Li, Nan Chen, Xuchen Wang, Tiewei Li
257 [GO] 2023―Aug―04 Incidence and severity of SARS-CoV-2 reinfection, a multicenter cohort study in Shanghai, China Weien Yu, Yue Guo, Tiantian Hu, Yuqi Liu, Qingqi Fan, Li Guo, et al. (+16)
258 [GO] 2023―Aug―03 Deciphering the evolutionary mechanisms of SARS-CoV-2: Absence of ORF8 protein and its potential advantage in the emergence of viral lineages Lauro Velazquez-Salinas
259 [GO] 2023―Jul―31 Azvudine therapy of common COVID-19 in hemodialysis patients Shunlai Shang, Bo Fu, Yanqiu Geng, Jian Zhang, Dawei Zhang, Fenglin Xiao, et al. (+6)
260 [GO] 2023―Jul―31 Effectiveness of oral antiviral agents on long-term cardiovascular risk in nonhospitalized patients with COVID-19: A multicenter matched cohort study Ting-Hui Liu, Min-Hsiang Chuang, Jheng-Yan Wu, Po-Yu Huang, Ya-Wen Tsai, Wan-Hsuan Hsu, Chih-Cheng Lai
261 [GO] 2023―Jul―31 Paxlovid reduces the risk of Long COVID in patients six months after hospital discharge Yu Wang, Danyang Zhao, Wenying Xiao, Jun Shi, Wei Chen, Qin Jia, et al. (+4)
262 [GO] 2023―Jul―29 COVID-19-induced autoimmune thyroiditis: Exploring molecular mechanisms Bita Mohammadi, Kamal Dua, Mohammadreza Saghafi, Sachin Kumar Singh, Zahra Heydarifard, Milad Zandi
263 [GO] 2023―Jul―29 The signature of SARS-CoV-2 evolution reflects selective pressures within human guts Anton Zhiyanov, Maxim Shkurnikov, Ashot Nersisyan, Cai Hui, Ancha Baranova, Alexander Tonevitsky
264 [GO] 2023―Jul―29 Comments on: Clinical characteristics of unvaccinated or incompletely vaccinated children with neurological manifestations due to SARS-CoV-2 Omicron infection Haleema Qayyum Abbasi
265 [GO] 2023―Jul―28 Impact of corticosteroids use on midterm sequelae in survivors of COVID-19 admitted to hospital Guangting Zeng, Jianqiang Li, Linlin Wang, Zanling Zhang
266 [GO] 2023―Jul―28 Can inspiratory muscle training benefit patients with COVID-19? A systematic review and meta-analysis Yusha Chen, Xuefeng Liu, Zhaohui Tong
267 [GO] 2023―Jul―28 Determinants of protection against SARS-CoV-2 Omicron BA.1 and Delta infections in fully vaccinated outpatients Alvaro Roy, Carla Saade, Laurence Josset, Bénédicte Clément, Florence Morfin, Grégory Destras, et al. (+15)
268 [GO] 2023―Jul―27 Correction to “Long-Term Risk of Herpes Zoster Following Covid-19: A Retrospective Cohort Study of 2 442 686 Patients”
269 [GO] 2023―Jul―26 Correction to “SARS-CoV-2 RNA load in nasopharyngeal specimens from outpatients with breakthrough COVID-19 due to Omicron BA.1 and BA.2”
270 [GO] 2023―Jul―26 Correction to “Clinical efficacy and safety of molnupiravir for nonhospitalized and hospitalized patients with COVID-19: a systematic review and meta-analysis of randomized control trials”
271 [GO] 2023―Jul―25 Redirecting the JAK-STAT signal blocks the SARS-CoV-2 replication George Augustine, Valappil Sisila, Mohan Indhu, Divya Gupta, Dixit Tandel, Krishnan Harinivas Harshan, et al. (+6)
272 [GO] 2023―Jul―24 Outpatient atorvastatin use and severe COVID-19 outcomes: A population-based study Irene Visos-Varela, Maruxa Zapata-Cachafeiro, Samuel Pintos-Rodríguez, Rosendo Bugarín-González, Francisco Javier González-Barcala, Maria T. Herdeiro, et al. (+3)
273 [GO] 2023―Jul―24 Regulation of autophagy by SARS-CoV-2: The multifunctional contributions of ORF3a Mohd Shariq, Asrar A. Malik, Javaid A. Sheikh, Seyed E. Hasnain, Nasreen Z. Ehtesham
274 [GO] 2023―Jul―21 Factors associated with 60-day readmission among inpatients with COVID-19 at 21 United States health systems Julie A. Kirsch, Wendy S. Slutske, Danielle E. McCarthy, Stevens S. Smith, Brian S. Williams, Thomas M. Piasecki, et al. (+2)
275 [GO] 2023―Jul―21 Extracorporeal membrane oxygenation for COVID-19-associated acute respiratory distress syndrome: A nationwide analysis Atsuyuki Watanabe, Aaqib Malik, Tadao Aikawa, Alexandros Briasoulis, Toshiki Kuno
276 [GO] 2023―Jul―20 Oral azvudine for mild-to-moderate COVID-19 in high risk, nonhospitalized adults: Results of a real-world study Hui Yang, Zhaojian Wang, Chunguo Jiang, Yi Zhang, Ying Zhang, Man Xu, et al. (+5)
277 [GO] 2023―Jul―19 Short-term exposure to ambient air pollution and COVID-19 severity during SARS-CoV-2 Delta and Omicron waves: A multicenter study Barbara Poniedziałek, Piotr Rzymski, Dorota Zarębska-Michaluk, Magdalena Rogalska, Marta Rorat, Piotr Czupryna, et al. (+6)
278 [GO] 2023―Jul―18 National trends in body mass index, overweight, and obesity among adults before and during the COVID-19 pandemic in 2009-2021: A representative longitudinal serial study in South Korea Yeji Kim, Soeun Kim, Hyeon Jin Kim, Rosie Kwon, Min Seo Kim, Sunyoung Kim, et al. (+4)
279 [GO] 2023―Jul―18 Verifying AXL and putative proteins as SARS-CoV-2 receptors by DnaE intein-based rapid cell-cell fusion assay Quan Fang, Xiaobai He, Xiaoguang Zheng, Yu Fu, Ting Fu, Jingyi Luo, et al. (+9)
280 [GO] 2023―Jul―14 Retraction: Zhang, N, Qi, X, Chang, H, et al. Combined effects of inflammation and coronavirus disease 2019 (COVID-19) on the risks of anxiety and depression: a cross-sectional study based on UK Biobank. J Med Virol. 2023; 95:e28726. doi:10.1002/jmv.28726.
281 [GO] 2023―Jul―14 Are the original SARS-CoV-2 novel mutants from in vitro culture able to escape the immune response? Jun He, Qingmin Mei, Yousong Peng, Jiajia Xie, Weiwei Li, Chengchao Ding, et al. (+18)
282 [GO] 2023―Jul―12 Robust and protective immune responses induced by heterologous prime-boost vaccination with DNA-protein dimeric RBD vaccines for COVID-19 Yaling An, Gan Zhao, Huixin Duan, Ning Zhang, Minrun Duan, Senyu Xu, et al. (+12)
283 [GO] 2023―Jul―12 The effect of nirmatrelvir-ritonavir on the long-term risk of neuropsychiatric sequelae following COVID-19 Ting-Hui Liu, Jheng-Yan Wu, Po-Yu Huang, Ya-Wen Tsai, Chih-Cheng Lai
284 [GO] 2023―Jul―12 Systematic review and meta-analysis on the serological, immunological, and cardiac parameters of the multisystem inflammatory syndrome (MIS-C) associated with SARS-CoV-2 infection Golnaz Ghazizadeh Esslami, Setareh Mamishi, Babak Pourakbari, Shima Mahmoudi
285 [GO] 2023―Jul―11 Response to the letter to the editor on “Long-term risk of herpes zoster following COVID-19: A retrospective cohort study of 2 442 686 patients” Yi-Chen Chen, Chung-Han Ho, Ting-Hui Liu, Jheng-Yan Wu, Po-Yu Huang, Ya-Wen Tsai, Chih-Cheng Lai
286 [GO] 2023―Jul―07 Comment on Huang PS et al. Clinical efficacy and safety of molnupiravir for nonhospitalized and hospitalized patients with COVID-19: A systematic review and meta-analysis of randomized control trials. Med Virol. 2023; 95: e28621 Chienhsiu Huang
287 [GO] 2023―Jul―06 The causal role of gut microbiota in susceptibility and severity of COVID-19: A bidirectional Mendelian randomization study Han Chen, Bixing Ye, Wei Su, Ying Song, Pei-Li Sun, Xiaoying Zhou, Guoxin Zhang
288 [GO] 2023―Jul―06 Changes in trends of pediatric β- and γ-herpesvirus infections during the COVID-19 pandemic: A single-center observational study Kei Kozawa, Yoshiki Kawamura, Fumihiko Hattori, Hiroki Miura, Yuki Higashimoto, Masaru Ihira, et al. (+3)
289 [GO] 2023―Jul―05 Comment on “Long-term risk of herpes zoster following COVID-19: A retrospective cohort study of 2 442 686 patients” Misha Khan, Kashmala Khan, Jatin Motwani
290 [GO] 2023―Jul―05 Response to the letter to the editor on “Clinical efficacy and safety of molnupiravir for nonhospitalized and hospitalized patients with COVID-19: A systematic review and meta-analysis of randomized control trials” Po-Yu Huang, Ting-Hui Liu, Jheng-Yan Wu, Ya-Wen Tsai, Chih-Cheng Lai
291 [GO] 2023―Jul―05 Serum neutralization of SARS-CoV-2 Omicron BA.2, BA.2.75, BA.2.76, BA.5, BF.7, BQ.1.1 and XBB.1.5 in individuals receiving Evusheld Qianqian Zhao, Xin Wang, Ze Zhang, Xuefei Liu, Ping Wang, Jin Cao, et al. (+3)
292 [GO] 2023―Jul―05 Clinical characteristics of unvaccinated or incompletely vaccinated children with neurological manifestations due to SARS-CoV-2 Omicron infection Winnie Wan-Yee Tso, Mike Yat-Wah Kwan, Janette Siu-Yin Kwok, Jessica Oi-Ling Tsang, Cyril Chik-Yan Yip, Lok-Kan Leung, et al. (+17)
293 [GO] 2023―Jul―05 Torque teno virus viral load predicts SARS-CoV-2 vaccine response in kidney transplant recipients Morgane Solis, Ilies Benotmane, Floriane Gallais, Sophie Caillard, Samira Fafi-Kremer
294 [GO] 2023―Jul―05 Antibody-dependent NK-cell and neutralizing antibody responses against the Spike protein of Wuhan-Hu-1 and Omicron BA.1 SARS-CoV-2 variants in vaccinated experienced and vaccinated naïve individuals Eliseo Albert, Daniel Fernández-Soto, Estela Giménez, José María Casanovas, Joao Zulaica, Beatriz Álvarez-Rodríguez, et al. (+4)
295 [GO] 2023―Jul―05 Postpandemic rebound of adeno-associated virus type 2 (AAV2) infections temporally associated with an outbreak of unexplained severe acute hepatitis in children in the United Kingdom Shannah Gates, Julien Andreani, Rebecca Dewar, Donald B. Smith, Kate Templeton, Harry T. Child, et al. (+7)
296 [GO] 2023―Jul―04 Dynamics of parainfluenza virus among hospitalized children with acute respiratory tract infection under two-child policy and COVID-19 pandemic in Hubei Province, China, 2014-2022 Song Yi, Shan-Shan Zhang, Xin-Rui Wang, Yiguo Zhou, Wan-Xue Zhang, Juan Du, et al. (+2)
297 [GO] 2023―Jul―03 Symptom profiles and vaccination status for COVID-19 after the adjustment of the dynamic zero-COVID policy in China: An observational study Haoyang Zhang, Zhenxing Lu, Fan Yang, Hongwei Chen, Le Zhang, Huiying Zhao, Yongkun Chen
298 [GO] 2023―Jul―03 COVID-19 vaccination and decreased death rates: A county-level study in Pennsylvania Maria Ramunno, Ryan Savitz
299 [GO] 2023―Jul―03 Accelerating pandemic response with the emergency Omicron RT-PCR test: A comprehensive solution for COVID-19 diagnosis and tracking Hsing-Yi Chung, Ming-Jr Jian, Chih-Kai Chang, Jung-Chung Lin, Kuo-Ming Yeh, Chien-Wen Chen, et al. (+9)
300 [GO] 2023―Jul―03 New-onset neurodegenerative diseases as long-term sequelae of SARS-CoV-2 infection: A systematic review and meta-analysis Masoud Rahmati, Dong Keon Yon, Seung Won Lee, Pinar Soysal, Ai Koyanagi, Louis Jacob, et al. (+5)
301 [GO] 2023―Jun―30 Long-term risk of herpes zoster following COVID-19: A retrospective cohort study of 2 442 686 patients Wen-Chun Lin, James Cheng-Chung Wei
302 [GO] 2023―Jun―30 Fatal outcome of severe fever with thrombocytopenia syndrome (SFTS) and severe and critical COVID-19 is associated with the hyperproduction of IL-10 and IL-6 and the low production of TGF-β Su Yeon Kang, Jeong Rae Yoo, Yejin Park, So-Hee Kim, Sang Taek Heo, Seong Hyeon Park, et al. (+8)
303 [GO] 2023―Jun―30 Potential cross-species transmission risks of emerging swine enteric coronavirus to human beings Zhenhua Guo, Qianyue Jin, Peng Li, Guangxu Xing, Qingxia Lu, Gaiping Zhang
304 [GO] 2023―Jun―30 Do quantitative levels of antispike-IgG antibodies aid in predicting protection from SARS-CoV-2 infection? Results from a longitudinal study in a police cohort Parham Sendi, Nadja Widmer, Mattia Branca, Marc Thierstein, Annina Elisabeth Büchi, Dominik Güntensperger, et al. (+10)
305 [GO] 2023―Jun―27 Comparative efficacy and safety of nirmatrelvir/ritonavir and molnupiravir for COVID-19: A systematic review and meta-analysis Bahman Amani, Arash Akbarzadeh, Behnam Amani, Rouhollah Shabestan, Saeed Khorramnia, Zia Navidi, et al. (+2)
306 [GO] 2023―Jun―24 Relationship between SARS-CoV-2 vaccination and cases, program breakthrough cases, and deaths in Dois Vizinhos, Paraná, Brazil Marina Wust Vasconcelos, Flavia Regina Oliveira de Barros, Jéssica Cousseau Pilonetto, Schelder Gabriel Bertoncello Rosa, Sandrieli Gonçalves, Betty Cristiane Kuhn, et al. (+5)
307 [GO] 2023―Jun―21 COVID-19db linkage maps of cell surface proteins and transcription factors in immune cells Koushul Ramjattun, Xiaojun Ma, Shou-Jiang Gao, Harinder Singh, Hatice Ulku Osmanbeyoglu
308 [GO] 2023―Jun―21 SARS-CoV-2 intrahost evolution in immunocompromised patients in comparison with immunocompetent populations after treatment Akram Sadat Ahmadi, Sevrin Zadheidar, Kaveh Sadeghi, Ahmad Nejati, Vahid Salimi, Mahboobeh Hajiabdolbaghi, et al. (+2)
309 [GO] 2023―Jun―21 Time-series transcriptome analysis of peripheral blood mononuclear cells obtained from individuals who received the SARS-CoV-2 mRNA vaccine Yoshiyuki Watanabe, Hiroyuki Yamamoto, Ikuro Matsuba, Karin Watanabe, Tomoyuki Kunishima, Yukako Takechi, et al. (+15)
310 [GO] 2023―Jun―20 New-onset pemphigus foliaceus after COVID-19 infection Yihang Xie, Mei Yang, Peimei Zhou, Jiaming Fan, Sijie Zhou
311 [GO] 2023―Jun―20 Change from low to out-of-season epidemics of influenza in China during the COVID-19 pandemic: A time series study Guiying Cao, Zirui Guo, Jue Liu, Min Liu
312 [GO] 2023―Jun―20 Deconstructing SARS-CoV-2 neutralization: A modular molecular framework for computational design and comparison of antibodies and nanobodies targeting the spike RBD Vincenzo Tragni, Ivan Mercurio, Diletta Pia Paoletti, Angelo Onofrio, Luna Laera, Lucas Cafferati Beltrame, et al. (+6)
313 [GO] 2023―Jun―19 SARS-CoV-2 spike codon mutations and risk of hospitalization after antispike monoclonal antibody therapy in solid organ transplant recipients Zachary A. Yetmar, Joseph D. Yao, Raymund R. Razonable
314 [GO] 2023―Jun―19 Prevalence and risk factors of long COVID 6-12 months after infection with the Omicron variant among nonhospitalized patients in Hong Kong Jingyuan Luo, Jialing Zhang, Hiu To Tang, Hoi Ki Wong, Aiping Lyu, Chun Hoi Cheung, Zhaoxiang Bian
315 [GO] 2023―Jun―16 Epidemiological characteristics of norovirus infection in pediatric patients during the COVID-19 pandemic Jiabin Li, Binghan Wang, Xinyu He, Ziqiao Li, Lidan Sun, Wei Li, Guannan Bai
316 [GO] 2023―Jun―16 Clinical effectiveness of oral antiviral agents in older patients with COVID-19 based on real-world data Ya-Wen Tsai, Jheng-Yan Wu, Ting-Hui Liu, Min-Hsiang Chuang, Wan-Hsuan Hsu, Po-Yu Huang, et al. (+3)
317 [GO] 2023―Jun―14 Clinical efficacy of nirmatrelvir and ritonavir combination for treating diabetic patients with COVID-19 Jheng-Yan Wu, Mei-Yuan Liu, Ting-Hui Liu, Min-Hsiang Chuang, Wan-Hsuan Hsu, Po-Yu Huang, et al. (+4)
318 [GO] 2023―Jun―14 Stability of SARS-CoV-2 and persistence of viral nucleic acids on common foods and widely used packaging material surfaces Fu Li, Ke Xu, Yang Pan, Peipei Liu, Jing Zhang, Mengjie Yang, et al. (+6)
319 [GO] 2023―Jun―14 Antiviral treatment or mAbs for persistent SARS-COV-2 infection in patients with hematologic malignancies: A case series Ignacio Pérez-Catalán, Iris Gómez-Alfaro, Sergio García-Muñoz, Celia Roig-Martí, Noelia Rodríguez-Lozano, Sergio Fabra-Juana, et al. (+10)
320 [GO] 2023―Jun―14 SARS-CoV-2 NSP13 interacts with host IRF3, blocking antiviral immune responses Kuan Feng, Hui-Jiao Zhang, Yuan-Qin Min, Min Zhou, Fei Deng, Hua-Lin Wang, et al. (+2)
321 [GO] 2023―Jun―13 Overview of autoantibodies in COVID-19 convalescents Krystyna Dobrowolska, Dorota Zarębska-Michaluk, Barbara Poniedziałek, Jerzy Jaroszewicz, Robert Flisiak, Piotr Rzymski
322 [GO] 2023―Jun―13 Continuous evolution and emerging lineage of seasonal human coronaviruses: A multicenter surveillance study Run-Ze Ye, Cheng Gong, Xiao-Ming Cui, Jin-Yue Liu, Hang Fan, Hui Xie, et al. (+17)
323 [GO] 2023―Jun―13 Novel SARS-CoV-2 entry inhibitors, 2-anilinoquinazolin-4(3H)-one derivatives, show potency as SARS-CoV-2 antivirals in a human ACE2 transgenic mouse model Meehyun Ko, Jun Young Lee, Young Sup Shin, Sangeun Jeon, Subeen Myung, Jung-Eun Cho, et al. (+6)
324 [GO] 2023―Jun―12 Maximal temperature varies by sex and ethnic group in hospital in-patients with Covid-19 infection Colin J. Crooks, Joe West, Tasso Gazis, Mark Simmonds, Dominick Shaw, Timothy R. Card, Andrew W. Fogarty
325 [GO] 2023―Jun―09 Traceability of SARS-CoV-2 transmission through quasispecies analysis Serena Messali, Alessandro Rondina, Marta Giovanetti, Carlo Bonfanti, Massimo Ciccozzi, Arnaldo Caruso, Francesca Caccuri
326 [GO] 2023―Jun―08 A systematic review and meta-analysis of long-term sequelae of COVID-19 2-year after SARS-CoV-2 infection: A call to action for neurological, physical, and psychological sciences Masoud Rahmati, Raphael Udeh, Dong Keon Yon, Seung Won Lee, Xenia Dolja-Gore, Mark McEVoy, et al. (+6)
327 [GO] 2023―Jun―08 A mathematical model of SARS-CoV-2 immunity predicts paxlovid rebound Benjamin L. Ranard, Carson C. Chow, Murad Megjhani, Shadnaz Asgari, Soojin Park, Yoram Vodovotz
328 [GO] 2023―Jun―08 SARS-CoV-2 Omicron (B.1.1.529) infection in rhesus macaques, hamsters, and BALB/c mice with severe lung histopathological damage Wenhai Yu, Junbin Wang, Yun Yang, Cong Tang, Chengyun Yang, Bai Li, et al. (+12)
329 [GO] 2023―Jun―07 Respiratory syncytial virus surge in 2022 caused by lineages already present before the COVID-19 pandemic Monika Redlberger-Fritz, David N. Springer, Stephan W. Aberle, Jeremy V. Camp, Judith H. Aberle
330 [GO] 2023―Jun―07 Comparative spatial transcriptomic profiling of severe acute respiratory syndrome coronavirus 2 Delta and Omicron variants infections in the lungs of cynomolgus macaques Taehwan Oh, Green Kim, Seung Ho Baek, YoungMin Woo, Bon-Sang Koo, Eun-Ha Hwang, et al. (+5)
331 [GO] 2023―Jun―02 New-onset type 1 diabetes in children and adolescents as postacute sequelae of SARS-CoV-2 infection: A systematic review and meta-analysis of cohort studies Masoud Rahmati, Dong Keon Yon, Seung Won Lee, Raphael Udeh, Mark McEVoy, Min Seo Kim, et al. (+8)
332 [GO] 2023―Jun―02 PACT inhibits the replication of SARS-CoV-2 through the blockage of GSK-3β-N-nsp3 cascade Ying-Ying Lin, Roubin Yao, Jiaxin Zhuang, Bo Wang, Liubing Du, Deyin Guo, et al. (+2)
333 [GO] 2023―May―31 Multi-omic and comparative analyses revealed monocyte-derived alpha-defensin-1 correlated with COVID-19 severity and inhibited SARS-CoV-2 infection Xijing Qian, Bingan Wu, Xiang Chen, Haoran Peng, Miao Liu, Hailin Tang, et al. (+3)
334 [GO] 2023―May―31 Statins in hospitalized COVID-19 patients: A systematic review and meta-analysis of randomized controlled trials Yajuan Ren, Guizuo Wang, Dong Han
335 [GO] 2023―May―29 Real-world effectiveness of Azvudine versus nirmatrelvir-ritonavir in hospitalized patients with COVID-19 Guangting Zeng, Linlin Wang, Jianqiang Li, Zanling Zhang
336 [GO] 2023―May―29 Transcranial magnetic stimulation in assessment of vocal cord paralysis due to post-viral (COVID-19) vagal neuropathy Braco Bošković, Irena Bilić, Joško Šoda, Ivana Kero, Maja Rogić Vidaković
337 [GO] 2023―May―29 Evolution of SARS-CoV-2 variants of concern over a period of Delta and Omicron cocirculation, among patients hospitalized for COVID-19 in an Italian reference hospital: Impact on clinical outcomes Annalisa Mondi, Ilaria Mastrorosa, Pierluca Piselli, Claudia Cimaglia, Giulia Matusali, Fabrizio Carletti, et al. (+31)
338 [GO] 2023―May―29 Impact of corticosteroids use on midterm sequelae in survivors of COVID-19 admitted to hospital: A prospective cohort study Nathalie Gault, Delphine Bachelet, Cédric Laouénan, Raphaël Borie, Claire Cracowski, Julien Poissy, et al. (+9)
339 [GO] 2023―May―26 Comments on “Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers” Omed A. Muhammed, Hiwa M. Tawfeeq, Sirwan M. A. Al-Jaf, Sherko S. Niranji
340 [GO] 2023―May―25 Nasal spray of an IgM-like ACE2 fusion protein HH-120 accelerates SARS-CoV-2 clearance: A single-center propensity score-matched cohort study Rui Song, Xiaoyou Chen, Baoliang Li, Hongbin Zhang, Xiaodi Guo, Zhe Liu, et al. (+7)
341 [GO] 2023―May―25 Response to comments to the editor on “Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers” Ayad M. Ali, Ahmed M. Tofiq, Hassan M. Rostam, Kameran M. Ali, Hassan M. Tawfeeq
342 [GO] 2023―May―25 Corrigendum on “Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers” Ayad M. Ali, Ahmed M. Tofiq, Hassan M. Rostam, Kameran M. Ali, Hassan M. Tawfeeq
343 [GO] 2023―May―24 SARS-CoV-2 XBB.1.16 variant: India in focus? Ryan Varghese, Sanidhya Pai, Dileep Kumar, Rohit Sharma
344 [GO] 2023―May―23 Artificial neural network based prediction of the lung tissue involvement as an independent in-hospital mortality and mechanical ventilation risk factor in COVID-19 Miłosz Parczewski, Jakub Kufel, Bogusz Aksak-Wąs, Joanna Piwnik, Daniel Chober, Tomasz Puzio, et al. (+12)
345 [GO] 2023―May―23 Comparison of the immunogenicity of nasal-spray rVSV vector, adenovirus vector, and inactivated COVID-19-based vaccines in rodent models Yuhang Zhang, Jiandong Liu, Hongyue Li, Fei Yuan, Congli Jiang, Tianle Cang, et al. (+4)
346 [GO] 2023―May―23 The causal links between gut microbiota and COVID-19: A Mendelian randomization study Jukun Song, Yadong Wu, Xinhai Yin, Hong Ma, Junmei Zhang
347 [GO] 2023―May―23 Antibody response to the third dose of inactivated COVID-19 vaccine in people living with HIV (PLWH): A longitudinal cohort Guang Zeng, Fei He, Xiaomin Zhang, Guilian Li, Xiaohui Wang, Yongxia Gan, et al. (+6)
348 [GO] 2023―May―23 Clinical effectiveness of nirmatrelvir plus ritonavir in patients with COVID-19 and substance use disorders based on real-world data Ting-Hui Liu, Po-Yu Huang, Jheng-Yan Wu, Min-Hsiang Chuang, Wan-Hsuan Hsu, Ya-Wen Tsai, et al. (+2)
349 [GO] 2023―May―23 A substrate for a cell free in vitro assay system to screen drugs targeting trypsin like protease-based cleavage of SARS-CoV-2 spike glycoprotein and viral entry Feroza Begum, Amit K. Srivastava, Prem Prakash Tripathi, Upasana Ray
350 [GO] 2023―May―19 Trends in the morbidity and mortality of coronavirus disease 2019 in different ethnic groups and gender in a large Brazilian city João Henrique Fonseca do Nascimento, André Bouzas de Andrade, André Gusmão-Cunha, Andréa Mendonça Gusmão Cunha
351 [GO] 2023―May―15 Comment on the immunogenicity of the Noora vaccine against SARS-CoV-2 Donald N. Forthal
352 [GO] 2023―May―15 COVID-19 vaccines reduce mortality in hospitalized patients with oxygen requirements: Differences between vaccine subtypes. A multicontinental cohort study Ivan A. Huespe, Augusto Ferraris, Antonio Lalueza, Pascual R. Valdez, Maria L. Peroni, Luis A. Cayetti, et al. (+18)
353 [GO] 2023―May―13 Genetic correlation, causal relationship, and shared loci between vitamin D and COVID-19: A genome-wide cross-trait analysis Shizheng Qiu, Keyang Zheng, Yang Hu, Guiyou Liu
354 [GO] 2023―May―13 Prolonged inflammation in patients hospitalized for coronavirus disease 2019 (COVID-19) resolves 2 years after infection Siew-Wai Fong, Yun Shan Goh, Anthony Torres-Ruesta, Zi Wei Chang, Yi-Hao Chan, Vanessa Kexin Neo, et al. (+13)
355 [GO] 2023―May―13 Sensitivity of rapid antigen tests for Omicron subvariants of SARS-CoV-2 Yuko Sakai-Tagawa, Seiya Yamayoshi, Peter J. Halfmann, Nancy Wilson, Max Bobholz, William C. Vuyk, et al. (+8)
356 [GO] 2023―May―13 Clinical considerations for a gastric Dieulafoy's disease patient: Cardiac arrhythmias caused by SARS-CoV-2 or terlipressin? Liangqi Chen, Quan Zhang, Hongyi Li, Ke Ma
357 [GO] 2023―May―10 Oral side effects of COVID-19 vaccines in 32 European countries: Analysis of EudraVigilance reports Abanoub Riad, Nelly Schulz-Weidner, Arkadiusz Dziedzic, Hans-Peter Howaldt, Sameh Attia
358 [GO] 2023―May―08 A comprehensive overview on the transmission, pathogenesis, diagnosis, treatment, and prevention of SARS-CoV-2 Yiting Zhang, Setrice Patricia Clarke, Huanwu Wu, Wenli Li, Chang Zhou, Kang Lin, et al. (+5)
359 [GO] 2023―May―03 Clinical validation of novel dried blood spot based collecting device using serum separation for measuring SARS-CoV-2 antibodies Sophie Jolien Schuurmans Stekhoven, Kirsten Gerdien te Winkel, Dennis Souverein, Brigitte Marlene Sondermeijer, Marianne A. van Houten, Sjoerd M. Euser, Steven Ferdinand Lodewijk van Lelyveld
360 [GO] 2023―May―03 Vaccination status for mild and asymptomatic infections with SARS-CoV-2 Omicron BA.2 variant in Shanghai Yong Yin, Jilei Lin, Shuhua Yuan, Shilu Tong, Yi He, Bin Dong, et al. (+4)
361 [GO] 2023―Apr―27 Comparison of the reactogenicity and immunogenicity between two-dose mRNA COVID-19 vaccine and inactivated COVID-19 vaccine followed by an mRNA vaccine in children aged 5-11 years Nasamon Wanlapakorn, Sitthichai Kanokudom, Harit Phowatthanasathian, Jira Chansaenroj, Nungruthai Suntronwong, Suvichada Assawakosri, et al. (+14)
362 [GO] 2023―Apr―25 Dysbiosis of oropharyngeal microbiome and antibiotic resistance in hospitalized COVID-19 patients Jiani Wu, Wei Liu, Lin Zhu, Nina Li, Gengyan Luo, Ming Gu, et al. (+14)
363 [GO] 2023―Apr―25 Real-world effectiveness of Azvudine versus nirmatrelvir-ritonavir in hospitalized patients with COVID-19: A retrospective cohort study Guangtong Deng, Daishi Li, Yuming Sun, Liping Jin, Qian Zhou, Chenggen Xiao, et al. (+6)
364 [GO] 2023―Apr―25 The roles of critical pro-inflammatory cytokines in the drive of cytokine storm during SARS-CoV-2 infection Muhammad Suhaib Qudus, Mingfu Tian, Summan Sirajuddin, Siyu Liu, Uzair Afaq, Muneeba Wali, et al. (+8)
365 [GO] 2023―Apr―24 Predicting the negative conversion time of nonsevere COVID-19 patients using machine learning methods Jiru Ye, Xiaonan Shao, Yong Yang, Feng Zhu
366 [GO] 2023―Apr―24 Mu SARS-CoV-2 (B.1.621) variant: A genomic snapshot across the Colombian-Venezuelan border Luz Helena Patiño, Nathalia Ballesteros, Marina Muñoz, Angie L. Ramírez, Nicolas Luna, Sergio Castañeda, et al. (+6)
367 [GO] 2023―Apr―21 Efficacy of nirmatrelvir and ritonavir for post-acute COVID-19 sequelae beyond 3 months of SARS-CoV-2 infection Min-Hsiang Chuang, Jheng-Yan Wu, Ting-Hui Liu, Wan-Hsuan Hsu, Ya-Wen Tsai, Po-Yu Huang, Chih-Cheng Lai
368 [GO] 2023―Apr―21 Airborne virus shedding of the alpha, delta, omicron SARS-CoV-2 variants and influenza virus in hospitalized patients David S. Y. Ong, Peter de Man, Tim Verhagen, Gerda Doejaaren, Marloes A. Dallinga, Esmee Alibux, et al. (+2)
369 [GO] 2023―Apr―20 Association of gut microbiota with COVID-19 susceptibility and severity: A two-sample Mendelian randomization study Weifeng Shang, Sheng Zhang, Hang Qian, Xiaojun Pan, Sisi Huang, Zhenliang Wen, et al. (+2)
370 [GO] 2023―Apr―20 RE: Colchicine and risk of hospitalization due to COVID-19: A population-based study María Sáenz-Aldea, Ángel Salgado-Barreira, Margarita Taracido-Trunk, María Piñeiro-Lamas, Maria T. Herdeiro, Manuel Portela-Romero, et al. (+2)
371 [GO] 2023―Apr―19 Immunodominant SARS-CoV-2-specific CD4 + and CD8 + T-cell responses elicited by inactivated vaccines in healthy adults Jie Ning, Qinjin Wang, Ying Chen, Taojun He, Fang Zhang, Xingchi Chen, et al. (+4)
372 [GO] 2023―Apr―18 Antiandrogens for the treatment of COVID-19 patients: A meta-analysis of randomized controlled trials Huzaifa Ahmad Cheema, Aqeeb Ur Rehman, Asmaa Ahmed Elrashedy, Aleenah Mohsin, Abia Shahid, Muhammad Ehsan, et al. (+3)
373 [GO] 2023―Apr―18 Long-term risk of herpes zoster following COVID-19: A retrospective cohort study of 2 442 686 patients Yi-Chen Chen, Chung-Han Ho, Ting-Hui Liu, Jheng-Yan Wu, Po-Yu Huang, Ya-Wen Tsai, Chih-Cheng Lai
374 [GO] 2023―Apr―18 A machine learning model for predicting serum neutralizing activity against Omicron SARS-CoV-2 BA.2 and BA.4/5 sublineages in the general population Jorge Camacho, Eliseo Albert, Beatriz Álvarez-Rodríguez, Luciana Rusu, Joao Zulaica, Alicia Rodríguez Moreno, et al. (+4)
375 [GO] 2023―Apr―17 SARS-CoV-2 vaccine antibody response and breakthrough infections in transplant recipients Benedict Vanlerberghe, Casper Vrij, Kris Bogaerts, Pieter Vermeersch, Katrien Lagrou, Geert Molenberghs, et al. (+14)
376 [GO] 2023―Apr―17 No association of vaccination with inactivated COVID-19 vaccines before conception with pregnancy complications and adverse birth outcomes: A cohort study of 5457 Chinese pregnant women Yan Zhao, Yongbo Zhao, Xin Su, Yicheng Zhou, Ziyi Zhang, Yijun Zhang, et al. (+2)
377 [GO] 2023―Apr―17 Clinical observation of neutralizing antibody DXP-604 for treatment critical COVID-19 patients infected with SARS-CoV-2 Delta variant Lijuan Chen, Zehua Shao, Hongmei Liu, Qian Shi, Chuanjian Lv, Yan Bai, et al. (+5)
378 [GO] 2023―Apr―17 Causal effects of COVID-19 on cancer risk: A Mendelian randomization study Jia Li, Haocheng Bai, Hao Qiao, Chong Du, Peizhuo Yao, Yu Zhang, et al. (+12)
379 [GO] 2023―Apr―14 TRIM21 promotes ubiquitination of SARS-CoV-2 nucleocapsid protein to regulate innate immunity Shenglan Mao, Xuefei Cai, Siqiang Niu, Jie Wei, Ning Jiang, Haijun Deng, et al. (+8)
380 [GO] 2023―Apr―14 sCXCL16 as a prognostic biomarker for COVID-19 outcome Yasmine Boukhalfa, Nejla Stambouli, Adel Driss, Maissa Daiki, Amal Abouda, Rabie Razgallah, et al. (+10)
381 [GO] 2023―Apr―14 Dynamic immunogenicity after primary and booster inactivated SARS-CoV-2 vaccination in people living with HIV: A longitudinal observational study Ting Lu, Zhiwei Chen, Yu Cao, Ling Ao, Zisheng Li, Xiaoyi Gu, et al. (+11)
382 [GO] 2023―Apr―13 Combined effects of inflammation and coronavirus disease 2019 (COVID-19) on the risks of anxiety and depression: A cross-sectional study based on UK Biobank Na Zhang, Xin Qi, Hong Chang, Chun'e Li, Xiaoyue Qin, Wenming Wei, et al. (+8)
383 [GO] 2023―Apr―13 Nirmatrelvir-ritonavir compared with other antiviral drugs for the treatment of COVID-19 patients: A systematic review and meta-analysis Fangyuan Tian, Zhaoyan Chen, Qiyi Feng
384 [GO] 2023―Apr―11 Associations of habitual glucosamine use with SARS-CoV-2 infection and hospital admission and death with COVID-19: Evidence from a large population based cohort study Meijun Meng, Yanjun Wu, Weihong Sha, Ruijie Zeng, Dongling Luo, Rui Jiang, et al. (+8)
385 [GO] 2023―Mar―31 Genome-based survey of the SARS-CoV-2 BF.7 variant from Asia Fabio Scarpa, Marta Giovanetti, Ilenia Azzena, Chiara Locci, Marco Casu, Pier Luigi Fiori, et al. (+8)
386 [GO] 2023―Mar―28 Enhancement of SARS-CoV-2 infection and growth by an ACE2-specific monoclonal antibody Guangxiang Luo
387 [GO] 2023―Mar―25 Effect and safety of mesenchymal stem cells for patients with COVID-19: systematic review and meta-analysis with trial sequential analysis Zhijing Zhang, Shuai Shao, Xuefeng Liu, Zhaohui Tong
388 [GO] 2023―Mar―23 Causal associations and shared genetics between hypertension and COVID-19 Ancha Baranova, Hongbao Cao, Fuquan Zhang
389 [GO] 2023―Mar―23 Monkeypox (Mpox) outbreak during COVID-19 pandemic - Past and the future Durre Aden, Sufian Zaheer, Rohit Kumar, Sunil Ranga
390 [GO] 2023―Mar―22 Colchicine and risk of COVID-19-associated hospitalization Hui-Chin Chang, Shuo-Yan Gau
391 [GO] 2023―Mar―22 Humoral responses after primary and booster SARS-CoV-2 inactivated vaccination in patients with chronic hepatitis B virus infection: a longitudinal observational study Zhiwei Chen, Tianquan Huang, Taiyu He, Guanhua Zha, Qian Zhu, Gaoli Zhang, et al. (+21)
392 [GO] 2023―Mar―22 SARS-CoV-2 infection alters the gut microbiome in diabetes patients: A cross-sectional study from Bangladesh Adnan Mannan, M. Nazmul Hoque, Sajjad Hossain Noyon, H. M. Hamidullah Mehedi, Javed Foisal, Asma Salauddin, et al. (+9)
393 [GO] 2023―Mar―21 Recombinant measles virus expressing prefusion spike protein stabilized by six rather than two prolines is more efficacious against SARS-CoV-2 infection Yuexiu Zhang, Mijia Lu, Ilada Thongpan, Jiayu Xu, Kc Mahesh, Piyush Dravid, et al. (+6)
394 [GO] 2023―Mar―17 The impact of statin therapy on in-hospital prognosis and endothelial function of patients at high-to-very high cardiovascular risk admitted for COVID-19 Vanessa Bianconi, Massimo R. Mannarino, Elena Cosentini, Filippo Figorilli, Cecilia Colangelo, Giulia Cellini, et al. (+5)
395 [GO] 2023―Mar―17 Longer intervals between SARS-CoV-2 infection and mRNA-1273 doses improve the neutralization of different variants of concern Javier García-Pérez, Mercedes Bermejo, Almudena Ramírez-García, Humberto Erick De La Torre Tarazona, Almudena Cascajero, María Castillo de la Osa, et al. (+11)
396 [GO] 2023―Mar―17 SARS-CoV-2 NSP8 suppresses type I and III IFN responses by modulating the RIG-I/MDA5, TRIF, and STING signaling pathways Jian Deng, Sheng-Nan Zheng, Yang Xiao, Mei-Ling Nan, Jing Zhang, Lulu Han, et al. (+5)
397 [GO] 2023―Mar―14 The origin and evolution of emerged swine acute diarrhea syndrome coronavirus with zoonotic potential De Yu, Zhuang-Yan Zhao, Yong-Le Yang, Yu Qin, Dan Pan, Li-Xia Yuan, et al. (+2)
398 [GO] 2023―Mar―14 Distinct In Vitro and In Vivo Neutralization Profiles of Monoclonal Antibodies Elicited by the Receptor Binding Domain of the Ancestral SARS-CoV-2 Hyung Joon Kwon, Jun Zhang, Matina Kosikova, Weichun Tang, Uriel Ortega-Rodriguez, Hanqin Peng, et al. (+15)
399 [GO] 2023―Mar―13 Causal association of the brain structure with the susceptibility, hospitalisation, and severity of COVID-19: A large-scale genetic correlation study Zhihua Fan, Zhe Ruan, Bin Guo, Chao Wang, Xuegong Fan, Lizhang Chen, Shushan Zhao
400 [GO] 2023―Mar―13 A novel mAb broadly neutralizes SARS-CoV-2 VOCs in vitro and in vivo , including the Omicron variants Qiuqi Kan, Xian Lin, Tuofan Li, Xianliang Ke, Xiaoqin Jian, Zhong Zou, et al. (+9)
401 [GO] 2023―Mar―11 Stable and durable antibody responses in SARS-recovered donors vaccinated with inactivated SARS-CoV-2 vaccine Tingting Jia, Yuankai Wu, Guancheng Liao, Yuxuan Lei, Zhengyu Wu, Fangji Yang, et al. (+6)
402 [GO] 2023―Mar―11 Risk of hospitalization and sequelae in patients with COVID-19 treated with 3-day early remdesivir vs. controls in the vaccine and Omicron era: A real-life cohort study Maria Mazzitelli, Mattia Trunfio, Lolita Sasset, Vincenzo Scaglione, Anna Ferrari, Daniele Mengato, et al. (+5)
403 [GO] 2023―Mar―09 Pre-existing immunity to SARS-CoV-2 associates with strong T cell responses induced by inactivated COVID-19 vaccines Xuan Yi, Yuhao Wang, Quanrun Li, Xiaoyi Li, Panli Zhang, Xin Fu, et al. (+8)
404 [GO] 2023―Mar―09 SARS-CoV-2 Omicron XBB subvariants exhibit enhanced fusogenicity and substantial immune evasion in elderly population, but high sensitivity to pan-coronavirus fusion inhibitors Shuai Xia, Fanke Jiao, Lijue Wang, Xueying Yu, Tianyu Lu, Yan Fu, et al. (+8)
405 [GO] 2023―Mar―09 Incidence and risk factors of myocarditis in hospitalized patients with COVID-19 Karsten Keller, Ingo Sagoschen, Stavros Konstantinides, Tommaso Gori, Thomas Münzel, Lukas Hobohm
406 [GO] 2023―Mar―09 Comparing the incubation period, serial interval, and infectiousness profile between SARS-CoV-2 Omicron and Delta variants Zihao Guo, Shi Zhao, Chris Ka Pun Mok, Ray T. Y. So, Carrie Ho Kwan Yam, Tsz Yu Chow, et al. (+6)
407 [GO] 2023―Mar―07 SARS-CoV-2 infection of kidney tissues in some severe and fatal cases of COVID-19 Hinh Ly
408 [GO] 2023―Mar―07 Reduced neutralizing antibody response to SARS-CoV-2 vaccine booster dose in people living with HIV with severe immunosuppression Anaïs Corma-Gómez, Marta Fernández-Fuertes, Laura Viñuela, Carmen Domínguez, Martos Santos, Ana Fuentes-López, et al. (+9)
409 [GO] 2023―Mar―05 Effectiveness of mRNA and viral-vector vaccines in epidemic period led by different SARS-CoV-2 variants: a systematic review and meta-analysis Jun Zhang, Wenxing Yang, Feijun Huang, Kui Zhang
410 [GO] 2023―Mar―02 Genetic variety of ORF3a shapes SARS-CoV-2 fitness through modulation of lipid droplet Weili Wang, Yafei Qu, Xin Wang, Maggie Z.X. Xiao, Joyce Fu, Lei Chen, et al. (+2)
411 [GO] 2023―Mar―01 The diversity in the clinical features of children hospitalized with COVID-19 during the nonvariant, Alpha (B.1.1.7), Delta (B.1.617.2), and Omicron (B.1.1.529) variant periods of SARS CoV-2: Caution for neurological symptoms in Omicron variant Aslıhan Sahin, Eda Karadag-Oncel, Osman Buyuksen, Yildiz Ekemen-Keles, Gulnihan Ustundag, Aysegul Elvan-Tuz, et al. (+7)
412 [GO] 2023―Mar―01 In vitro and in vivo suppression of SARS-CoV-2 replication by a modified, short, cell-penetrating peptide targeting the C-terminal domain of the viral spike protein Dongbum Kim, Jinsoo Kim, Seungchan An, Minyoung Kim, Kyeongbin Baek, Bo Min Kang, et al. (+10)
413 [GO] 2023―Feb―28 Genome-based comparison between the recombinant SARS-CoV-2 XBB and its parental lineages Fabio Scarpa, Daria Sanna, Ilenia Azzena, Marco Casu, Piero Cossu, Pier Luigi Fiori, et al. (+8)
414 [GO] 2023―Feb―27 Clinical efficacy and safety of molnupiravir for nonhospitalized and hospitalized patients with COVID-19: A systematic review and meta-analysis of randomized control trials Po-Yu Huang, Ting-Hui Liu, Jheng-Yan Wu, Ya-Wen Tsai, Chih-Cheng Lai
415 [GO] 2023―Feb―25 Features and significance of the recent enormous COVID-19 epidemic in China Ji-Ming Chen, Huan-Yu Gong, Rui-Xu Chen, Si-Tong Liu, Ming-Hui Sun, Guo-Hui Li, et al. (+2)
416 [GO] 2023―Feb―25 Epidemiological features, genomic characteristics, and origin tracing of the COVID-19 outbreaks in Beijing from January to September 2022 Zhaomin Feng, Da Huo, Shujuan Cui, Bing Lvy, Zhichao Liang, Fu Li, et al. (+5)
417 [GO] 2023―Feb―25 Human coronavirus 3CL proteases cleave Septins and disrupt Hedgehog signaling, causing ciliary dysfunction Ah Reum Lee, Yeong Cheon Kweon, Sang Min Lee, Chan Young Park
418 [GO] 2023―Feb―25 Sulforaphane is a reversible covalent inhibitor of 3-chymotrypsin-like protease of SARS-CoV-2 Zinuo Chen, Ruikun Du, Laura Cooper, Jazmin Galvan Achi, Meiyue Dong, Yan Ran, et al. (+4)
419 [GO] 2023―Feb―25 Emergence of BS.1 and BS.1.1, highly mutated new SARS-CoV-2 Omicron variants Kenichiro Takahashi, Masumichi Saito, Tsuyoshi Sekizuka, Kentaro Itokawa, Michikazu Tanio, Hazuka Yoshida-Furihata, et al. (+5)
420 [GO] 2023―Feb―23 Effectiveness of Different Vaccine Platforms in Reducing Mortality and Length of ICU Stay in Severe and Critical Cases of COVID-19 in the Omicron Variant Era: A National Cohort Study in Iran Hamidreza Jamaati, Saeed Karimi, Fariba Ghorbani, Yunes Panahi, Fatemeh Sadat Hosseini-Baharanchi, Maryam Hajimoradi, et al. (+15)
421 [GO] 2023―Feb―23 Changes in Epstein-Barr virus infections in the children before and after the COVID-19 pandemic in Zhengzhou, China Yafeng Wang, Lihuan Shi, Dandan Liu, Yanna Mao, Wei Liu
422 [GO] 2023―Feb―23 Is a new COVID-19 wave coming from China due to an unknown variant of concern? Keep calm and look at the data Francesco Branda, Fabio Scarpa, Massimo Ciccozzi, Antonello Maruotti
423 [GO] 2023―Feb―23 Ocular Tropism of SARS-CoV-2 Infection Shuai Zhang, Jianguo Ju, Fang Yang, Chunfu Zheng, Jingbo Zhai
424 [GO] 2023―Feb―21 Gilteritinib: Repurposing of AXL-targeting kinase inhibitors against COVID-19 Yisa Chen, Yiying Xue, Jing Yang
425 [GO] 2023―Feb―17 Monitoring of SARS-CoV-2 concentration and circulation of variants of concern in wastewater of Leuven, Belgium. Annabel Rector, Mandy Bloemen, Marijn Thijssen, Leen Delang, Joren Raymenants, Jonathan Thibaut, et al. (+7)
426 [GO] 2023―Feb―16 An integrated strategy to identify COVID-19 causal genes and characteristics represented by LRRC37A2 Zijun Zhu, Xinyu Chen, Chao Wang, Sainan Zhang, Rui Yu, Yubin Xie, et al. (+4)
427 [GO] 2023―Feb―16 Receptor-binding domain-based SARS-CoV-2 vaccine adjuvanted with cyclic di-adenosine monophosphate enhances humoral and cellular immunity in mice María José Germanó, Constanza Giai, Diego Esteban Cargnelutti, María Isabel Colombo, Sebastián Blanco, Brenda Konigheim, et al. (+6)
428 [GO] 2023―Feb―16 Live-virus neutralization of the omicron variant in children and adults 14 months after SARS-CoV-2 wild-type infection Maximilian Stich, Louise Benning, Claudius Speer, Sven F. Garbade, Marie Bartenschlager, Heeyoung Kim, et al. (+11)
429 [GO] 2023―Feb―13 Nasal mucosa is much more susceptible than oral mucosa to infection of SARS-CoV-2 Omicron subvariants: wearing nasal masks where facial masks cannot be used Zijie Lin, Lujia Sun, Liliang Li, Shibo Jiang
430 [GO] 2023―Feb―11 “Mitochondrial pathogenic mutations and metabolic alterations associated with COVID-19 disease severity” Diksha Kumari, Yamini Singh, Sayar Singh, Vikas Dogra, Ashish Kumar Srivastava, Swati Srivastava, et al. (+5)
431 [GO] 2023―Feb―10 Disentangling the common genetic architecture and causality of rheumatoid arthritis and systemic lupus erythematosus with COVID-19 outcomes: genome-wide cross trait analysis and bi-directional Mendelian randomization study Minhao Yao, Xin Huang, Yunshan Guo, Jie V. Zhao, Zhonghua Liu
432 [GO] 2023―Feb―09 Persistent Circulation of Soluble and Extracellular vesicle-linked Spike Protein in Individuals with Post-Acute Sequelae of COVID-19 Vaughn Craddock, Aatish Mahajan, Leslie Spikes, Balaji Krishnamachary, Anil Kumar Ram, Ashok Kumar, et al. (+3)
433 [GO] 2023―Feb―09 Analysis on the Physiological Changes of Residents Before and During the COVID-19 Pandemic: A Cross-Sectional Study Jinlong Chen, Xueying Cheng, Yue Xu, Tingting Shi, Chunran Zhu, Xu Wang
434 [GO] 2023―Feb―09 Comparable humoral and cellular immunity against Omicron variant BA.4/5 of once-boosted BA.1/2 convalescents and twice-boosted COVID-19-naïve individuals Chang Kyung Kang, Min-Gang Kim, Seong-wook Park, Yong-Woo Kim, Chan Mi Lee, Pyoeng Gyun Choe, et al. (+9)
435 [GO] 2023―Feb―09 SARS-CoV-2 NSP7 inhibits type I and III IFN production by targeting the RIG-I/MDA5, TRIF, and STING signaling pathways Jian Deng, Yi Zheng, Sheng-Nan Zheng, Mei-Ling Nan, Lulu Han, Jing Zhang, et al. (+4)
436 [GO] 2023―Feb―09 Immunogenicity of novel DNA vaccines encoding receptor-binding domain (RBD) dimer-Fc fusing antigens derived from different SARS-CoV-2 variants of concern Ting Zhang, Zhirong Wang, Jiaojiao Yang, Xuemei Xu
437 [GO] 2023―Feb―09 Cross reactivity of SARS-CoV-2 with other pathogens, especially dengue virus: A historical perspective Debrupa Dutta, Anisa Ghosh, Chiroshri Dutta, Soumi Sukla, Subhajit Biswas
438 [GO] 2023―Feb―09 SARS-CoV-2 infection of kidney tissues from severe COVID-19 patients Shawn Radovic, Wen Meng, Luping Chen, Alberto E. Paniz Mondolfi, Clare Bryce, Zachary Grimes, et al. (+5)
439 [GO] 2023―Feb―09 WHOLE-GENOME SINGLE MOLECULE REAL-TIME SEQUENCING OF SARS-CoV-2 OMICRON Florence Nicot, Pauline Trémeaux, Justine Latour, Romain Carcenac, Sofia Demmou, Nicolas Jeanne, et al. (+5)
440 [GO] 2023―Feb―04 Appearance of extrapyramidal symptoms in adolescent psychiatry patients during Covid-19 infection Aysegul Tonyali, Gul Karacetin, Celal Yesilkaya, Feyza Nur Tas Arik, Binay Kayan Ocakoglu
441 [GO] 2023―Feb―03 Impact of alcohol consumption on COVID-19 severity: A systematic review and meta-analysis Baozhu Wei, Yang Liu, Hang Li, Yuanyuan Peng, Zhi Luo
442 [GO] 2023―Feb―03 Factors Affecting Prolonged SARS-CoV-2 Infection and Development and Validation of Predictive Nomograms Yifei Guo, Yue Guo, Yongmei Zhang, Fahong Li, Jie Yu, Yao Zhang, et al. (+4)
443 [GO] 2023―Feb―03 SARS-COV-2 omicron subvariant BF.7 is again triggering the Covid fear: What we need to know and what we should do? Adnan Akif, Mohiuddin Ahmed Bhuiyan, Md. Rabiul Islam
444 [GO] 2023―Feb―02 Discovery of Isojacareubin as a covalent inhibitor of SARS-CoV-2 main protease using structural and experimental approaches Abbas Khan, Kashif Imran, Guanghao Zhu, Jun Ji, Yani Zhang, Xiaoqing Guan, et al. (+3)
445 [GO] 2023―Feb―02 Treatment with integrase inhibitors alters SARS-CoV-2 neutralization levels measured with HIV-based pseudotypes in people living with HIV Erick De La Torre-Tarazona, Alba González-Robles, Almudena Cascajero, Paloma Jiménez, José María Miró, Sonsoles Sánchez-Palomino, et al. (+3)
446 [GO] 2023―Feb―01 Cross-sectional analysis reveals autoantibody signatures associated with COVID-19 severity Gabriela Crispim Baiocchi, Aristo Vojdani, Avi Z Rosenberg, Elroy Vojdani, Gilad Halpert, Yuri Ostrinski, et al. (+25)
447 [GO] 2023―Feb―01 Limited enhancement of antibody and B-cell responses to prototype booster vaccination following SARS-CoV-2 Delta breakthrough infection Xun Wang, Xing He, Shujun Jiang, Zhangfan Fu, Shuai Jiang, Xiaoyu Zhao, et al. (+8)
448 [GO] 2023―Jan―30 Evaluation of the performance of a rapid antigen test (Roche) for COVID-19 diagnosis in an emergency setting in Sweden Anna Heydecke, Karolina Gullsby
449 [GO] 2023―Jan―27 Does viral inoculum play a role in disease severity in COVID-19? Chenyu Sun, Vicky Yau, John Patrick Nanola Uy, Scott Lowe, Yanghua Tian
450 [GO] 2023―Jan―26 Delayed cutaneous hypersensitivity reactions following the use of infliximab or adalimumab in patients with coronavirus disease 2019 Jing Wang, Xuedong Yin, Linlin Yu, Weiwei Cheng, Ling Wang, Bin Zhao, et al. (+2)
451 [GO] 2023―Jan―25 Twelve-month clinical, functional and radiological outcomes in patients hospitalized for SARS-CoV-2 pneumonia Marco Bongiovanni, Giuseppe Barilaro, Francesco Bini
452 [GO] 2023―Jan―24 The case fatality rate of COVID-19 during the Delta and the Omicron epidemic phase: A meta-analysis Kisong Kim, Kyuyeon Cho, Junmin Song, Masoud Rahmati, Ai Koyanagi, Seung Won Lee, et al. (+3)
453 [GO] 2023―Jan―24 Enhanced recombination among omicron subvariants of SARS-CoV-2 contributes to viral immune escape Rishad Shiraz, Shashank Tripathi
454 [GO] 2023―Jan―23 Low prevalence of influenza viruses and predominance of A(H3N2) virus with respect to SARS-CoV-2 during the 2021-2022 season in Bulgaria Neli Korsun, Ivelina Trifonova, Veselin Dobrinov, Iveta Madzharova, Iliyana Grigorova, Iva Christova
455 [GO] 2023―Jan―21 Significant neutralizing escapes of Omicron and its sub-lineages in SARS-CoV-2-infected individuals vaccinated with inactivated vaccines Fan Shen, Cui-Xian Yang, Ying Lu, Mi Zhang, Ren-Rong Tian, Xing-Qi Dong, et al. (+3)
456 [GO] 2023―Jan―20 Impact of air pollutants on influenza-like illness outpatient visits under COVID-19 pandemic in the sub-center of Beijing, China Xin-Yao Lian, Lu Xi, Zhong-Song Zhang, Li-Li Yang, Juan Du, Yan Cui, et al. (+7)
457 [GO] 2023―Jan―20 Torque teno virus (TTV): a gentle spy virus of immune status, predictive marker of seroconversion to COVID-19 vaccine in kidney and lung transplant recipients Piergiorgio Roberto, Lilia Cinti, Anna Napoli, Daniele Paesani, Rodolfo J. Riveros Cabral, Fabrizio Maggi, et al. (+7)
458 [GO] 2023―Jan―19 IFNL3/4 polymorphisms as a two-edged sword: an association with COVID-19 outcome Sanja Matic, Dragan Milovanovic, Zeljko Mijailovic, Predrag Djurdjevic, Predrag Sazdanovic, Srdjan Stefanovic, et al. (+11)
459 [GO] 2023―Jan―19 Two-year impact of COVID-19 pandemic on hospitalized patients with skin diseases in China Jie Pan, Songchun Yang, Xiaozhen Chen, Xuanlin Che, Wenrui Lin, Mingliang Chen, et al. (+3)
460 [GO] 2023―Jan―19 A protocol of trial of ivermectin in COVID-19 treatment critically changed after its completion Kouji H. Harada, Arthit Phosri
461 [GO] 2023―Jan―19 It Is Time to Improve the Acceptance of COVID-19 Vaccines Among People with Chronic Diseases: A Systematic Review and Meta-analysis Yang Zhao, Juan Du, Zhen Li, Yaxin Wu, Wenshan Duan, Wenjing Wang, et al. (+4)
462 [GO] 2023―Jan―19 A hepatitis B virus core antigen-based virus-like particle vaccine expressing SARS-CoV-2 B and T cell epitopes induces epitope-specific humoral and cell-mediated immune responses but confers limited protection against SARS-CoV-2 infection Anna M. Hassebroek, Harini Sooryanarain, C. Lynn Heffron, Seth A. Hawks, Tanya LeRoith, Thomas E. Cecere, et al. (+11)
463 [GO] 2023―Jan―18 Persistent effects of COVID-19 in patients hospitalized during the first wave of the pandemic: The impact of persistent fatigue on quality of life in a cross-sectional study Joseph P. Skinner, Lauren V. Moran
464 [GO] 2023―Jan―18 Nirmatrelvir-ritonavir Therapy and COVID-19 Vaccination Improve Clinical Outcomes of SARS-CoV-2 Omicron Variant Infection Tangkai Qi, Yinpeng Jin, He Wang, Yixin Liao, Tiefu Liu, Enqiang Mao, et al. (+4)
465 [GO] 2023―Jan―14 Colchicine and risk of hospitalisation due to COVID-19: a population-based study. María Sáenz Aldea, Ángel Salgado-Barreira, Margarita Taracido Trunk, María Piñeiro Lamas, Maria T. Herdeiro, Manuel Portela-Romero, et al. (+2)
466 [GO] 2023―Jan―14 Baricitinib or imatinib in hospitalized COVID-19 patients: results from COVINIB, an exploratory randomized clinical trial. Alejandro Morales-Ortega, Ana Isabel Farfán-Sedano, Juan Víctor San Martín-López, Almudena Escribá-Bárcena, Beatriz Jaenes-Barrios, Elena Madroñal-Cerezo, et al. (+23)
467 [GO] 2023―Jan―12 Efficacy of Serum Apelin and Galectin-3 as Potential Predictors of Mortality in Severe COVID-19 Patients Nurcan Kırıcı Berber, Ayşegül Altıntop Geçkil, Nazife Özge Altan, Tuğba Raika Kıran, Önder Otlu, Mehmet Erdem, Erdal İn
468 [GO] 2023―Jan―11 A decrease in the incidence of encephalitis in South Korea during the COVID-19 pandemic: A nationwide study between 2010 and 2021 Se Hee Kim, Jee Yeon Baek, Minkyung Han, Myeongjee Lee, Sung Min Lim, Ji Young Lee, et al. (+4)
469 [GO] 2023―Jan―10 Needle-free injection system delivery of ZyCoV-D DNA vaccine demonstrated improved immunogenicity and protective efficacy in Rhesus macaques against SARS-CoV-2 Pragya D. Yadav, Sanjay Kumar, Kshitij Agarwal, Mukul Jain, Dilip R. Patil, Kapil Maithal, et al. (+25)
470 [GO] 2023―Jan―10 How does SARS-CoV-2 Infection impact on immunity, procession and treatment of Pan Cancers Nan Xiong, Qiangming Sun
471 [GO] 2023―Jan―10 Machine learning-driven blood transcriptome-based discovery of SARS-CoV-2 specific severity biomarkers Pandikannan Krishnamoorthy, Athira S Raj, Himanshu Kumar
472 [GO] 2023―Jan―10 Letter to the Editor Regarding “Effects of inactivated SARS-CoV-2 vaccination on male fertility: a retrospective cohort study” Mingqiang Wang, Lingtong Huang
473 [GO] 2023―Jan―07 The pattern of cytokines expression and dynamic changes of renal function at 6 months in patients with Omicron COVID-19 Lanbo Teng, Xinyuan Song, Miaomiao Zhang, Yingying Han, Ge Chang, Wenxiu Chang, Zhongyang Shen
474 [GO] 2023―Jan―07 Upregulation of PD-L1 by SARS-CoV-2 promotes immune evasion Hsiang-Chi Huang, Shih-Han Wang, Guo-Chen Fang, Wen-Cheng Chou, Chun-Che Liao, Cheng-Pu Sun, et al. (+20)
475 [GO] 2023―Jan―07 The third vaccine dose significantly reduces susceptibility to the B.1.1.529 (Ômicron) SARS-CoV-2 variant Jéssica Pires Farias, Josilene Ramos Pinheiro, Robert Andreata-Santos, Mayanna Moreira Costa Fogaça, Ruth Dalety da Silva Brito, Edgar Ferreira da Cruz, et al. (+14)
476 [GO] 2023―Jan―06 Nirmatrelvir-ritonavir for the treatment of COVID-19 patients: a systematic review and meta-analysis Huzaifa Ahmad Cheema, Uzair Jafar, Aruba Sohail, Abia Shahid, Syeda Sahra, Muhammad Ehsan, et al. (+3)
477 [GO] 2023―Jan―06 A vaccine delivery system promotes strong immune responses against SARS-CoV-2 variants Zhiwei Lei, Leqing Zhu, Pan Pan, Zhihui Ruan, Yu Gu, Xichun Xia, et al. (+13)
478 [GO] 2023―Jan―05 National trends in physical activity among adolescents in South Korea before and during the COVID-19 pandemic, 2009-2021 Rosie Kwon, Min Ji Koo, Seung Won Lee, Yong Sung Choi, Youn Ho Shin, Jung U Shin, et al. (+13)
479 [GO] 2023―Jan―05 Real-World Effectiveness of Sotrovimab and Remdesivir for Early Treatment of High-Risk Hospitalized COVID-19 Patients - a Propensity Score Adjusted Retrospective Cohort Study Lin Pin Koh, Siang Li Chua, Shawn Vasoo, Matthias Paul Han Sim Toh, Jeremy Nicholas Cutter, Puay Hoon Nah, et al. (+5)
480 [GO] 2023―Jan―05 The effect of synbiotic adjunct therapy on clinical and paraclinical outcomes in hospitalized COVID-19 patients: A randomized placebo-controlled trial Mahsa Vaezi, Sahar Ravanshad, Mina Akbari Rad, Hossein Zarrinfar, Mona Kabiri
481 [GO] 2023―Jan―05 Memory impairment among recovered COVID-19 patients: the prevalence and risk factors, a retrospective cohort study Muayad A. Merza, Hind B. Almufty, Heewa Abdulsalam Younis, Suzan Omer Rasool, Shinah A. Mohammed
482 [GO] 2023―Jan―05 Development and validation of a deep learning model to diagnose COVID-19 using time-series heart rate values before the onset of symptoms Heewon Chung, Hoon Ko, Hooseok Lee, Dong Keon Yon, Won Hee Lee, Tae-Seong Kim, et al. (+2)
483 [GO] 2023―Jan―05 Infection by SARS-CoV-2 with alternate frequencies of mRNA vaccine boosting Jeffrey P. Townsend, Hayley B. Hassler, Alex Dornburg
484 [GO] 2023―Jan―04 Contribution of genotypes in Prothrombin and Factor V Leiden to COVID-19 and disease severity in patients at high risk for hereditary thrombophilia Aslıhan Kiraz, Ozlem Sezer, Adem Alemdar, Sezin Canbek, Nilgun Duman, Atıl Bisgin, et al. (+44)
485 [GO] 2023―Jan―04 Title: Integrative systems immunology uncovers molecular networks of the cell cycle that stratify COVID-19 severity Caroline Aliane de Souza Prado, Dennyson Leandro M. Fonseca, Youvika Singh, Igor Salerno Filgueiras, Gabriela Crispim Baiocchi, Desirée Rodrigues Plaça, et al. (+23)
486 [GO] 2023―Jan―04 Association between trans fatty acids and COVID-19: a multivariate Mendelian randomization study Xuxu Liu, Zhiwei Du, Jing Wang, Qiang Wang, Yi Zheng, Le Niu, et al. (+3)
487 [GO] 2023―Jan―03 PREDICTORS OF SEVERITY IN SEVERE RESPIRATORY INFECTION IN CHILDREN WITH COVID-19 RESPIRATORY INFECTION IN A DEVELOPING COUNTRY Daniel Mauricion Beltran, Milena Villamil Osorio, Sara Liliana Goyeneche Fonseca, Sonia Restrepo, María José Rosero Garcia, Carlos Rodriguez-Martinez
488 [GO] 2022―Dec―30 Weekly Symptom Profiles of Non-hospitalized Individuals Infected with SARS-CoV-2 During the Omicron Outbreak in Hong Kong: A Retrospective Observational Study from a Telemedicine Centre Jingyuan Luo, Jialing Zhang, Hiu To Tang, Hoi Ki Wong, Yanfang Ma, Duoli Xie, et al. (+4)
489 [GO] 2022―Dec―30 The salivary and nasopharyngeal microbiomes are associated with SARS-CoV-2 infection and disease severity Josh G. Kim, Ai Zhang, Adriana M. Rauseo, Charles W. Goss, Philip A. Mudd, Jane A. O'Halloran, Leyao Wang
490 [GO] 2022―Dec―29 Surveillance for SARS-CoV-2 and its variants in wastewater of tertiary care hospitals correlates with increasing case burden and outbreaks Nicole Acosta, Maria A. Bautista, Barbara J. Waddell, Kristine Du, Janine McCalder, Puja Pradhan, et al. (+36)
491 [GO] 2022―Dec―29 Early administration of Paxlovid reduces the viral elimination time in patients infected with SARS-CoV-2 omicron variants Yu Wang, Danyang Zhao, Xinbing Liu, Xubo Chen, Wenying Xiao, Liuliu Feng
492 [GO] 2022―Dec―29 Dynamics of nosocomial SARS-CoV-2 transmissions: facing the challenge of variants of concern in a Brazilian reference hospital Andressa Taíz Hoffmann, Mariana Soares da Silva, Juliana Schons Gularte, Alessandro Comaru Pasqualotto, José Luiz Proença Módena, Alana Witt Hansen, et al. (+10)
493 [GO] 2022―Dec―29 A novel, ultrafast, ultrasensitive diagnosis platform for the detection of SARS-COV-2 using restriction endonuclease-mediated reverse transcription multiple cross displacement amplification Junfei Huang, Xinggui Yang, Lijuan Ren, Weijia Jiang, Yan Huang, Ying Liu, et al. (+3)
494 [GO] 2022―Dec―28 Efficacy and safety of nirmatrelvir/ritonavir (Paxlovid) for COVID-19 : a rapid review and meta-analysis Behnam Amani, Bahman Amani
495 [GO] 2022―Dec―27 Influence of the COVID-19 Pandemic on the Vitamin D Status of Children: A Cross-Sectional Study Tiewei Li, Xiaojuan Li, Nan Chen, Jianli Yang, Junmei Yang, Lijun Bi
496 [GO] 2022―Dec―27 Characterization of cross-reactive monoclonal antibodies against SARS-CoV-1 and SARS-CoV-2: implication for rational design and development of pan-sarbecovirus vaccines and neutralizing antibodies Shibo Li, Jianbo Wu, Weiyu Jiang, Haiyan He, Yunjiao Zhou, Wei Wu, et al. (+19)
497 [GO] 2022―Dec―27 Infectivity of pseudotyped SARS-CoV-2 variants of concern in different human cell types and inhibitory effects of recombinant spike protein and entry-related cellular factors George Fei Zhang, Wen Meng, Luping Chen, Ling Ding, Shenyu Sun, Xian Wang, et al. (+3)
498 [GO] 2022―Dec―27 Viruses Responsible for Acute Respiratory Infections Before (2016-2019) and During (2021) Circulation of the SARS-CoV-2 virus in Pediatric Patients in a Reference Center at Barranquilla Colombia: A Pattern Analysis S Zarur-Torralvo, I Stand-Niño, V Flórez-García, H Mendoza, E Viana-Cárdenas
499 [GO] 2022―Dec―26 Shared genetics and causal associations between COVID-19 and multiple sclerosis Ancha Baranova, Hongbao Cao, Shaolei Teng, Kuan-Pin Su, Fuquan Zhang
500 [GO] 2022―Dec―26 CLEC5A expression can be triggered by spike glycoprotein and may be a potential target for COVID-19 therapy Thiago Lazari Machado, Alanna Calheiros Santos, Tamiris Azamor, Andrea Marques Vieira da Silva, Vanessa Rocha Pimenta, Luciana Neves Tubarão, et al. (+7)
501 [GO] 2022―Dec―26 Association of inactivated COVID-19 vaccination with in vitro fertilization and early pregnancy outcomes Yan Zhao, Yongbo Zhao, Ai Ai, Liping Jin
502 [GO] 2022―Dec―26 Coronavirus disease 2019 rebounds following nirmatrelvir/ritonavir treatment Chih-Cheng Lai, Po-Ren Hsueh
503 [GO] 2022―Dec―26 Risk of waning humoral responses after inactivated or subunit recombinant SARS-CoV-2 vaccination in patients with chronic diseases: Findings from a prospective observational study in China Hu Li, Dachuan Cai, Depeng Jiang, Xingsheng Li, Xiaohui Liao, Dongfang Liu, et al. (+11)
504 [GO] 2022―Dec―26 Booster shot of inactivated SARS-CoV-2 vaccine induces potent immune responses in people living with HIV Haoting Zhan, Huixia Gao, Yongmei Liu, Xihong Zhang, Haolong Li, Xiaomeng Li, et al. (+6)
505 [GO] 2022―Dec―21 Emergence of a unique SARS-CoV-2 Delta sub-cluster harboring a constellation of co-appearing non-Spike mutations Anindita Banerjee, Anup Mazumder, Jayita Roy, Jagyashila Das, Agniva Majumdar, Ananya Chatterjee, et al. (+5)
506 [GO] 2022―Dec―17 Mouth Rinses Efficacy on Salivary SARS-CoV-2 Viral Load: A Randomized Clinical Trial Manar M. Alzahrani, Shatha Bamashmous, Hanaa Alkharobi, Abdullah Alghamdi, Rahaf H. Alharbi, Ahmed M. Hassan, et al. (+8)
507 [GO] 2022―Dec―16 Changes in endemic patterns of respiratory syncytial virus infection in pediatric patients under the pressure of nonpharmaceutical interventions for COVID-19 in Beijing, China Ming-Li Jiang, Yan-Peng Xu, Hui Wu, Ru-Nan Zhu, Yu Sun, Dong-Mei Chen, et al. (+7)
508 [GO] 2022―Dec―15 Possible transmission of COVID-19 epidemic by a dog as a passive mechanical carrier of SARS-CoV-2, Chongqing, China, 2022 Chunbei Zhou, Ailin Wu, Sheng Ye, Zongliang Zhou, Hongjun Zhang, Xiyou Zhao, et al. (+8)
509 [GO] 2022―Dec―15 Influence of COVID-19 pandemic on inhaled allergens in children with allergic diseases, Henan, China Xiaojuan Li, Tiewei Li, Nan Chen, Xuchen Wang, Junmei Yang, Lijun Bi
510 [GO] 2022―Dec―15 Key mutations in the spike protein of SARS-CoV-2 affecting neutralization resistance and viral internalization Qiong Wang, Sheng-Bao Ye, Zhi-Jian Zhou, A-Ling Song, Xi Zhu, Jia-Mei Peng, et al. (+7)
511 [GO] 2022―Dec―15 In silico study of SARS-CoV-2 Spike protein RBD and human ACE-2 affinity dynamics across variants and Omicron sub-variants Shamali Abeywardhana, Upeka Bandaranayake, Deshan B. Perera, Malinda Premathilaka, Dinithi C. Peiris
512 [GO] 2022―Dec―14 The Natural Killer cell-associated rs9916629 - C allele is a novel genetic risk factor for fatal COVID-19 Hannes Vietzen, Philippe L. Furlano, Marianna Traugott, David Totschnig, Wolfgang Hoepler, Robert Strassl, et al. (+2)
513 [GO] 2022―Dec―14 Bacterial profiles and their antibiotic resistance background in superinfections caused by multidrug-resistant bacteria among COVID-19 ICU patients from southwest Iran Sousan Akrami, Effat Abbasi Montazeri, Morteza Saki, Niloofar Neisi, Reza Khedri, Sahar Allah Dini, et al. (+2)
514 [GO] 2022―Dec―13 Impact of the COVID-19 pandemic on the circulation of other pathogens in England Lauren J. Hayes, Hannah Uri, Denisa Bojkova, Jindrich Cinatl, Mark N. Wass, Martin Michaelis
515 [GO] 2022―Dec―12 A Performance Comparison of two (Electro) chemiluminescence Immunoassays for Detection and Quantitation of Serum Anti-Spike Antibodies According to SARS-CoV-2 Vaccination and Infections Status Jorge Camacho, Eliseo Albert, Joao Zulaica, Beatriz Álvarez-Rodríguez, Luciana Rusu, Beatriz Olea, et al. (+4)
516 [GO] 2022―Dec―10 Evaluation the efficacy and safety of N-acetylcysteine inhalation spray in controlling the symptoms of patients with COVID-19: An open-label randomized controlled clinical trial Yunes Panahi, Mostafa Ghanei, Morteza Rahimi, Abbas Samim, Amir Vahedian-Azimi, Stephen L. Atkin, Amirhossein Sahebkar
517 [GO] 2022―Dec―08 A study on the morbid Histopathological changes in COVID-19 patients with or without comorbidities using minimally invasive tissue sampling A. Goel, A. Ray, A. Chavan, S. Sahni, B. K. Gupta, S.K. Raut, et al. (+23)
518 [GO] 2022―Dec―08 SARS-CoV-2 infection activates CREB/CBP in cellular cyclic AMP-dependent pathways Qi Yang, Jielin Tang, Juan Cao, Fengjiang Liu, Muqing Fu, Bao Xue, et al. (+7)
519 [GO] 2022―Dec―07 Maternal and neonatal safety of COVID-19 vaccination during peri-pregnancy period: a prospective study Minghui Li, Jianzhen Hao, Tingting Jiang, Wen Deng, Huihui Lu, Shiyu Wang, et al. (+3)
520 [GO] 2022―Dec―07 Humoral and cellular immunity of two-dose inactivated COVID-19 vaccination in Chinese children: a prospective cohort study Hao Wang, Mengze Gan, Bihao Wu, Rui Zeng, Zhen Wang, Jun Xu, et al. (+29)
521 [GO] 2022―Dec―07 Longitudinal study comparing IgG antibodies induced by heterologous prime-boost COVID-19 vaccine Hui Tzu Lin-Wang, Lucas Petri Damiani, Eduardo da Silva Farias, Marcio Chaim Bajgelman, Carlos Gun
522 [GO] 2022―Dec―07 Low COVID-19 Vaccine Coverage and Guardian Acceptance Among Pediatric Transplant Recipients Zhigang Zheng, Yefeng Lu, Min Wang, Yi Luo, Ping Wan, Tao Zhou, et al. (+11)
523 [GO] 2022―Dec―07 Persistent detection and sequencing of SARS-CoV-2 in the bloodstream of an immunocompromised patient Alberto Rizzo, Antonella Foschi, Fiorenza Bracchitta, Ivano Faggion, Federica Salari, Fabio Borgonovo, et al. (+6)
524 [GO] 2022―Dec―03 Relationship of Prior COVID-19 infection and Side Effects of Pfizer-BioNTech Vaccine: Results from a Community Hospital Maryam Bayat Mokhtari, Vanessa Samaniego, Moein Bayat Mokhtari, Angela Ishak, Arvin Esgandanian
525 [GO] 2022―Dec―02 Liquid biomarkers of macrophage dysregulation and circulating spike protein illustrate the biological heterogeneity in patients with post-acute sequelae of COVID-19 Christoph Schultheiß, Edith Willscher, Lisa Paschold, Cornelia Gottschick, Bianca Klee, Lidia Bosurgi, et al. (+8)
526 [GO] 2022―Dec―02 RELATIVE TELOMERE LENGTH IMPACT ON MORTALITY OF COVID-19: SEX DIFFERENCES Ana VIRSEDA-BERDICES, Leyre CONCOSTRINA-MARTINEZ, Oscar MARTÍNEZ-GONZÁLEZ, Rafael BLANCAS, Salvador RESINO, Pablo RYAN, et al. (+8)
527 [GO] 2022―Dec―02 Comparison of Secondary Attack Rate and Viable Virus Shedding between Patients with SARS-CoV-2 Delta and Omicron Variants: A Prospective Cohort Study Sung-Woon Kang, Ji Yeun Kim, Heedo Park, So Yun Lim, Jeonghun Kim, Euijin Chang, et al. (+9)
528 [GO] 2022―Dec―02 Molecular evolution of SARS-CoV-2 from December 2019 to August 2022 Jonas Michel Wolf, Lucas Michel Wolf, Graziele Lima Bello, Juçara Gasparetto Maccari, Luiz Antonio Nasi
529 [GO] 2022―Dec―02 Omicron-specific mRNA vaccine induced cross-protective immunity against ancestral SARS-CoV-2 infection with low neutralizing antibodies Kuan-Yin Shen, Chung-Hsiang Yang, Chiung-Tong Chen, Hui-Min Ho, Fang-Feng Chiu, Chiung-Yi Huang, et al. (+7)
530 [GO] 2022―Dec―02 Higher SARS-CoV-2 shedding in exhaled aerosol probably contributed to the enhanced transmissibility of Omicron BA.5 subvariant Jiaming Li, Jing Zheng, Peng Chen, Baochun Wang, Yidun Zhang, Jinwei Xiong, et al. (+11)
531 [GO] 2022―Dec―01 Early Plasma Interferon-β Levels as a Predictive Marker of COVID-19 Severe Clinical Events in Adult Patients Berri Fatma, N'Guyen Yohan, Callon Domitille, Lebreil Anne-Laure, Glenet Marie, Heng Laetitia, et al. (+3)
532 [GO] 2022―Nov―30 Non-Pharmaceutical Interventions Reduce the Incidence, and Mortality of COVID-19: A Study based on the Survey from the International COVID-19 Research Network (ICRN) Seung Hyun Park, Sung Hwi Hong, Kwanghyun Kim, Seung Won Lee, Dong Keon Yon, Sun Jae Jung, et al. (+98)
533 [GO] 2022―Nov―30 The immunodominance of RBD antigen of delta variant as vaccine candidate against SARS-CoV-2 infection Deyan Luo, Tao Li, Xiaolan Yang, Nianzhi Ning, Liangyan Zhang, Hongjing Gu, et al. (+4)
534 [GO] 2022―Nov―30 DURABILITY OF HUMORAL AND CELL-MEDIATED IMMUNE RESPONSE AFTER SARS-CoV-2 mRNA VACCINE ADMINISTRATION Anastasiya Mihaylova, Spaska Lesichkova, Marta Baleva, Milena Nikolova-Vlahova, Todor Kundurzhiev, Alexander Kolevski, Elissaveta Naumova
535 [GO] 2022―Nov―29 Haplotypic variants of COVID-19 related genes are associated with blood pressure and metabolites levels Morteza Gholami, Marziyeh Zoughi, Mandana Hasanzad, Bagher Larijani, Mahsa M. Amoli
536 [GO] 2022―Nov―29 The third inactivated vaccine booster dramatically enhanced SARS-CoV-2 antibody responses and did not influence the profile of prothrombotic antibody Yunbao Pan, Shilin Wang, Guohong Liu, Liping Wang, Liu Yang, Xiaojiao Zeng, et al. (+4)
537 [GO] 2022―Nov―25 Production of a versatile SARS-CoV-2 main protease biosensor based on a dimerization-dependent red fluorescent protein Haohao Yan, Rui Zhang, Gangan Yan, Zhicheng Liu, Xiaoli Liu, Xiaoping Liu, Yunyu Chen
538 [GO] 2022―Nov―24 Immune Repertoire Sequencing Reveals an Abnormal Adaptive Immune System in COVID-19 Survivors Chen Jia, Zhiguo Zhou, Wenjing Pan, Pan Zhang, Ming Yang, Mingming Zhao, et al. (+14)
539 [GO] 2022―Nov―24 Impact of combination preventative interventions on hospitalization and death under the pandemic of SARS-CoV-2 Omicron variant in China Yi-Fan Lin, Xinsheng Wu, Yuwei Li, Junye Bian, Kuibiao Li, Yawen Jiang, et al. (+6)
540 [GO] 2022―Nov―23 Effects of inactivated SARS-CoV-2 vaccination on male fertility: a retrospective cohort study Yehao Dong, Xiaoyun Li, Zewu Li, Yunting Zhu, Zichun Wei, Jiarui He, et al. (+3)
541 [GO] 2022―Nov―22 Comparative analysis of SARS-CoV-2 Omicron BA.2.12.1 and BA.5.2 variants Chon Phin Ong, Zi-Wei Ye, Kaiming Tang, Ronghui Liang, Yubin Xie, Hongzhuo Zhang, et al. (+8)
542 [GO] 2022―Nov―22 Clinical features, therapeutic outcomes and recovery period of long COVID Kazuki Takakura, Machi Suka, Mikio Kajihara, Shigeo Koido
543 [GO] 2022―Nov―19 Characterisation and analysis of linear epitopes corresponding to SARS-CoV-2 outbreak in Jilin Province, China Wenying Gao, Zhaolong Li, Qingtian Guan, Wenzhe Cui, Baishong Zheng, Qiang Ding, et al. (+3)
544 [GO] 2022―Nov―19 The effect of SARS-CoV-2 infection on cardiac function in post-COVID-19 survivors: A systematic review and meta-analysis Masoud Rahmati, Ai Koyanagi, Ebrahim Banitalebi, Dong Keon Yon, Seung Won Lee, Jae Il Shin, Lee Smith
545 [GO] 2022―Nov―18 SARS-CoV-2 Infection in Children Evaluated in an Ambulatory Setting During Delta and Omicron Time Periods Hana Smith, Allison Mahon, Angela Moss, Suchitra Rao
546 [GO] 2022―Nov―18 Letter to the Editor Regarding “The clinical and bioinformatics analysis for the role of antihypertension drugs on mortality among patients with hypertension hospitalized with COVID-19 Chi-Chih Chan, Yung-Po Liaw
547 [GO] 2022―Nov―16 Reply to Letter to the Editor on disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers Ayad M. Ali, Ahmed M. Tofiq, Hassan M. Rostam, Kameran M. Ali, Hassan M. Tawfeeq
548 [GO] 2022―Nov―15 Pathogenesis and histological changes of nephropathy associated with COVID-19 Lirong Lin, Junhui Deng, Jie Li, Luquan Zheng, Zhifeng Wu, Wei Tan, Jurong Yang
549 [GO] 2022―Nov―15 The "vaccine" hubbub: Viral load comparisons of SARS-CoV-2 Delta and Omicron variants against different vaccine-booster vaccine combinations Mahmut Cerkez Ergoren, Gokce Akan, Ender Volkan, Emine Kandemis, Emine Unal Evren, Hakan Evren, et al. (+4)
550 [GO] 2022―Nov―14 Approaching COVID-19 with epidemiological genomic surveillance and the sustainability of biodiversity informatics in Africa Abdullahi Tunde Aborode, Helen Huang, Wireko Andrew Awuah, Aashna Mehta, Jacob Kalmanovich, Toufik Abdul-Rahman, et al. (+2)
551 [GO] 2022―Nov―14 Varicella Zoster Virus Reactivation Following COVID-19 Vaccination in patients with autoimmune inflammatory rheumatic diseases: A cross-sectional Chinese study of 318 cases Jiali Chen, Fen Li, Jing Tian, Xi Xie, Qi Tang, Yiyue Chen, Yan Ge
552 [GO] 2022―Nov―12 The widest use of paracetamol in home therapy might have actually increased the occurrence of severe forms of COVID-19 in Italy, affecting hospitalization and death rates. Salvatore Chirumbolo
553 [GO] 2022―Nov―11 Nonpharmaceutical interventions for COVID-19 disrupt the dynamic balance between influenza A virus and human immunity Qing Ye, Huihui Liu, Jianhua Mao, Qiang Shu
554 [GO] 2022―Nov―11 The effect of adherence to high-quality dietary pattern on COVID-19 outcomes: A systematic review and meta-analysis Masoud Rahmati, Rouholah Fatemi, Dong Keon Yon, Seung Won Lee, Ai Koyanagi, Jae Il Shin, Lee Smith
555 [GO] 2022―Nov―11 Implementation of Public Health Genomics in Africa: Lessons from the COVID-19 pandemic, Challenges, and Recommendations Enos Moyo, Perseverance Moyo, Tapfumanei Mashe, Mathias Dzobo, Itai Chitungo, Tafadzwa Dzinamarira
556 [GO] 2022―Nov―11 Association between emphysema and other pulmonary computed tomography patterns in COVID-19 pneumonia Ke Han, Jing Wang, Yulin Zou, Yuxin Zhang, Lin Zhou, Yiping Yin
557 [GO] 2022―Nov―11 Transplacental transmission of SARS-CoV-2 immunoglobulin G antibody to infants from maternal COVID-19 vaccine immunization before pregnancy Yuting Yang, Huiwu Xing, Yao Zhao
558 [GO] 2022―Nov―09 Clinical trials on the pharmacological treatment of long COVID: a systematic review Ying Jie Chee, Bingwen Eugene Fan, Barnaby Edward Young, Rinkoo Dalan, David Chien Lye
559 [GO] 2022―Nov―05 Cumulative incidence of SARS-CoV-2 infection in the general population of the Valencian Community (Spain) after the surge of the Omicron BA.1 variant Jorge Camacho, Estela Giménez, Eliseo Albert, Joao Zulaica, Beatriz Álvarez-Rodríguez, Ignacio Torres, et al. (+12)
560 [GO] 2022―Nov―04 Zhu, C, He, G, Yin, Q, et al. Molecular biology of the SARs-CoV-2 spike protein: A review of current knowledge. J Med Virol . 2021;93: 5729- 5741.
561 [GO] 2022―Nov―04 Bovine lactoferrin inhibits SARS-CoV-2 and SARS-CoV-1 by targeting the RdRp complex and alleviates viral infection in the hamster model Shi-ting He, Hongbo Qin, Lin Guan, Ke Liu, Bixia Hong, Xiaoxu Zhang, et al. (+13)
562 [GO] 2022―Nov―04 Effectiveness of SARS-CoV-2 inactivated vaccine and the correlation to neutralizing antibodies: a test-negative case-control study Can Liu, Jiawei Zhang, Yongbin Zeng, Chun Huang, Falin Chen, Yingping Cao, et al. (+18)
563 [GO] 2022―Nov―03 Post-exposure-vaccine-prophylaxis against COVID-19 Zohar Shmuelian, Yehuda Warszawer, Omri Or, Sagit Arbel-Alon, Hilla Giladi, Meytal Avgil Tsadok, et al. (+7)
564 [GO] 2022―Nov―03 Comments on Rahmati et al., The global impact of COVID-19 pandemic on the incidence of pediatric new-onset type 1 diabetes and ketoacidosis: A systematic review and meta-analysis. J Med Virol. 2022; 1-16 (doi: 10.1002/jmv.27996) Joachim Rosenbauer, Anna Stahl-Pehe, Sabrina Schlesinger, Oliver Kuß
565 [GO] 2022―Nov―03 IgG autoantibodies against ACE2 in SARS-CoV-2 infected patients Ewelina Hallmann, Dominika Sikora, Barbara Poniedziałek, Karol Szymański, Katarzyna Kondratiuk, Jakub Żurawski, et al. (+2)
566 [GO] 2022―Nov―03 Cartography of SARS-CoV-2 variants based on the susceptibility to therapeutic monoclonal antibodies Yuki Furuse
567 [GO] 2022―Nov―02 Cross Neutralization of SARS-CoV-2 Omicron Subvariants after repeated doses of COVID-19 mRNA vaccines Joanna Luczkowiak, Gonzalo Rivas, Nuria Labiod, Fátima Lasala, Marta Rolo, Jaime Lora-Tamayo, et al. (+5)
568 [GO] 2022―Nov―02 Irradiation accelerates SARS-CoV-2 infection by enhancing sphingolipid metabolism Zhuanzhuan Wei, Yiyi Jiang, Gaomei Zhao, Chenwenya Li, Songling Han, Yin Chen, et al. (+4)
569 [GO] 2022―Nov―01 A phenome-wide investigation of risk factors for severe COVID-19 Ancha Baranova, Hongbao Cao, Shaolei Teng, Fuquan Zhang
570 [GO] 2022―Oct―31 Effect of COVID-19 vaccination on semen parameters: a systematic review and meta-analysis Jialyu Huang, Zheng Fang, Lingling Huang, Lu Fan, Yiqi Liu, Leizhen Xia, et al. (+7)
571 [GO] 2022―Oct―28 Efficient recall of SARS-CoV-2 variant-reactive B cells and T responses in the elderly upon heterologous mRNA vaccines as boosters Angeline Rouers, Nathan Wong, Yun Shan Goh, Anthony Torres-Ruesta, Matthew Zirui Tay, Zi Wei Chang, et al. (+24)
572 [GO] 2022―Oct―28 Parents’ willingness to vaccinate themselves and their children with the booster vaccine against SARS-CoV-2: a cross-sectional study in Puyang city, China Yiguo Zhou, Guo-Xing Li, Tian-Shuo Zhao, Juan Du, Wan-Xue Zhang, Ming-Zhu Xie, et al. (+7)
573 [GO] 2022―Oct―22 Development and Characterization of a New Monoclonal Antibody against SARS-CoV-2 NSP12 Wen Meng, Siying Guo, Simon Cao, Masahiro Shuda, Lindsey R. Robinson-McCarthy, Kevin R. McCarthy, et al. (+13)
574 [GO] 2022―Oct―20 Association of COVID-19 vaccination before conception with maternal thyroid function during early pregnancy: a single-center study in China Yan Zhao, Yongbo Zhao, Yijun Zhang, Mengyuan Li, Xin Su, Yicheng Zhou, et al. (+2)
575 [GO] 2022―Oct―20 In silico evaluation of the impact of Omicron variant of concern sublineage BA.4 and BA.5 on the sensitivity of RT-qPCR assays for SARS-CoV-2 detection using whole genome sequencing Divya Sharma, Kin Israel Notarte, Rey Arturo Fernandez, Giuseppe Lippi, M. Michael Gromiha, Brandon Michael Henry
576 [GO] 2022―Oct―19 Antiviral Treatment of COVID-19 is associated with lack of immune response Baran Erdik
577 [GO] 2022―Oct―19 Microbiome analysis revealing microbial interactions and secondary bacterial infections in COVID-19 patients co-morbidly affected by type 2 diabetes Hassan M. Al-Emran, M. Shaminur Rahman, Md. Shazid Hasan, A. S. M. Rubayet Ul Alam, Ovinu Kibria Islam, Ajwad Anwar, et al. (+2)
578 [GO] 2022―Oct―19 Factor Structure of the 10-item CES-D Scale Among Patients with Persistent COVID-19 Robinson Ramírez-Vélez, Laiene Olabarrieta-Landa, Diego Rivera, Mikel Izquierdo
579 [GO] 2022―Oct―19 Development of SARS-CoV-2 animal vaccines using a stable and efficient NDV expression system Lei He, Jiaying Zhong, Guichang Li, Zhengfang Lin, Peijing Zhao, Chuhua Yang, et al. (+4)
580 [GO] 2022―Oct―18 Global case fatality rate from COVID-19 has decreased by 96.8% during 2.5 years of the pandemic Nobuyuki Horita, Takeshi Fukumoto
581 [GO] 2022―Oct―17 Comparison of nucleocapsid and spike antibody ELISAs for determining SARS-CoV-2 seropositivity in Kenyan women and infants Carolyn S. Fish, Prestone Owiti, Emily R. Begnel, Hannah L. Itell, Ednah Ojee, Judith Adhiambo, et al. (+13)
582 [GO] 2022―Oct―15 The acceptance of SARS-CoV-2 rapid antigen self-testing: a cross-sectional study in China Fan Wu, Yue Yuan, Yanjun Li, Di Yin, Bing Lang, Yangguo Zhao, et al. (+5)
583 [GO] 2022―Oct―14 High titers of neutralizing antibodies in the blood fail to eliminate SARS-CoV-2 viral RNA in the upper respiratory tract Lu Li, Jianping Cui, Jingyan Tang, Jingrong Shi, Xilong Deng, Xiaowen Zheng, et al. (+6)
584 [GO] 2022―Oct―14 SARS-CoV-2, HIV, HPV: convergent evolution of selective regulation of cGAS-STING signaling Si Shen, Yajuan Rui, Yanpu Wang, Jiaming Su, Xiao-Fang Yu
585 [GO] 2022―Oct―14 Characterization and application of a series of monoclonal antibodies against SARS-CoV-2 nucleocapsid protein Liling Zhou, Chuncong Mo, Yujie Yang, Zhichao Zhou, Aiping You, Ye Fan, et al. (+4)
586 [GO] 2022―Oct―14 Clinical characteristics of 1139 mild cases of the SARS-CoV-2 Omicron variant infected patients in Shanghai Miao Wang, Zhidong Liu, Zengliang Wang, Ke Li, Yu Tian, Wei Lu, et al. (+5)
587 [GO] 2022―Oct―13 In response to: Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers Sherko S. Niranji, Sirwan M. Amin Al-Jaf
588 [GO] 2022―Oct―13 Spike protein mediated membrane fusion during SARS-CoV-2 infection Xinyu Li, Huijun Yuan, Xiaozhen Li, Hongliang Wang
589 [GO] 2022―Oct―13 Omicron variant of SARS-CoV-2: A pandemic of global concern warrants a cautious approach Ashwini Mahadeo Gahukar, Krishna Khairnar
590 [GO] 2022―Oct―13 Persistence of Neutrophil extracellular traps and anti-cardiolipin auto-antibodies in post-acute phase COVID-19 patients Ekaterina Pisareva, Stephanie Badiou, Lucia Mihalovičová, Alexia Mirandola, Brice Pastor, Andrei Kudriavstev, et al. (+6)
591 [GO] 2022―Oct―13 Long COVID following Omicron wave in Eastern India - A retrospective cohort study Arjun M. C., Arvind Kumar Singh, Payel Roy, Mythry Ravichandran, Srijani Mandal, Debkumar Pal, et al. (+7)
592 [GO] 2022―Oct―11 Will Monkeypox Outbreak mirror COVID-19 or AIDs? Kannan RR Rengasamy
593 [GO] 2022―Oct―11 Impact of COVID-19 Pandemic on Influenza virus Prevalence in Children in Sichuan, China Pinjia Wang, Yidan Xu, SU Zhe, Chengbin Xie
594 [GO] 2022―Oct―11 Does ACE2 mediate the detrimental effect of exposures related to COVID-19 risk: A Mendelian randomization investigation Shiu Lun Au Yeung, Tommy Hon Ting Wong, Baoting He, Shan Luo, Kin On Kwok
595 [GO] 2022―Oct―11 SARS-CoV-2 evolves to reduce but not abolish neutralizing action Yandi Zhang, Jo-Lewis Banga Ndzouboukou, Xiaosong Lin, Hongyan Hou, Feng Wang, Leyong Yuan, et al. (+5)
596 [GO] 2022―Oct―08 Current immunoassays and detection of antibodies elicited by Omicron SARS-CoV-2 infection M. Migueres, S. Chapuy-Regaud, M. Miédougé, T. Jamme, C. Lougarre, I. Da Silva, et al. (+5)
597 [GO] 2022―Oct―07 Associations between pulse rate and COVID-19 Ancha Baranova, Yong Xu, Hongbao Cao, Fuquan Zhang
598 [GO] 2022―Oct―04 Immunophenotyping Characteristics of COVID-19 Patients: Peripheral Blood CD8+ HLA-DR+ T Cells as a Biomarker for Mortality Outcome Ensie Sadat Mirsharif, Maryam Rajabnia Chenary, Mahmood Bozorgmehr, Saeed Mohammadi, Seyed Mahmoud Hashemi, Susan Kabudanian Ardestani, et al. (+6)
599 [GO] 2022―Oct―03 Viral load decrease in SARS-CoV-2 BA.1 and BA.2 Omicron sublineages infection after treatment with monoclonal antibodies and direct antiviral agents Mazzotta Valentina, Cozzi Lepri Alessandro, Colavita Francesca, Rosati Silvia, Lalle Eleonora, Cimaglia Claudia, et al. (+18)
600 [GO] 2022―Sep―30 Excess risk for acute myocardial infarction mortality during the COVID-19 pandemic Yee Hui Yeo, Maggie Wang, Xinyuan He, Fan Lv, Yue Zhang, Jian Zu, et al. (+6)
601 [GO] 2022―Sep―30 Impact of COVID-19 vaccination on transmission risk of breakthrough infections: Lessons from Adapted N95 Mask Sampling for Emerging Variants and Interventions Kalpana Sriraman, Ambreen Shaikh, Smriti Vaswani, Tejal Mestry, Grishma Patel, Shalini Sakthivel, et al. (+6)
602 [GO] 2022―Sep―30 Clinical evaluation of an automated, rapid mariPOC® antigen test in screening of symptomatics and asymptomatics for SARS-CoV-2 infection Marianne Gunell, Kaisa Rantasärkkä, Rita Arjonen, Antti Sandén, Tytti Vuorinen
603 [GO] 2022―Sep―28 Whole-transcriptome sequencing data reveals a disparate cognitive and immune signature in COVID-19 patients with and without dementia Jue Yang, Hui Song, Xiaojiang Hao
604 [GO] 2022―Sep―27 SARS-CoV-2 ORF3a inhibits cGAS-STING-mediated autophagy flux and antiviral function Jiaming Su, Si Shen, Ying Hu, Shiqi Chen, Leyi Cheng, Yong Cai, et al. (+4)
605 [GO] 2022―Sep―26 Development of variant-proof SARS-CoV-2, pan-sarbecovirus and pan-β-coronavirus vaccines Jie Zhou, Zezhong Liu, Guangxu Zhang, Wei Xu, Lixiao Xing, Lu Lu, et al. (+2)
606 [GO] 2022―Sep―23 Effectiveness of remdesivir with corticosteroids for COVID-19 patients in intensive care unit: a hospital-based observational study Mariko Hanafusa, Nobutoshi Nawa, Yuki Goto, Tomoki Kawahara, Shigeru Miyamae, Yutaka Ueki, et al. (+5)
607 [GO] 2022―Sep―22 Positive SARS-CoV-2 RT-qPCR of a nasal swab spot after 30 days of conservation on filter paper at room temperature Guillaume André Durand, Abdennour Amroun, Gilda Grard, Cyril Badaut
608 [GO] 2022―Sep―21 Transcriptome-wide Summary Data based Mendelian Randomization analysis reveals 38 novel genes associating with Severe COVID-19 Suhas Krishnamoorthy, Gloria Hoi-Yee Li, Ching-Lung Cheung
609 [GO] 2022―Sep―21 GETTING AHEAD OF MONKEYPOX: Learning from the COVID-19 pandemic experience to prevent the potentially new monkeypox pandemic Widaliz Vega-Rodriguez, Hinh Ly
610 [GO] 2022―Sep―20 Single-cell transcriptome atlas reveals protective characteristics of COVID-19 mRNA vaccine Yong Tan, Shuaiyao Lu, Bo Wang, Xuewen Duan, Yunkai Zhang, Xiaozhong Peng, et al. (+4)
611 [GO] 2022―Sep―19 Anti-SARS-CoV-2 Activity of Targeted Kinase Inhibitors: Repurposing Clinically Available Drugs for COVID-19 Therapy RuthMabel Boytz, Mikołaj Słabicki, Sita Ramaswamy, J.J. Patten, Charles Zou, Chengcheng Meng, et al. (+11)
612 [GO] 2022―Sep―19 SARS-CoV-2 and Natural Infection in Animals Xinyu Qiu, Yi Liu, Ailong Sha
613 [GO] 2022―Sep―17 COVID-19 Vaccine Hesitancy and Related Factors in Canada: A Systematic Review and Meta-analysis Jude Mary Cénat, Pari-Gole Noorishad, Seyed Mohammad Mahdi Moshirian Farahi, Wina Paul Darius, Aya Mesbahi, Olivia Onesi, et al. (+7)
614 [GO] 2022―Sep―17 GSK3326595 is a promising drug to prevent SARS-CoV-2 Omicron and other variants infection by inhibiting ACE2-R671 di-methylation Zhongwei Li, Hongmei Yong, Wenwen Wang, Yue Gao, Pengfei Wang, Xintian Chen, et al. (+3)
615 [GO] 2022―Sep―17 SARS-CoV-2 pandemic, Influenza, and Influenza like illness epidemics: allies or enemies? Giancarlo Ceccarelli, Gabriele d'Ettorre, Alessandro Russo, Silvia Fabris, Massimo Ciccozzi, Gabriella d'Ettorre
616 [GO] 2022―Sep―17 Unveiling HERV-K113-ENV as SARS-CoV-2 severity admissible biomarker by mining transcriptome data Perumal Arumugam Desingu, K. Nagarajan
617 [GO] 2022―Sep―16 ‘Olfactory dysfunction in COVID-19, new insights from a cohort of 353 patients: The ANOSVID study' - Author's reply Timothée Klopfenstein, Vincent Gendrin, Souheil Zayet
618 [GO] 2022―Sep―16 Dysregulation of glutamine/glutamate metabolism in COVID-19 patients: a metabolism study in African population and mini meta-analysis Xiao-kun Li, Bo Tu, Xiao-Ai Zhang, Wen Xu, Jia-hao Chen, Biao Xu, et al. (+9)
619 [GO] 2022―Sep―13 Pan-coronavirus fusion inhibitors to combat COVID-19 and other emerging coronavirus infectious diseases Qiaoshuai Lan, Lijue Wang, Fanke Jiao, Lu Lu, Shuai Xia, Shibo Jiang
620 [GO] 2022―Sep―13 Bioinformatics Analysis of the s2m Mutations within the SARS-CoV-2 Omicron Lineages Caleb J. Frye, Morgan Shine, Joseph A. Makowski, Adam H. Kensinger, Caylee L. Cunningham, Ella J. Milback, et al. (+3)
621 [GO] 2022―Sep―13 The outbreak of SARS-CoV-2 Omicron lineages, immune escape and vaccine effectivity Yongbing Zhou, Huilin Zhi, Yong Teng
622 [GO] 2022―Sep―13 DETECTION OF SARS-COV-2 RNA AND ANTIBODIES IN BREAST MILK OF INFECTED MOTHERS Marianna Calabretto, Rossella D'Alisa, Sara Faraone, Laura Mazzuti, Francesco Pecorini, Ombretta Turriziani
623 [GO] 2022―Sep―12 Development of a multi-recombinase polymerase amplification assay for rapid identification of COVID-19, Influenza A and B Li-Guo Liang, Miao-jin Zhu, Rui He, Dan-Rong Shi, Rui Luo, Jia Ji, et al. (+9)
624 [GO] 2022―Sep―12 Rapid and reliable inactivation protocols for the diagnostics of emerging viruses: the example of SARS-CoV-2 and monkeypox virus Grégory Quéromès, Emilie Frobert, Maude Bouscambert-Duchamp, Antoine Oblette, Martine Valette, Geneviève Billaud, et al. (+4)
625 [GO] 2022―Sep―10 SARS-CoV-2-encoded Inhibitors of Human LINE-1 Retrotransposition Yan Li, Jiaxin Yang, Siyu Shen, Wei Wang, Nian Liu, Haoran Guo, Wei Wei
626 [GO] 2022―Sep―10 COVID-19 is associated with bystander polyclonal autoreactive B cell activation as reflected by a broad autoantibody production, but none is linked to disease severity Wei Jiang, Douglas Johnson, Ruth Adekunle, Hughes Heather, Wanli Xu, Xiaomei Cong, et al. (+5)
627 [GO] 2022―Sep―08 SARS-CoV-2 IgG “heritage” in newborn: a credit of maternal natural infection Laura Marchi, Annalisa Vidiri, Emanuele Arturo Fera, Marta Pallottini, Federica Perelli, Monica Gardelli, et al. (+9)
628 [GO] 2022―Sep―07 Alterations in Vaginal Microbiota among Pregnant Women with COVID-19 Ebru Celik, Gulin Ozcan, Cansel Vatansever, Erxiati Paerhati, Mert Ahmet Kuşkucu, Ozlem Dogan, et al. (+5)
629 [GO] 2022―Sep―07 Hypertension is still a moving target in the context of COVID-19 and post-acute COVID-19 syndrome Mohnad Abdalla, Amr Ahmed El-Arabey, Zhongtao Gai
630 [GO] 2022―Sep―07 COVID-19 Vaccinations and Rates of Infections, Hospitalizations, ICU Admissions, and Deaths in Europe during SARS-CoV-2 Omicron wave in the first quarter of 2022 Piotr Rzymski, Nadiia Kasianchuk, Dominika Sikora, Barbara Poniedziałek
631 [GO] 2022―Sep―07 A Potential Association between Obesity and Reduced Effectiveness of COVID-19 Vaccine-Induced Neutralizing Humoral Immunity Arwa A. Faizo, Fadi S. Qashqari, Sherif A. El- Kafrawy, Osamah Barasheed, Majed N. Almashjary, Mohammed Alfelali, et al. (+6)
632 [GO] 2022―Sep―05 On the SARS-CoV-2 BA.2.75 variant: a genetic and structural point of view Fabio Scarpa, Daria Sanna, Ilenia Azzena, Marta Giovanetti, Domenico Benvenuto, Silvia Angeletti, et al. (+5)
633 [GO] 2022―Sep―03 Differences in incidence and fatality of COVID-19 by SARS-CoV-2 Omicron variant versus Delta variant in relation to vaccine coverage: a world-wide review Chao Wang, Bei Liu, Sihui Zhang, Ninghua Huang, Tianshuo Zhao, Qing-Bin Lu, Fuqiang Cui
634 [GO] 2022―Sep―03 COVID-19 immunopathology: From acute diseases to chronic sequelae Mohd Arish, Wei Qian, Harish Narasimhan, Jie Sun
635 [GO] 2022―Sep―03 Native and activated antithrombin inhibits TMPRSS2 activity and SARS-CoV-2 infection Lukas Wettstein, Patrick Immenschuh, Tatjana Weil, Carina Conzelmann, Yasser Almeida-Hernández, Markus Hoffmann, et al. (+10)
636 [GO] 2022―Sep―03 Key mutations on spike protein altering ACE2 receptor utilization and potentially expanding host range of emerging SARS-CoV-2 variants Qiong Wang, Sheng-Bao Ye, Zhi-Jian Zhou, Jin-Yan Li, Ji-Zhou Lv, Bodan Hu, et al. (+3)
637 [GO] 2022―Sep―03 WHOLE GENOME SEQUENCING OF SARS-CoV-2: COMPARISON OF TARGET CAPTURE AND AMPLICON SINGLE MOLECULAR REAL TIME SEQUENCING PROTOCOLS Florence Nicot, Pauline Trémeaux, Justine Latour, Jeanne Nicolas, Noémie Ranger, Stéphanie Raymond, et al. (+4)
638 [GO] 2022―Aug―31 A Significant Predictor of In-Hospital and Long-term Mortality and Progression In COVID-19 Patients: The End-Stage Liver Disease (MELD) Score Model Yasemin Kaya, Oktay Gülcü, Emrah Aksakal, Kamuran Kalkan, Sidar Şiyar Aydın, Ahmet Kaya, Sedat Bostan
639 [GO] 2022―Aug―30 Genetic predisposition to blood cell indices in relation to severe COVID-19 Yao Yao, Hongfei Song, Fanshuang Zhang, Jibin Liu, Dong Wang, Quansheng Feng, et al. (+2)
640 [GO] 2022―Aug―30 Causal Effect of COVID-19 on Alzheimer's Disease: A Mendelian Randomization Study Ancha Baranova, Hongbao Cao, Fuquan Zhang
641 [GO] 2022―Aug―30 Stability and transmissibility of SARS-CoV-2 in the environment Yansheng Geng, Youchun Wang
642 [GO] 2022―Aug―29 Outbreak of acute respiratory disease caused by human adenovirus type 7 and Human Coronavirus-229E in Zhejiang Province, China Shelan Liu, Jian Cai, Yumin Li, Lihong Ying, Huan Li, An Zhu, et al. (+8)
643 [GO] 2022―Aug―29 The emergence, spread and vanishing of a French SARS-CoV-2 variant exemplifies the fate of RNA virus epidemics and obeys the Mistigri rule Philippe COLSON, Philippe GAUTRET, Jeremy DELERCE, Hervé CHAUDET, Pierre PONTAROTTI, Patrick FORTERRE, et al. (+12)
644 [GO] 2022―Aug―28 Inhibition of MEK signaling prevents SARS-CoV2-induced lung damage and improves the survival of infected mice Jingwu Xie, Michael J. Klemsz, Melissa A. Kacena, George Sandusky, Xiaoli Zhang, Mark H. Kaplan
645 [GO] 2022―Aug―27 Bidirectional causal associations between type 2 diabetes and COVID-19 Hongbao Cao, Ancha Baranova, Xuejuan Wei, Chun Wang, Fuquan Zhang
646 [GO] 2022―Aug―27 Safety and Immunogenicity of a Recombinant Receptor Binding Domain-Based Protein Subunit Vaccine (Noora Vaccine™) Against COVID-19 in Adults: A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Trial Jafar Salimian, Ali Ahmadi, Jafar Amani, Gholamreza Olad, Raheleh Halabian, Ali Saffaei, et al. (+5)
647 [GO] 2022―Aug―27 Disease Severity and Efficacy of Homologous Vaccination Among Patients Infected with SARS-CoV-2 Delta or Omicron VOCs, Compared to Unvaccinated using Main Biomarkers Ayad M. Ali, Ahmed M. Tofiq, Hassan M. Rostam, Kameran M. Ali, Hassan M. Tawfeeq
648 [GO] 2022―Aug―27 Autoimmune Rheumatic Disease after SARS-CoV-2 Vaccination Byeongzu Ghang, Sunjoo Kim, Jinseok Kim
649 [GO] 2022―Aug―27 Highly sensitive and rapid detection of SARS-CoV-2 via a portable CRISPR-Cas13a-based lateral flow assay Hongbo Liu, Shuailei Chang, Sijia Chen, Yue Du, Hui Wang, Chao Wang, et al. (+6)
650 [GO] 2022―Aug―25 What are the long-term holistic health consequences of COVID-19 among survivors? An umbrella systematic review Catherine Paterson, Deborah Davis, Michael Roche, Bernie Bissett, Cara Roberts, Murray Turner, et al. (+2)
651 [GO] 2022―Aug―24 Clinical characteristics and outcomes of patients with COVID-19 and psoriasis Yu Meng, Furong Zeng, Huiyan Sun, Yayun Li, Xiang Chen, Guangtong Deng
652 [GO] 2022―Aug―20 SARS-CoV-2 RNA load in nasopharyngeal specimens from outpatients with breakthrough COVID-19 due to Omicron BA.1 and BA.2 Paula de Michelena, Beatriz Olea, Ignacio Torres, Fernando González-Candelas, David Navarro
653 [GO] 2022―Aug―20 Evaluation of humoral immune responses induced by different SARS-CoV-2 spike trimers from wild-type and emerging variants with individual, sequential, and combinational delivered strategies Chengchao Ding, Shuangshuang Ni, Xiangyu Zhang, Jiajia Xie, Yong Sun, Jun He, et al. (+5)
654 [GO] 2022―Aug―19 Suicidal ideation and attempted suicide among cancer patients during the COVID-19 pandemic Zikun Ma, Yize Mao, Yuanyuan Wang, Zhizhou Duan, Diyang Qu, Chaofeng Li, et al. (+2)
655 [GO] 2022―Aug―19 Ultra-Rapid and Ultra-Sensitive Detection of SARS-CoV-2 Antibodies in COVID-19 Patients via A 3D-Printed Nanomaterial-Based Biosensing Platform Md. Azahar Ali, George Fei Zhang, Chunshan Hu, Bin Yuan, Sanjida Jahan, Georgios D. Kitsios, et al. (+3)
656 [GO] 2022―Aug―16 COVID-19 and inflammatory bowel disease crosstalk: from emerging association to clinical proposal Sha-Sha Tao, Xin-Yi Wang, Xiao-Ke Yang, Yu-Chen Liu, Zi-Yue Fu, Li-Zhi Zhang, et al. (+4)
657 [GO] 2022―Aug―13 A delayed resurgence of respiratory syncytial virus (RSV) during the COVID-19 pandemic: An unpredictable outbreak in a small proportion of children in the Southwest of Iran, April 2022 Leila Mohebi, Hassan Karami, Negar Mirsalehi, Nima Hoveidi Ardestani, Jila Yavarian, Maysam Mard-Soltani, et al. (+2)
658 [GO] 2022―Aug―13 Proportion of asymptomatic infection and non-severe disease caused by SARS-CoV-2 Omicron variant: a systematic review Weien Yu, Yifei Guo, Shenyan Zhang, Yide Kong, Zhongliang Shen, Jiming Zhang
659 [GO] 2022―Aug―10 Tracing the origin of Severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2): A systematic review and narrative synthesis Nagendra Thakur, Sayak Das, Swatantra Kumar, Vimal K. Maurya, Kuldeep Dhama, Janusz T. Paweska, et al. (+5)
660 [GO] 2022―Aug―09 Using Time Weighted Average Change from Baseline of SARS-CoV-2 Viral Load to Assess Impact of Hydroxychloroquine (HCQ) as Post-exposure Prophylaxis and Early Treatment for COVID-19 Raaka Kumbhakar, Moni Neradilek, Ruanne V. Barnabas, Jenell Stewart, Helen C. Stankiewicz Karita, Raphael J. Landovitz, et al. (+11)
661 [GO] 2022―Aug―09 CLINICAL UTILITY OF CIRCULATING CALPROTECTIN TO ASSIST PREDICTION AND MONITORING OF COVID-19 SEVERITY: AN ITALIAN STUDY Maria Infantino, Mariangela Manfredi, Maria Grazia Alessio, Giulia Previtali, Valentina Grossi, Maurizio Benucci, et al. (+10)
662 [GO] 2022―Aug―09 Rapid quantitative monitoring of SARS-CoV-2 spike protein mediated syncytia formation using split NanoLuc Hongliang Wang, Shangrui Guo, Hang Yang
663 [GO] 2022―Aug―09 Production of single-cycle infectious SARS-CoV-2 through a trans-complemented replicon Pak-Hin Hinson Cheung, Zi-Wei Ye, Wai-Yin Lui, Chon Phin Ong, Pearl Chan, Tak-Wang Terence Lee, et al. (+7)
664 [GO] 2022―Aug―09 Humoral responses after inactivated COVID-19 vaccination in individuals with and without prior SARS-CoV-2 infection: A prospective cohort study Mengmeng Jia, Xinming Wang, Wensheng Gong, Jingchuan Zhong, Zhiwei Leng, Lili Ren, et al. (+22)
665 [GO] 2022―Aug―08 Could red cell distribution width be used for predicting cardiac injury in neonates with COVID-19? Sarkhan Elbayiyev, Gülsüm Kadıoğlu Şimşek, Burak Ceran, Mustafa Şenol Akın, H.Gözde Kanmaz Kutman, Fuat Emre Canpolat
666 [GO] 2022―Aug―06 Serosurvey in SARS-CoV-2 inactivated vaccine-elicited neutralizing antibodies against authentic SARS-CoV-2 and its viral variants Lirong Zou, Huan Zhang, Zhonghua Zheng, Yushan Jiang, Yushi Huang, Shujian Lin, et al. (+5)
667 [GO] 2022―Aug―02 Combination therapy with remdesivir and immunomodulators improves respiratory status in COVID-19: A retrospective study Yuichi Kojima, Sho Nakakubo, Keisuke Kamada, Yu Yamashita, Nozomu Takei, Junichi Nakamura, et al. (+6)
668 [GO] 2022―Aug―02 When 3D genome technology meets viral infection, including SARS-CoV-2 Weizheng Liang, Shuangqing Wang, Hao Wang, Xiushen Li, Qingxue Meng, Yan Zhao, Chunfu Zheng
669 [GO] 2022―Aug―02 Influenza Vaccine Awareness and Acceptance in Kidney Disease during the Corononavirus Disease 2019 pandemic Cynthia Ciwei Lim, Jun Jie Leeu, Irene YJ Mok, Hui Zhuan Tan, Jason CJ Choo
670 [GO] 2022―Jul―30 What are the levels of risk of humans contracting SARS-CoV-2 from pets and vice versa? Hannah Murphy, Hinh Ly
671 [GO] 2022―Jul―30 Distinct immune responses in the early phase to natural SARS-CoV-2 infection or vaccination Pai Peng, Haijun Deng, Zhihong Li, Yao Chen, Liang Fang, Jie Hu, et al. (+9)
672 [GO] 2022―Jul―29 Initial Introduction and Spread of the SARS-CoV-2 AY.4.2.1 Delta Variant in Bulgaria, a Genomic Insight Ivailo Alexiev, Marta Giovanetti, Eleonora Cella, Ivan Ivanov, Ivan Stoikov, Deyan Donchev, et al. (+11)
673 [GO] 2022―Jul―29 Neutralizing Antibodies to SARS-CoV-2 Variants of Concern Including Delta and Omicron in Subjects Receiving mRNA-1273, BNT162b2 and Ad26.COV2.S Vaccines George Fei Zhang, Wen Meng, Luping Chen, Ling Ding, Jian Feng, Joseph Perez, et al. (+6)
674 [GO] 2022―Jul―27 Evaluation of response to different COVID-19 vaccines in vaccinated healthcare workers in a single center in Iran Babak Pourakbari, Mona Mirbeyk, Shima Mahmoudi, Reihaneh Hosseinpour Sadeghi, Nima Rezaei, Raheleh Ghasemi, et al. (+2)
675 [GO] 2022―Jul―27 Distributing Effective SARS-CoV-2 Medicines in a Timely Manner Noah Kojima, Vivek Desai, Jeffrey D Klausner
676 [GO] 2022―Jul―26 Reinfection with SARS-CoV-2 in general population, South Korea; nationwide retrospective cohort study Eun Jung Jang, Young June Choe, Go-Woon Yun, Seongjin Wang, U Jin Cho, Seonju Yi, et al. (+2)
677 [GO] 2022―Jul―25 The mutation features and geographical distributions of the surface glycoprotein (S gene) in SARS-CoV-2 strains: a comparative analysis of the early and current strains. Rang Liu, Xinran Lin, Bing Chen, Zhenhui Hou, Qiuju Zhang, Shouren Lin, et al. (+5)
678 [GO] 2022―Jul―23 A soluble DR5-Fc chimeric protein (sDR5-Fc) attenuates inflammatory responses induced by coronavirus MHV-A59 and SARS-CoV-2 Hong Peng, Birong Zheng, Sidi Yang, Jie Du, Liu Cao, Lihong Liu, et al. (+5)
679 [GO] 2022―Jul―22 Concordance of B and T cell responses to SARS-CoV-2 infection, irrespective of symptoms suggestive of COVID-19 Marc F. Österdahl, Eleni Christakou, Deborah Hart, Ffion Harris, Yasaman Shahrabi, Emily Pollock, et al. (+9)
680 [GO] 2022―Jul―21 Rapid and universal detection of SARS-CoV-2 and influenza A virus using a reusable dual-channel optic fiber immunosensor Yi Yang, Rongtao Zhao, Yule Wang, Dan Song, Bo Jiang, Xudong Guo, et al. (+4)
681 [GO] 2022―Jul―21 Single-cell transcriptomic atlas reveals distinct immunological responses between COVID-19 vaccine and natural SARS-CoV-2 infection Yi Wang, Xiaoxia Wang, Laurence Don Wai Luu, Jieqiong Li, Xiaodai Cui, Hailan Yao, et al. (+12)
682 [GO] 2022―Jul―20 Association between COVID-19 and telomere length: a bidirectional Mendelian randomization study Danqi Huang, Siqi Lin, Junting He, Qi Wang, Yiqiang Zhan
683 [GO] 2022―Jul―20 EARLY PREDICTORS OF CLINICAL DETERIORATION IN A COHORT OF OUTPATIENTS WITH COVID-19 IN SOUTHERN ITALY: A MULTICENTER OBSERVATIONAL STUDY Caterina Monari, Mariantonietta Pisaturo, Paolo Maggi, Margherita Macera, Giovanni Di Caprio, Raffaella Pisapia, et al. (+4)
684 [GO] 2022―Jul―20 Safety and efficacy of molnupiravir in SARS-CoV-2 infected patients: a real-life experience Andrea De Vito, Agnese Colpani, Alessandra Bitti, Beatrice Zauli, Maria Chiara Meloni, Marco Fois, et al. (+6)
685 [GO] 2022―Jul―19 Differential avidity determination of IgG directed towards the receptor-binding domain (RBD) of SARS-CoV-2 wildtype and its variants in one assay: Rational tool for the assessment of protective immunity. Georg Bauer, Friedhelm Struck, Eva Staschik, Julia Maile, Karin Wochinz-Richter, Manfred Motz, Erwin Soutschek
686 [GO] 2022―Jul―18 Change in willingness to COVID-19 vaccination in China: two online surveys during the pandemic Ninghua Huang, Chao Wang, Bingfeng Han, Tianshuo Zhao, Bei Liu, Linyi Chen, et al. (+8)
687 [GO] 2022―Jul―15 The deciphering of the immune cells and marker signature in COVID-19 pathogenesis: An update Saade Abdalkareem Jasim, Roaa Salih Mahdi, Dmitry Olegovich Bokov, Mazin A.A. Najm, Guzal N. Sobirova, Zarnigor O. Bafoyeva, et al. (+5)
688 [GO] 2022―Jul―15 Comparison of the respiratory tract microbiome in hospitalized COVID-19 patients with different disease severity Jiali Chen, Xiong Liu, Wei liu, Chaojie Yang, Ruizhong Jia, Yuehua Ke, et al. (+4)
689 [GO] 2022―Jul―14 In response to: Olfactory dysfunction in COVID-19, new insights from a cohort of 353 patients: the ANOSVID study. Luigi Angelo Vaira, Giacomo De Riu, Paolo Boscolo-Rizzo, Claire Hopkins, Jerome R. Lechien
690 [GO] 2022―Jul―14 The global impact of COVID-19 pandemic on the incidence of pediatric new-onset type 1 diabetes and ketoacidosis: A systematic review and meta-analysis Masoud Rahmati, Maryam Keshvari, Shahrzad Mirnasuri, Dong Keon Yon, Seung Won Lee, Jae Il Shin, Lee Smith
691 [GO] 2022―Jul―14 Clinical characteristics and outcomes of healthcare workers with COVID-19 pre- and post-vaccination. Fábio Fernandes Dantas Filho, Eunice Beatriz Martin Chaves, Karen Gomes D'Avila, Jeruza Lavanholi Neyeloff, Rodrigo Pires dos Santos, Denise Rossato Silva
692 [GO] 2022―Jul―14 Dynamics of nasopharyngeal tract phageome and association with disease severity and age of patients during three waves of COVID-19 Carlo Ferravante, Berin S. Arslan-Gatz, Federica Dell'Annunziata, Domenico Palumbo, Jessica Lamberti, Elena Alexandrova, et al. (+11)
693 [GO] 2022―Jul―12 SARS-CoV-2 Infection and Lytic Reactivation of Herpesviruses: a Potential Threat at Post-pandemic Era? Jungang Chen, Jiao Song, Lu Dai, Steven R. Post, Zhiqiang Qin
694 [GO] 2022―Jul―11 Relevant SARS-CoV-2 viremia is associated with COVID-19 severity: prospective cohort study and validation cohort Laura Cardeñoso Domingo, Emilia Roy Vallejo, Nelly Daniela Zurita Cruz, Marta Chicot Llano, Elena Ávalos Pérez-Urria, Ana Barrios, et al. (+32)
695 [GO] 2022―Jul―11 Safety and Immunogenicity of COVID-19 Vaccination in Patients with Hepatocellular Carcinoma (CHESS-NMCID 2101): A Multicenter Prospective Study Xiaolong Qi, Jitao Wang,, Qiran Zhang, Jingwen Ai, Chuan Liu, et al. (+39)
696 [GO] 2022―Jul―11 Rhinovirus persistence during the COVID-19 pandemic - impact on paediatric acute wheezing admissions Kah Wee Teo, Deepa Patel, Shilpa Sisodia, Damian Roland, Erol A Gaillard, Julian W Tang
697 [GO] 2022―Jul―11 COVID-19 vaccine breakthrough infection among fully vaccinated healthcare workers in Duhok governorate, Iraqi Kurdistan; a retrospective cohort study. Hind B. Almufty, Masoud M.Ameen Mamani, Ali Hishyar Ali, Muayad A. Merza
698 [GO] 2022―Jul―11 “Analysis of ACE2 and TMPRSS2 coding variants as a risk factor for SARS-CoV-2 from 946 whole exome sequencing data in the Turkish Population Nilgun Duman, Gulten Tuncel, Atil Bisgin, Sevcan Tug Bozdogan, Sebnem Ozemri Sag, Seref Gul, et al. (+21)
699 [GO] 2022―Jul―11 Clinical Presentations of Adult and Pediatric SARS-CoV-2-Positive Cases in a Community Cohort, Nashville, Tennessee Danielle A. Rankin, Ahmad Yanis, Rana Talj, Harrison L. Howe, Sean M. Bloos, Kailee N. Fernandez, et al. (+8)
700 [GO] 2022―Jul―08 The complex evolutionary dynamics of SARS-CoV-2, a big challenge to control the pandemic of COVID-19 Lauro Velazquez-Salinas
701 [GO] 2022―Jul―08 Ending the COVID-19 pandemic: We still have a long way to go Guangting Zeng, Xia Wang
702 [GO] 2022―Jul―08 Variant-specific burden of SARS-CoV-2 in Michigan: March 2020 through November 2021 Joshua G. Petrie, Marisa C. Eisenberg, Adam S. Lauring, Julie Gilbert, Samantha M. Harrison, Peter M. DeJonge, Emily T. Martin
703 [GO] 2022―Jul―08 Immunoassay and mass cytometry revealed immunological profiles induced by inactivated BBIBP COVID-19 vaccine Zhangkai J. Cheng, Huimin Huang, Qiwen Liu, Ruifen Zhong, Zhiman Liang, Mingshan Xue, et al. (+6)
704 [GO] 2022―Jul―06 Viral load of SARS-CoV-2 Omicron is not high despite its high infectivity Sonoka Yuasa, Jun Nakajima, Yuna Takatsuki, Yuta Takahashi, Chihiro Tani-Sassa, Yumi Iwasaki, et al. (+10)
705 [GO] 2022―Jul―02 INVESTIGATION OF THE EFFECT OF COVID-19 ON SPERM COUNT, MOTILITY AND MORPHOLOGY Tiinçe AKSAK, Deniz AKA SATAR, BAĞCI Rıdvan, Efdal OKTAY GÜLTEKİN, Arzu COŞKUN, Umut DEMİRDELEN
706 [GO] 2022―Jun―29 Temporal Changes in the Accessory Protein Mutations of SARS-CoV-2 Variants and Their Predicted Structural and Functional Effects Christian Alfredo Cruz, Paul Mark Medina
707 [GO] 2022―Jun―29 SARS-CoV-2 ORF10 antagonizes STING-dependent interferon activation and autophagy Lulu Han, Yi Zheng, Jian Deng, Mei-Ling Nan, Yang Xiao, Meng-Wei Zhuang, et al. (+4)
708 [GO] 2022―Jun―28 Response to Finsterer on the letter to the editor ‘‘Diagnose SARS-CoV-2 associated Guillain-Barre syndrome upon appropriate criteria and after exclusion of differentials’’ Nihal Akçay, Gonca Bektaş, Mehmet Emin Menentoğlu, Esra Şevketoğlu
709 [GO] 2022―Jun―27 Genomic diversity of SARS-CoV-2 in Pakistan during the fourth wave of pandemic Massab Umair, Aamer Ikram, Zaira Rehman, Syed Adnan Haider, Muhammad Ammar, Nazish Badar, et al. (+3)
710 [GO] 2022―Jun―27 Pediatric and Adolescent COVID-19 Vaccination Side Effects: A Retrospective Cohort Study of Iranian Teenage group in 2021 Nader Tavakoli, Nahid Nafissi, Sima Shokri, Morteza Fallahpour, Sanaz Soleimani, Taghi Riahi, et al. (+4)
711 [GO] 2022―Jun―27 Molecular imaging on ACE2-dependent transocular infection of coronavirus Danni Li, Liyan Xiong, Guixia Pan, Tingfang Wang, Rou Li, Lizhi Zhu, et al. (+6)
712 [GO] 2022―Jun―27 Disinfection and Decontamination in the Context of SARS-CoV-2 Specific Data Nevio Cimolai
713 [GO] 2022―Jun―25 Impaired serological response to COVID-19 vaccination following anti-cancer therapy: a systematic review and meta-analysis Kefu Tang, Zhiying Wei, Xi Wu
714 [GO] 2022―Jun―24 Antibody Titers After a Third Dose of the SARS-CoV-2 BNT162b2 Vaccine in immunocompromised adults in Greece: is a fourth dose necessary? Konstantina Kontopoulou, Christos T Nakas, Chrysoula Belai, Georgios Papazisis
715 [GO] 2022―Jun―23 Antiviral efficacy of selective estrogen receptor modulators against SARS-CoV-2 infection in vitro and in vivo reveals bazedoxifene acetate as an entry inhibitor Gen Miao, Haoran Peng, Hailin Tang, Yangang Liu, Xu Zheng, Bin Liu, et al. (+8)
716 [GO] 2022―Jun―22 A highly powerful non-specific strategy to reduce COVID-19 deaths Ji-Ming Chen, Guo-Hui Li, Yu-Fei Ji, Ming-Hui Sun, Huan-Yu Gong, Rui-Xu Chen, Ji-Wang Chen
717 [GO] 2022―Jun―18 Emergence of SARS-CoV-2 Omicron BA.5 variant of concern in Western Pennsylvania, United States Tung Phan, Stephanie Boes, Melissa McCullough, Jamie Gribschaw, Jane W. Marsh, Lee H. Harrison, Alan Wells
718 [GO] 2022―Jun―17 COVID-19 pandemic in southern Brazil: Hospitalizations, intensive care unit admissions, lethality rates, and length of stay between March 2020 and April 2022 Jonas Michel Wolf, Helena Petek, Juçara Gasparetto Maccari, Luiz Antonio Nasi
719 [GO] 2022―Jun―17 ARE H1 AND H3 HAPLOTYPES OF ENDOTHELIAL PROTEIN C RECEPTOR (PROCR) AN IMPORTANT FACTOR IN CONTRACTING COVID-19? Mehmet Reşat Ceylan, Nazım Kankılıç, Özlem Öz
720 [GO] 2022―Jun―17 Evaluation of diagnostic test procedures for SARS-CoV-2 using latent class models Jacob Stærk-Østergaard, Carsten Kirkeby, Lasse Engbo Christiansen, Michael Asger Andersen, Camilla Holten Møller, Marianne Voldstedlund, Matthew J. Denwood
721 [GO] 2022―Jun―16 Human seasonal coronavirus neutralisation and COVID-19 severity David A. Wells, Diego Cantoni, Martin Mayora-Neto, Cecilia Di Genova, Alexander Sampson, Matteo Ferrari, et al. (+9)
722 [GO] 2022―Jun―16 Safety and Efficacy of COVID-19 Vaccines in Children and Adolescents: a Systematic Review of Randomized Controlled Trials Fangyuan Tian, Ruonan Yang
723 [GO] 2022―Jun―15 Comparative effectiveness and durability of COVID-19 vaccination against death and severe disease in an ongoing nationwide mass vaccination campaign Theodore Lytras, Flora Kontopidou, Angeliki Lambrou, Sotirios Tsiodras
724 [GO] 2022―Jun―14 Patient Characteristics Associated with Conversion from Negative to Positive SARS-CoV2 PCR Test Results: Implications for Clinical False-Negativity from a Single-Center: A Case-Control Study Vidya L Atluri, Randy M Stalter, Sarah A. McGuffin, Luke Johnson, Bailey Healy, Hailey A. Benesch, et al. (+4)
725 [GO] 2022―Jun―11 Coronavirus disease 2019 (COVID-19) update: From metabolic reprogramming to immunometabolism Mohammad Rudiansyah, Saade Abdalkareem Jasim, Zeinab Gol Mohammad pour, Sara Sohrabi Athar, Ali Salimi Jeda, Rumi Iqbal doewes, et al. (+6)
726 [GO] 2022―Jun―10 Omicron (BA.1) and Sub-Variants (BA.1.1, BA.2 and BA.3) of SARS-CoV-2 Spike Infectivity and Pathogenicity: A Comparative Sequence and Structural-based Computational Assessment Suresh Kumar, Kalimuthu Karuppanan, Gunasekaran Subramaniam
727 [GO] 2022―Jun―09 Dual impacts of the COVID-19 non-pharmaceutical interventions on other infectious diseases Yi-Qing Chen, Yu-Fei Ji, Ji-Ming Chen
728 [GO] 2022―Jun―09 T cell epitopes are largely conserved in the SARS-CoV-2 Omicron subvariant (BA.1, BA.2, BA.3 and GKA) Hu Li, Zhiwei Chen, Xiaoqing Liu, Peng Hu
729 [GO] 2022―Jun―09 SARS-CoV-2and Mutation RT-qPCR Test Positivity Correlation with ABO and Rh Blood Types Burcu Gürer GİRAY, Gökçe Güven AÇIK
730 [GO] 2022―Jun―09 COVID-19 and platelet traits: A bidirectional Mendelian randomization study Ching-Lung Cheung, Shun-Cheong Ho, Suhas Krishnamoorthy, Gloria H.-Y. Li
731 [GO] 2022―Jun―08 Olfactory dysfunction in COVID-19, new insights from a cohort of 353 patients: the ANOSVID study Julien Mercier, Molka Osman, Kevin Bouiller, Can Tipirdamaz, Vincent Gendrin, Catherine Chirouze, et al. (+9)
732 [GO] 2022―Jun―07 Immunophenotyping of lymphocytes and monocytes and the status of cytokines in the clinical course of Covid-19 patients Ufuk Oguz Idiz, Tahir Talat Yurttas, Serife Degirmencioglu, Bagnu Orhan, Emre Erdogan, Husnu Sevik, Mert Mahsuni Sevinc
733 [GO] 2022―Jun―04 Clinical efficacy and in vitro neutralization capacity of monoclonal antibodies for SARS-CoV-2 delta and omicron variants Thomas Theo Brehm, Susanne Pfefferle, Ronald Possel, Mario Karolyi, Alexander Zoufaly, Dominic Wichmann, et al. (+7)
734 [GO] 2022―Jun―03 The potential rationale of COVID-19 vaccine-induced myopericarditis Tsz Yuen Au, Chanika Assavarittirong
735 [GO] 2022―Jun―03 Transchromosomic bovines (TcB)-derived broadly neutralizing antibodies as potent biotherapeutics to counter important emerging viral pathogens with a special focus on SARS-CoV-2, MERS-CoV, Ebola, Zika, HIV-1 and Influenza A virus AbdulRahman A. Saied, Manuela Sales Lima Nascimento, Adriano Henrique do Nascimento Rangel, Krzysztof Skowron, Katarzyna Grudlewska-Buda, Kuldeep Dhama, et al. (+5)
736 [GO] 2022―Jun―03 The clinical and bioinformatics analysis for the role of anti-hypertension drugs on mortality among patients with hypertension hospitalized with COVID-19 Liyang Zhao, Yusi Li, Wenjuan Yi, Kuo Yan, Chao Yang, Sridhar Radhakrishnan, et al. (+6)
737 [GO] 2022―Jun―03 Antibody Response Three Months After SARS-CoV-2 Infection Efdal OKTAY GULTEKIN, Onur GULTEKIN, Arzu COSKUN, Tiince AKSAK
738 [GO] 2022―Jun―03 Analytical sensitivity of the Rapid Antigen Test kits for detection of SARS-CoV-2 Omicron variant BA.2 sub-lineage Gannon C.K. Mak, Stephen S.Y. Lau, Kitty K.Y. Wong, C.S. Lau, Ken H.L. Ng, Edman T.K. Lam, Rickjason C.W. Chan.
739 [GO] 2022―Jun―03 Antibody response after two doses of homologous or heterologous SARS-CoV-2 vaccines in healthcare workers at health promotion centers: a prospective observational study Eun-Hee Nah, Seon Cho, Hyeran Park, Suyoung Kim, Dongwon Noh, Eunjoo Kwon, Han-Ik Cho
740 [GO] 2022―Jun―01 The changing pattern of common respiratory and enteric viruses among outpatient children in Shanghai, China: Two years of the COVID-19 pandemic Pengcheng Liu, Menghua Xu, Lijuan Lu, Ao Ma, Lingfeng Cao, Liyun Su, et al. (+4)
741 [GO] 2022―Jun―01 Unremarkable antibody responses against various infectious agents after inoculation with the BNT162b2 COVID-19 vaccine Kei Kozawa, Hiroki Miura, Yoshiki Kawamura, Yuki Higashimoto, Masaru Ihira, Tetsushi Yoshikawa
742 [GO] 2022―Jun―01 Performance of nasopharyngeal swab and saliva in detecting Delta and Omicron SARS-CoV-2 variants Tina Uršič, Rok Kogoj, Jaka Šikonja, Damijana Roškarič, Monika Jevšnik Virant, Petra Bogovič, Miroslav Petrovec
743 [GO] 2022―May―30 GENOMIC SURVEILLANCE OF LAMBDA SARS-COV-2 VARIANT IN A GLOBAL PHYLOGENETIC CONTEXT Orson Mestanza, Wendy Lizarraga, Carlos Padilla-Rojas, Víctor Jimenez-Vasquez, Verónica Hurtado, Iris S. Molina, et al. (+15)
744 [GO] 2022―May―27 Higher intensive care unit consultations for COVID-19 patients living with HIV compared to those without HIV coinfection in Uganda Brian Fleischer, Ronald Olum, Frederick Nelson Nakwagala, Dianah Rhodah Nassozi, Ivaan Pitua, Elijah Paintsil, et al. (+2)
745 [GO] 2022―May―26 Humoral immune response to authentic circulating SARS-CoV-2 variants elicited by booster vaccination with distinct RBD subunits in mice Yushan Jiang, Huan Zhang, Jianhai Yu, Dong Huang, Linlin Zhai, Mengjun Li, et al. (+11)
746 [GO] 2022―May―26 Receptor Binding Domain Proteins of SARS-CoV-2 Variants Produced in Nicotiana benthamiana Elicit Neutralizing Antibodies Against Variants of Concern Narach Khorattanakulchai, Suwimon Manopwisedjaroen, Kaewta Rattanapisit, Chalisa Panapitakkul, Taratorn Kemthong, Nutchanat Suttisan, et al. (+6)
747 [GO] 2022―May―23 The modified COVID-19 Yorkshire Rehabilitation Scale (C19-YRSm) patient-reported outcome measure for Long Covid or Post-COVID-19 syndrome Manoj Sivan, Nick Preston, Amy Parkin, Sophie Makower, Jeremy Gee, Denise Ross, et al. (+5)
748 [GO] 2022―May―20 Disease of influenza virus and SARS-CoV-2 coinfection: Flurona or Flucovid? Shuwen Liu, Weihua Li, Shibo Jiang
749 [GO] 2022―May―19 Neutralizing activity to SARS-CoV-2 in 1.2 to 10.0 month convalescent plasma samples of COVID-19: a transversal surrogate in vitro study performed in Quito-Ecuador. Boris Villacrés, Elius Paz, María José Burbano, Irina Villacrés-Granda, Daniela Armijos, Mauricio Aguirre
750 [GO] 2022―May―19 May the concurrent use of indomethacin and an anti-oxidant in the SARS-CoV2 infection treatment induce an exacerbation of COVID-19? Salvatore Chirumbolo
751 [GO] 2022―May―19 Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine in people living with HIV: A cross-sectional study Shaohang Cai, Guichan Liao, Tao Yu, Qiqing Gao, Lirong Zou, Huan Zhang, et al. (+6)
752 [GO] 2022―May―19 Frequency and distribution of H1N1 influenza A viruses with oseltamivir-resistant mutations worldwide before and after the 2009 pandemic Weixu Zhang, Hefeng Xu, Shuxuan Guan, Chengmin Wang, Guoying Dong
753 [GO] 2022―May―19 Clinical Manifestations of COVID-19 Breakthrough Infections: A Systematic Review and Meta-Analysis Christine J. Lee, Wongi Woo, Ah Young Kim, Dong Keon Yon, Seung Won Lee, Ai Koyanagi, et al. (+6)
754 [GO] 2022―May―19 SARS-CoV-2 Omicron BA.1 variant breakthrough infections in nursing home residents after an homologous third dose of the Comirnaty® COVID-19 vaccine: Looking for correlates of protection Ignacio Torres, Estela Giménez, Eliseo Albert, Joao Zulaica, Beatriz Álvarez-Rodríguez, Javier S. Burgos, et al. (+18)
755 [GO] 2022―May―18 Unignorable public health risk of avian influenza virus during COVID-19 pandemic Yu Ye, Zaijiao Ye, Liangyu Yang, Bin Xiang, Chunfu Zheng
756 [GO] 2022―May―17 Genomics of Post-Vaccination SARS-CoV-2 Infections During the Delta Dominated Second Wave of COVID-19 Pandemic, from Mumbai Metropolitan Region (MMR), India Kayzad Nilgiriwala, Pratibha Kadam, Grishma Patel, Ambreen Shaikh, Tejal Mestry, Smriti Vaswani, et al. (+10)
757 [GO] 2022―May―17 Respiratory virus circulation in children after relaxation of COVID-19 restrictions in fall 2021 - a nationwide register study in Finland Ilari Kuitunen, Miia Artama, Marjut Haapanen, Marjo Renko
758 [GO] 2022―May―16 ORF8 protein of SARS-CoV-2 reduces male fertility in mice Ting Yu, Qiao Ling, Mengxin Xu, Niu Wang, Lixia Wang, Hanwen Lin, et al. (+12)
759 [GO] 2022―May―16 In silico analysis of mutations near S1/S2 cleavage site in SARS-CoV-2 spike protein reveals increased propensity of glycosylation in Omicron strain Christopher A. Beaudoin, Arun P. Pandurangan, So Yeon Kim, Samir W. Hamaia, Christopher L.-H. Huang, Tom L. Blundell, et al. (+2)
760 [GO] 2022―May―14 Immunogenicity of COVID-19 Vaccines in Patients with Diverse Health Conditions: a Comprehensive Systematic Review Kyuyeon Cho, Seoyeon Park, Eun-Young Kim, Ai Koyanagi, Louis Jacob, Dong Keon Yon, et al. (+6)
761 [GO] 2022―May―11 Individual Genetic Variability Mainly of Proinflammatory Cytokines, Cytokine Receptors and Toll-like receptors Dictates Pathophysiology of COVID-19 Disease Mohammad Kazem Vakil, Yaser Mansoori, Ghaidaa Raheem Lateef Al-Awsi, Ali Hosseinipour, Samaneh Ahsant, Sedigheh Ahmadi, et al. (+10)
762 [GO] 2022―May―10 First detection of SARS-CoV-2 Omicron BA.4 variant in Western Pennsylvania, United States Tung Phan, Stephanie Boes, Melissa McCullough, Jamie Gribschaw, Jane W. Marsh, Lee H. Harrison, Alan Wells
763 [GO] 2022―May―10 Evaluation of water gargle samples for SARS-CoV-2 detection using Abbott ID NOW COVID-19 assay Simon Lévesque, Stéphanie Beauchemin, Maud Vallée, Jean Longtin, Mariève Jacob-Wagner, Jeannot Dumaresq, et al. (+2)
764 [GO] 2022―May―10 Detection of SARS-CoV-2 in Different Human Biofluids Using the Loop-Mediated Isothermal Amplification Assay: A Prospective Diagnostic Study in Fortaleza, Brazil Marco Clementino, Karene Ferreira Cavalcante, Vania Angelica Feitosa Viana, Dayara de Oliveira Silva, Caroline Rebouças Damasceno, Jessica Fernandes de Souza, et al. (+12)
765 [GO] 2022―May―07 Estimation of the COVID-19 Mean Incubation Time: Systematic Review, Meta-analysis, and Sensitivity Analysis Yijia Weng, Grace Y. Yi
766 [GO] 2022―May―07 Use of Saliva and RT-PCR Screening for SARS-CoV-2 Variants of Concern: Surveillance and Monitoring Rodrigo Melim Zerbinati, Michelle Palmieri, Gabriela Schwab, Alvina Clara Felix, Herculano Martinho, Simone Giannecchini, et al. (+4)
767 [GO] 2022―May―06 Immunogenicity and safety of different platforms of COVID-19 vaccines given as a 3rd (booster) dose in healthy adults Zemin Lin, Mengnan Cheng, Fenghua Zhu, Xiaoqian Yang, Jianping Zuo, Shijun He
768 [GO] 2022―May―06 Virus-virus interactions of febrile respiratory syndrome among patients in China based on surveillance data from February 2011 to December 2020 Yucen Dai, Jiao Zhong, Yajia Lan
769 [GO] 2022―May―05 Persistent high-level shedding of cultivable SARS-CoV-2 Delta virus 33 days after onset of COVID-19 in a hospitalized patient with pneumonia Ki Wook Kim, Xinye Wang, Anurag Adhikari, Malinna Yeang, Frances Jenkins, Zin Naing, et al. (+13)
770 [GO] 2022―May―05 Memory impairment and concentration problems in COVID-19 survivors eight weeks after non-ICU hospitalization: a retrospective cohort study C.J.P.W. Keijsers, M.E.A.C. Broeders, V. Baptista Lopes, A.F. Klinkert, J.W.M. Baar, L.M.W. Nahar - van Venrooij, A.P.M. Kerckhoffs
771 [GO] 2022―May―04 Epstein-Barr virus and COVID-19 Arman Shafiee, Sepehr Aghajanian, Mohammad Mobin Teymouri Athar, Omid Kohandel Gargari
772 [GO] 2022―May―04 Acceptance of COVID-19 Booster Vaccination Based on the Protection Motivation Theory (PMT): A Cross-Sectional Study in China Fan Wu, Yue Yuan, Zhaomin Deng, Di Yin, Qiufeng Shen, Jiehua Zeng, et al. (+7)
773 [GO] 2022―May―04 Longer length of stay, days between discharge/first readmission, and pulmonary involvement ≥50% increase prevalence of admissions in ICU in unplanned readmissions after COVID-19 hospitalizations Sarah G. Peixoto, Jonas M. Wolf, Andressa B. Glaeser, Juçara G. Maccari, Luiz A. Nasi
774 [GO] 2022―May―04 Persistently positive SARS-CoV-2 specific IgM during one-year follow-up Marcela Helena Gambim Fonseca, Maria Francilene Souza Silva, Ana Carolina Matias Dinelly Pinto, Amanda Campelo Lima de Melo, Fátima de Cássia Evangelista de Oliveira, Fernanda Montenegro de Carvalho Araújo, Luiz Odorico Monteiro de Andrade
775 [GO] 2022―May―04 Pulse versus Non-pulse Steroid Regimens in Patients with Coronavirus Disease 2019: A Systematic Review and Meta-Analysis Waleed Khokher, Azizullah Beran, Saffa Iftikhar, Saif-Eddin Malhas, Omar Srour, Mohammed Mhanna, et al. (+7)
776 [GO] 2022―May―02 Linear mixed model analysis to evaluate correlations between remdesivir adverse effects with age and gender of patients with mild Covid-19 pneumonia Mohsen Sedighi, Alireza Amanollahi, Omid Moradi Moghaddam, Hamed Basir Ghafouri, Seyede Elahe Hoseini, Nader Tavakoli
777 [GO] 2022―Apr―30 Outbreak of Acute Hepatitis of Unknown etiology in Children; The Critical Role of Healthcare Professionals in Neutralizing Misleading Narratives during the COVID-19 Pandemic Yusra Habib Khan, Tauqeer Hussain Mallhi, Abdullah Salah Alanazi, Muhammad Hammad Butt, Amjad Khan, Muhammad Salman
778 [GO] 2022―Apr―30 Comprehensive Role of SARS-CoV-2 Spike Glycoprotein in Regulating Host Signaling Pathway Shuvomoy Banerjee, Xinyu Wang, Shujuan Du, Caixia Zhu, Yuping Jia, Yuyan Wang, Qiliang Cai
779 [GO] 2022―Apr―28 Influenza is More Severe than Our Newest Enemy (COVID-19) in Hospitalized Children: Experience from a Tertiary Center Selin Tasar, Eda Karadag-Oncel, Dilek Yilmaz-Ciftdogan, Ahu Kara-Aksay, Yildiz Ekemen-Keles, Aysegul Elvan-Tuz, et al. (+4)
780 [GO] 2022―Apr―27 Nonpharmaceutical interventions against the COVID-19 pandemic significantly decreased the spread of enterovirus in children Junfeng Zhang, JiaJia Cao, Qing Ye
781 [GO] 2022―Apr―27 Vaccines for Covid-19: An Insight on Their Effectiveness and Adverse Effects Naila Qamar, Gul Rukh, Sadiq Noor Khan
782 [GO] 2022―Apr―27 Survival of SARS-CoV-2 in artificial seawater and on the surface of inanimate materials Zhi-ping Sun, Si-yu Yang, Xia Cai, Wen-dong Han, Gao-wei Hu, Yun Qian, et al. (+4)
783 [GO] 2022―Apr―27 Impact of SARS-CoV-2 Mu variant on vaccine effectiveness: a comparative genomics study at the peak of the third wave in Bogota, Colombia Angie L. Ramirez, Nicolas Luna, Luz H. Patiño, Sergio Castañeda, Marina Muñoz, Nathalia Ballesteros, et al. (+8)
784 [GO] 2022―Apr―27 Evaluation of A NEW “All in One” SARS-CoV-2 antigen-detecting rapid diagnostic test AND self-test: diagnostic performance and usability in child and adult populationS Thierry Prazuck, Anne Gravier, Daniela Pires-Roteira, Aurelie Theillay, Sandra Pallay, Mathilda Colin, et al. (+3)
785 [GO] 2022―Apr―27 T cell responses to SARS-CoV-2 Omicron spike epitopes with mutations after the third booster dose of an inactivated vaccine Yongzheng Li, Xiuwen Wang, Junyan Jin, Zhenglai Ma, Yan Liu, Xin Zhang, Bin Su
786 [GO] 2022―Apr―27 A fourth dose of Omicron RBD vaccine enhances broad neutralization against SARS-CoV-2 variants including BA.1 and BA.2 in vaccinated mice Bing Zhou, Shuo Song, Huimin Guo, Xinrong Zhou, Qing Fan, Weilong Liu, et al. (+4)
787 [GO] 2022―Apr―27 Coinfection of leptospirosis and coronavirus disease 2019: A retrospective case series from a coastal region in South India Nitin Gupta, William Wilson, Prithvishree Ravindra, Roshini Raghu, Kavitha Saravu
788 [GO] 2022―Apr―25 Comparison of haematologic abnormalities between hospitalized Coronavirus disease 2019 (COVID-19) positive and negative patients with correlation to disease severity and outcome. Swasti Jain, Rachana Meena, Vijay Kumar, Ranvinder Kaur, Umesh Tiwari
789 [GO] 2022―Apr―25 Culture and identification of a “Deltamicron” SARS-CoV-2 in a three cases cluster in southern France Philippe Colson, Pierre-Edouard Fournier, Jeremy Delerce, Matthieu Million, Marielle Bedotto, Linda Houhamdi, et al. (+6)
790 [GO] 2022―Apr―22 Clinical evaluation of the Cue’s COVID-19 diagnostic test to detect Tung Phan, Zachary Cravener, Melissa McCullough, Ashley Mays, Jamie Gribschaw, Alan Wells
791 [GO] 2022―Apr―22 Is monoclonal antibody administration necessary in all vaccinated patients with breakthrough COVID-19 infections? Massimiliano Lanzafame, Enrico Gibbin, Emanuela Lattuada, Sandro Vento
792 [GO] 2022―Apr―22 Dynamics of influenza-like illness under urbanization procedure and COVID-19 pandemic in the sub-center of Beijing during 2013-2021 Chao Wang, Yan-Na Yang, Lu Xi, Li-Li Yang, Juan Du, Zhong-Song Zhang, et al. (+7)
793 [GO] 2022―Apr―22 Generation and Characterization of Humanized Synergistic Neutralizing Antibodies against SARS-CoV-2 Jiazheng Guo, Jun Zhang, Peng Du, Jiansheng Lu, Lei Chen, Ying Huang, et al. (+4)
794 [GO] 2022―Apr―21 SARS-CoV-2 Delta-variant breakthrough infections in nursing home residents at mid-term after Comirnaty® COVID-19 vaccination Ignacio Torres, Juan B. Bellido-Blasco, Concepción Gimeno, Javier S. Burgos, Eliseo Albert, Raúl Moya-Malo, et al. (+17)
795 [GO] 2022―Apr―21 Performance and Application Evaluation of SARS-CoV-2 Antigen Assay Qing Ye, Wenxia Shao, Hanyan Meng
796 [GO] 2022―Apr―20 Identification of SARS-CoV-2 Omicron variant using spike gene target failure and genotyping assays, Gauteng, South Africa, 2021 Kathleen Subramoney, Nkhensani Mtileni, Avani Bharuthram, Ashlyn Davis, Beauty Kalenga, Mikateko Rikhotso, et al. (+16)
797 [GO] 2022―Apr―18 COVID-19 transmission among vaccinated laboratory workers during the second wave in eastern Uttar Pradesh, India Niraj Kumar, Brij Ranjan Misra, Mahendra M Reddy, Hirawati Deval, Kamran Zaman, Rajni Kant
798 [GO] 2022―Apr―18 SARS-CoV-2 specific antibody responses in healthcare workers after a third booster dose of CoronaVac or BNT162b2 vaccine Erdinç Yavuz, Özgür Günal, Eşe Başbulut, Ahmet Şen
799 [GO] 2022―Apr―15 Vaccination strategy for preventing the spread of SARS-CoV-2 in the limited supply condition: a mathematical modelling study Yi-Fan Lin, Yuwei Li, Qibin Duan, Hao Lei, Dechao Tian, Shenglan Xiao, et al. (+5)
800 [GO] 2022―Apr―14 Risks of catching COVID-19 according to vaccination status of healthcare workers during the SARS COV-2 Delta variant dominant period and their clinical characteristics Osman Özüdoğru, Ömer Acer, Yasemin Genç Bahçe
801 [GO] 2022―Apr―14 The recombinant variants of SARS-CoV-2: concerns continues amid COVID-19 pandemic Ranjan K. Mohapatra, Venkataramana Kandi, Hardeep Singh Tuli, Chiranjib Chakraborty, Kuldeep Dhama
802 [GO] 2022―Apr―14 Using Artificial Intelligence to Improve the Diagnostic Efficiency of Pulmonologists in Differentiating COVID-19 Pneumonia from Community-Acquired Pneumonia Erdal İn, Ayşegül Altıntop Geçkil, Gürkan Kavuran, Mahmut Şahin, Nurcan Kırıcı Berber, Mutlu Kuluöztürk
803 [GO] 2022―Apr―14 Gradual increase in RDW is similarly prognostic for in-hospital mortality in both anemic and non-anemic COVID-19 patients Marko Lucijanic, Ena Soric, Martina Sedinic Lacko, Anica Sabljic, Ivan Krecak, Petra Bistrovic, et al. (+6)
804 [GO] 2022―Apr―14 Sequential IgG antibody monitoring for virus-inactivated and adenovirus-vectored COVID-19 vaccine in Brazilian healthcare workers Hui Tzu Lin-Wang, Rogerio Correa Lemes, Eduardo da Silva Farias, Marcio Chaim Bajgelman, Kleber Gomes Franchini, Renata Viana, Carlos Gun
805 [GO] 2022―Apr―14 The kinetics and predictors of anti-SARS-CoV-2 antibodies up to eight months after symptomatic COVID-19: a Czech cross-sectional study Ladislav Štěpánek, Magdaléna Janošíková, Lubomír Štěpánek, Marie Nakládalová, Alena Boriková
806 [GO] 2022―Apr―13 Clinical Characteristics, Complications and Predictors of Outcome of Hospitalized Adult Sudanese Patients with COVID-19 and Malaria Co-Infection in Sudan: A Multi-Center Retrospective Cross-sectional Study Khabab Abbasher Hussien Mohamed Ahmed, Elfatih A. Hasabo, Mazin S. Haroun, Moh.Mah.Fadelallah Eljack, Esraa Hassan Salih, Yousif F. O. Altayeb, et al. (+4)
807 [GO] 2022―Apr―13 Natural infections of SARS-CoV-2 increased in animals: How should humans get along with animals? Shao-Lun Zhai, Chun-Ling Li, Ming-Fei Sun, Jian-Feng Zhang, Chunfu Zheng, Ming Liao
808 [GO] 2022―Apr―13 Association of polymorphisms in genes encoding prothrombotic and cardiovascular risk factors with disease severity in COVID-19 patients: a pilot study Ivana Lapić, Margareta Radić Antolic, Ivana Horvat, Vedran Premužić, Jozefina Palić, Dunja Rogić, Renata Zadro
809 [GO] 2022―Apr―13 A pyrosequencing protocol for rapid identification of SARS-CoV-2 variants Richard A. Allen, Christopher L. Williams, Yvonne Penrod, Cindy McCloskey, Kristin Carpenter-Azevedo, Richard C. Huard, et al. (+2)
810 [GO] 2022―Apr―12 Remdesivir treatment in hospitalized patients affected by COVID-19 pneumonia: a case-control study. Lucio Boglione, Valentina Dodaro, Giulia Meli, Roberto Rostagno, Federica Poletti, Roberta Moglia, et al. (+3)
811 [GO] 2022―Apr―07 RDW shows prognostic potential in hospitalised patients with COVID-19 Sergio Gama
812 [GO] 2022―Apr―07 Evaluation of interleukin-38 levels in serum of patients with coronavirus disease 2019. Wasan W. Al-bassam, Ibtihal A. Al-Karaawi, Inas K. Sharquie, Ali H. Ad'hiah
813 [GO] 2022―Apr―07 The Post-Omicron Situation: The End of the Pandemic or a Bigger Challenge? Esmaeil Mehraeen, SeyedAhmad SeyedAlinaghi, Amirali Karimi
814 [GO] 2022―Apr―05 Concern over Nipah Virus Cases Amidst the COVID-19 Pandemic in India Abdullahi Tunde Aborode, Wireko Andrew Awuah, Aashna Mehta, Toufik Abdul-Rahman, Esther Patience Nansubuga, Mrinmoy Kundu, et al. (+3)
815 [GO] 2022―Apr―04 Dominant clade-featured SARS-CoV-2 co-occurring mutations reveal plausible epistasis: An in silico based hypothetical model
816 [GO] 2022―Apr―04 Variant-specific SARS-CoV-2 within-host kinetics Baptiste Elie, Bénédicte Roquebert, Mircea T. Sofonea, Sabine Trombert-Paolantoni, Vincent Foulongne, Jérémie Guedj, et al. (+2)
817 [GO] 2022―Apr―02 INVESTIGATION AND LONG-TERM MONITORING OF THE PRESENCE OF NEUTRALIZING ANTIBODY IN PATIENTS WITH COVID-19 DISEASE OF DIFFERENT CLINICAL SEVERITY Sedat Kaygusuz, Gülay Korukluoğlu, Yasemin Coşgun, Ömer Şahin, Ferhat Arslan
818 [GO] 2022―Apr―02 COVID-19 Vaccine Side Effects among Nursing Home Residents and Staff Sankalp Bhatnagar, Karen Jones, Ana Montoya
819 [GO] 2022―Apr―02 Inactivated vaccines prevent severe COVID-19 in patients infected with the Delta variant: a comparative study of the Delta and Alpha variants from China. Chanyuan Ye, Yan Lv, Wei Kuang, Lisha Yang, Yingfeng Lu, Jueqing Gu, et al. (+3)
820 [GO] 2022―Apr―02 The impact of COVID-19 on the patient, clinician, healthcare services and society: A patient pathway review Chun Shing Kwok, Elena-Andra Muntean, Christian D Mallen
821 [GO] 2022―Apr―02 Severity of the first 207 infections with the SARS-CoV-2 Omicron BA.2 variant, in Marseille, France, December, 2021-February, 2022. Philippe Gautret, Van Thuan Hoang, Marie Thérèse Jimeno, Jean-Christophe Lagier, Pascal Rossi, Pierre Edouard Fournier, et al. (+2)
822 [GO] 2022―Mar―31 FURIN gene variants (rs6224/rs4702) as potential markers of deat hand cardiovascular traits in severe COVID-19 Eliecer Coto, Guillermo M. Albaiceta, Laura Amado-Rodríguez, Marta García-Clemente, Elías Cuesta-Llavona, Daniel Vázquez-Coto, et al. (+9)
823 [GO] 2022―Mar―31 Comparison of model-specific histopathology in mouse models of COVID-19 Sidi Yang, Liu Cao, Wenting Xu, Tiefeng Xu, Birong Zheng, Yanxi Ji, et al. (+11)
824 [GO] 2022―Mar―31 Letter to the editor: Post COVID-19 joint pain: Preliminary report of the relationship with antinuclear antibodies and inflammation Leonardo Tamariz, Elizabeth Bast, Maria Abad, Nancy Klimas, Pat Caralis, Ana Palacio
825 [GO] 2022―Mar―31 Effect of elevated fasting blood glucose level on the one-year mortality and sequelae in hospitalized COVID-19 patients: a bidirectional cohort study Chen Chai, Kui Chen, Shoupeng Li, Gang Cheng, Wendan Wang, Hongxiang Wang, et al. (+4)
826 [GO] 2022―Mar―31 SARS-CoV-2 cold-chain transmission: Characteristics, risks and strategies Cao Chen, Yenan Feng, Zhixiao Chen, Ying Xia, Xiang Zhao, Ji Wang, et al. (+4)
827 [GO] 2022―Mar―31 Cycle Threshold Values and SARS-CoV-2: Relationship to Demographic Characteristics and Disease Severity Jessica Penney, Amanda Jung, Benjamin Koethe, Shira Doron
828 [GO] 2022―Mar―30 Refractory hyper-eosinophilia associated with newly diagnosed rheumatoid arthritis following inactivated BBV152 COVID-19 vaccine Rohit Singh, Upinder Kaur, Ankur Singh, Sankha Shubhra Chakrabarti
829 [GO] 2022―Mar―26 Melatonin Use for SARS-CoV-2 Infection:Time to Diversify the Treatment Portfolio Russel J. Reiter, Ramaswamy Sharma, Dun Xian Tan, Richard L. Neel, Fedor Simko, Walter Manucha, et al. (+2)
830 [GO] 2022―Mar―24 Mendelian randomization study on the causal effects of COVID-19 on childhood intelligence Gaizhi Zhu, Shan Zhou, Yaqi Xu, Ran Gao, Huan Li, Wenting Su, et al. (+2)
831 [GO] 2022―Mar―24 Comparative characterization of SARS-CoV-2 variants of concern and mouse-adapted strains in mice Qi Chen, Xing-Yao Huang, Yu Liu, Meng-Xu Sun, Bin Ji, Chao Zhou, et al. (+7)
832 [GO] 2022―Mar―24 Reverse genetics systems for SARS-CoV-2 Wenhao Wang, Xiaoxue Peng, Yunyun Jin, Ji-An Pan, Deyin Guo
833 [GO] 2022―Mar―23 SARS-CoV-2, SARS-CoV, and MERS-CoV encode circular RNAs of spliceosome-independent origin Shaomin Yang, Hong Zhou, Mingde Liu, Dabbu Jaijyan, Ruth Cruz-Cosme, Santhamani Ramasamy, et al. (+10)
834 [GO] 2022―Mar―22 Frequency and Severity of COVID-19 in Patients with Various Rheumatic Diseases Treated Regularly with Colchicine or Hydroxychloroquine Mert Oztas, Murat Bektas, Ilker Karacan, Numune Aliyeva, Ayten Dag, Sarvan Aghamuradov, et al. (+9)
835 [GO] 2022―Mar―22 Exploring the Recovery Curve for Gastrointestinal Symptoms from the Acute COVID-19 Phase to Long-term Post-COVID: The LONG-COVID-EXP-CM Multicenter Study César Fernández-de-las-Peñas, José D. Martín-Guerrero, Esperanza Navarro-Pardo, Juan Torres-Macho, Carlos Guijarro, Oscar J. Pellicer-Valero
836 [GO] 2022―Mar―22 Molnupiravir: a lethal mutagenic drug against rapidly mutating SARS-CoV-2 - A narrative review Sri Masyeni, Muhammad Iqhrammullah, Andri Frediansyah, Firzan Nainu, Trina Tallei, Talha Bin Emran, et al. (+3)
837 [GO] 2022―Mar―16 Efficacy and safety of favipiravir plus interferon-beta versus lopinavir/ritonavir plus interferon-beta in moderately ill patients with covid-19: a randomized clinical trial Mehdi Hassaniazad, Hossein Farshidi, Abdollah Gharibzadeh, Ali Bazram, Elham Khalili, Afsaneh Noormandi, Mohammad Fathalipour
838 [GO] 2022―Mar―15 When cyclin-dependent kinases meet viral infections, including SARS-CoV-2 Yan Yan, Yan-dong Tang, Chunfu Zheng
839 [GO] 2022―Mar―15 Are we moving towards ending SARS-CoV-2? Anurag R Mishra, Debasis Nayak, Siddappa N Byrareddy
840 [GO] 2022―Mar―14 Review of selected animal models for respiratory coronavirus infection and its application in drug research Shengle Qin, Runfeng Li, Zhaoguang Zheng, Xuxin Zeng, Yutao Wang, Xinhua Wang
841 [GO] 2022―Mar―12 Factors associated with dexamethasone efficacy in COVID-19. A retrospective investigative cohort study Robin Arcani, Raphael Cauchois, Pierre Suchon, Rodolphe Jean, Pierre-André Jarrot, Quentin Gomes De Pinho, et al. (+6)
842 [GO] 2022―Mar―12 SARS-CoV-2 variants and vulnerability at the global level Vivek P Chavda, Aayushi B. Patel, Darsh D. Vaghasiya
843 [GO] 2022―Mar―12 Short and mid-term SARS-CoV-2 antibody response after inactivated COVID-19 vaccine in hemodialysis and kidney transplant patients Hamad Dheir, Aysel Tocoglu, Hande Toptan, Musa Pinar, Taner Demirci, Mehmet Koroglu, et al. (+6)
844 [GO] 2022―Mar―11 Survival of the hospitalized patients with COVID-19 receiving Atorvastatin: a randomized clinical trial Majid Ghafouri, Hassan Saadati, Mohammad Reza Taghavi, Amir Azimian, Peiman Alesheikh, Mina Sadat Mohajerzadeh, et al. (+3)
845 [GO] 2022―Mar―11 Comparison of Extraction-based and Elution-based Polymerase Chain Reaction Testing, and Automated and Rapid Antigen Testing for the Diagnosis of Severe Acute Respiratory Syndrome Coronavirus 2 Nori Yoshioka, Matsuo Deguchi, Hideharu Hagiya, Masanori Kagita, Hiroko Tsukamoto, Miyuki Takao, et al. (+5)
846 [GO] 2022―Mar―11 Prolonged fecal shedding of SARS-CoV-2 in a young immunocompetent COVID-19 patient: a case report and literature overview Fang Xiao, Peiqi Wan, Qiuling Wei, Guiyang Wei, Yanhong Yu
847 [GO] 2022―Mar―09 Adverse events and Breakthrough infections associated with COVID-19 vaccination in the Indian population G Arora, J Taneja, P Bhardwaj, S Goyal, K Naidu, SK Yadav, et al. (+2)
848 [GO] 2022―Mar―08 When RING Finger Family Proteins meet SARS-CoV-2 Chunmei Cai, Yan-Dong Tang, Chunfu Zheng
849 [GO] 2022―Mar―08 ANALYSIS OF MITOCHONDRIAL DNA CYTOCHROME-B ( CYB ) and ATPase-6 GENE MUTATIONS IN COVID-19 PATIENTS Ebubekir Dirican, Şeyda Tuba Savrun, İsmail Erkan Aydın, Gonca Gülbay, Ülkü Karaman
850 [GO] 2022―Mar―05 New laboratory evidence for the association between endothelial dysfunction and COVID-19 disease progression Nan Liu, Hui Long, Jianhua Sun, Huan Li, Yunting He, Qiang Wang, et al. (+5)
851 [GO] 2022―Mar―05 Current Evidence on Efficacy of COVID-19 Booster Dose Vaccination Against the Omicron Variant. A Systematic Review. Santenna Chenchula, Padmavathi Karunakaran
852 [GO] 2022―Mar―04 Hotspots for SARS-CoV-2 Omicron Variant Spread: Lessons from New York City Juan David Ramírez, Sergio Castañeda, Nathalia Ballesteros, Marina Muñoz, Matthew Hernández, Radhika Banu, et al. (+8)
853 [GO] 2022―Mar―03 Relationship between changes in symptoms and antibody titers after a single vaccination in patients with Long COVID Tomoya Tsuchida, Masanori Hirose, Yoko Inoue, Hiroyuki Kunishima, Takehito Otsubo, Takahide Matsuda
854 [GO] 2022―Mar―02 Active surveillance and early detection of community transmission of SARS-CoV-2 Mu variant (B.1.621) in the Brazilian Amazon Gabriella Sgorlon Oliveira, Luciana Silva-Flannery, Juliana F. da Silva, Charlene Siza, Roberto J. Esteves, Barbara J. Marston, et al. (+9)
855 [GO] 2022―Mar―02 Pityriasis rosea during COVID-19: Pathogenesis, diagnosis, and treatment Giulia Ciccarese, Francesco Drago, Eugenio Marinaro, Aurora Parodi
856 [GO] 2022―Mar―01 Gut Dysbiosis and Long COVID-19: Feeling Gutted Panagiotis Giannos, Konstantinos Prokopidis
857 [GO] 2022―Mar―01 No Human Respiratory Syncytial Virus but SARS-CoV-2 in children under 5 years old referred to Children Medical Center in 2021, Tehran, Iran Arash Letafati, Fahimeh Sadat Aghamirmohammadali, Abbas Rahimi-Foroushani, Seyed Abbas Hasani, Talat Mokhtari-Azad, Jila Yavarian
858 [GO] 2022―Mar―01 The SARS-CoV-2 pandemic in Germany may represent the sum of a large number of local but independent epidemics each initiated by individuals aged 10 - 19 years, middle aged males, or elderly individuals Martin Häusler, Michael Kleines
859 [GO] 2022―Mar―01 SARS-COV-2 GENOMIC MONITORING IN THE STATE OF SÃO PAULO UNVEILS TWO EMERGING AY.43 SUBLINEAGES Alex Ranieri Jerônimo Lima, Gabriela Ribeiro, Vincent Louis Viala, Loyze Paola Oliveira de Lima, Antonio Jorge Martins, Claudia Renata dos Santos Barros, et al. (+34)
860 [GO] 2022―Feb―26 Analysis of influenza trend and impact of COVID-19 in Kezhou, Xinjiang for 8 consecutive years Lin Zeng, Feng Zang, Ninghong Song, Zhanjie Li
861 [GO] 2022―Feb―26 A method comparison study of the high throughput automated HISCL ® SARS-CoV-2 antigen assay using nasopharyngeal swab samples from symptomatic and asymptomatic subjects against conventional RT-PCR. Joachim Linssen, Claire Schapendonk, Marion Münster, Paul Daemen, Janette Rahamat-Langendoen, Heiman Wertheim
862 [GO] 2022―Feb―25 Comparison of performance between three SARS-CoV-2 molecular assays (Aptima™, Laboratory developed test-Fusion and R-GENE®) with a special attention on turn-around time, key point in the laboratory management Caroline Lefeuvre, Adeline Pivert, Emilie Przyrowski, Elise Bouthry, Estelle Darviot, Rafaël Mahieu, et al. (+3)
863 [GO] 2022―Feb―25 Cross-sectional study of SARS-CoV-2 seropositivity among health-care workers and residents of long-term facilities in Italy, January 2021. Valerio Bordino, Noemi Marengo, Jacopo Garlasco, Alessandro Roberto Cornio, Davide Meddis, Savina Ditommaso, et al. (+5)
864 [GO] 2022―Feb―25 TET2 is Required for Type I IFN-mediated Inhibition of Bat-Origin Swine Acute Diarrhea Syndrome Coronavirus Yueyue Duan, Cong Yuan, Xuepeng Suo, Liyan Cao, Xiangyu Kong, Xiangtong Li, et al. (+2)
865 [GO] 2022―Feb―25 Detection and isolation of SARS-CoV-2 Eta variant from the international travelers and local residents of India Pragya D. Yadav, Dimpal A. Nyayanit, Nivedita Gupta, Jayanthi Shastri, Rima R. Sahay, Deepak Y. Patil, et al. (+11)
866 [GO] 2022―Feb―25 Association of viral load with age, gender, disease severity and death in SARS-CoV-2 variants Ömer ACER, Yasemin GENÇ BAHÇE, Osman ÖZÜDOĞRU
867 [GO] 2022―Feb―24 Real world evaluation of the impact of two Anti-SARS-CoV-2 monoclonal antibody regimens on COVID-19 hospitalizations in older adults Kristine A. Sobolewski, Steven M. Smoke, Alison Brophy, Andrew V. Vassallo, Brandon Chen, Patrick Hilden, et al. (+5)
868 [GO] 2022―Feb―21 Vaccination provides protection from respiratory deterioration and death among hospitalized COVID-19 patients: differences between vector and mRNA vaccines Nikolina Busic, Tomo Lucijanic, Bruno Barsic, Ivica Luksic, Iva Busic, Goran Kurdija, et al. (+4)
869 [GO] 2022―Feb―17 The SARS-CoV-2 mu variant shouldn’t be left aside: it warrants attention for its immuo-escaping ability Stefano Pascarella, Martina Bianchi, Marta Giovanetti, Daniele Narzi, Roberto Cauda, Antonio Cassone, Massimo Ciccozzi
870 [GO] 2022―Feb―17 The importance of fecal nucleic acid detection in patients with coronavirus disease(COVID-19):a systematic review and meta-analysis Jin-Qiu Zhou, Gong-Xiang Liu, Xiao- Li Huang, Hua-Tian Gan
871 [GO] 2022―Feb―16 Food for thought: Eating before saliva collection and interference with SARS-CoV-2 detection Matthew M. Hernandez, Mariawy Riollano-Cruz, Mary C. Boyle, Radhika Banu, Paras Shrestha, Brandon Gray, et al. (+17)
872 [GO] 2022―Feb―16 Discrepant serological findings in SARS-CoV-2 PCR negative, hospitalised patients with fever and acute respiratory symptoms during the pandemic Gail Brenda Cross, Claire M. Naftalin, Jinghao Nicholas Ngiam, Natasha Bagdasarian, Chek Meng Poh, Yun Shan Goh, et al. (+12)
873 [GO] 2022―Feb―12 Adverse Events Following Immunization of COVID-19 (Covaxin) vaccine at a Tertiary Care Center of India Swayam Pragyan Parida, Dinesh Prasad Sahu, Arvind Kumar Singh, G Alekhya, Sonu Hangma Subba, Abhisek Mishra, et al. (+2)
874 [GO] 2022―Feb―12 Novel statistics predict the COVID-19 pandemic could terminate in 2022 Ji-Ming Chen
875 [GO] 2022―Feb―11 The impact of the COVID-19 pandemic on the global burden of influenza Dr Temi Lampejo
876 [GO] 2022―Feb―09 Construction and characterization of two SARS-CoV-2 minigenome replicon systems Hu Zhang, Douglas K. Fischer, Masahiro Shuda, Patrick S. Moore, Shou-Jiang Gao, Zandrea Ambrose, Haitao Guo
877 [GO] 2022―Feb―07 Oxidative Stress and Decreased Nrf2 Level in Paediatric Patients with COVID-19 Hüseyin Gümüş, Tuğba Erat, İrfan Öztürk, Abit Demir, Ismail Koyuncu
878 [GO] 2022―Feb―07 Efficacy of Antibody Response Following the Vaccination of SARS-CoV-2 Infected and Non-Infected Healthcare Workers by Two-Dose Inactive Vaccine against COVID-19 Bagnu Dundar, Kadriye Karahangil, Cagri Serdar Elgormus, Hatice Nur Halipci Topsakal
879 [GO] 2022―Feb―07 Long-Term Immunity in Convalescent Syrian Hamsters Provides Protection against New-Variant SARS-CoV-2 Infection of the Lower but not Upper Respiratory Tract Charles B. Stauft, Prabhuanand Selvaraj, Christopher Z. Lien, Matthew F. Starost, Tony T. Wang
880 [GO] 2022―Feb―07 Association of atrial fibrillation with infectivity and severe complications of COVID-19: A nationwide cohort study Jin Park, Jae Il Shin, Dong-Hyeok Kim, Junbeom Park, Jimin Jeon, Jinkwon Kim, Tae-Jin Song
881 [GO] 2022―Feb―04 The emergence and epidemic characteristics of the highly mutated SARS-CoV-2 Omicron variant Dandan Tian, Yanhong Sun, Huihong Xu, Qing Ye
882 [GO] 2022―Feb―04 Third Dose of SARS-CoV-2 Vaccine: A Systematic Review of 30 Published Studies Fausto Petrelli, Andrea Luciani, Karen Borgonovo, Mara Ghilardi, Maria Chiara Parati, Daniela Petrò, et al. (+3)
883 [GO] 2022―Feb―04 COMMENTARYOmicron (B.1.1.529) variant of SARS-CoV-2- Concerns, challenges and recent updates Ranjan K. Mohapatra, Ruchi Tiwari, Ashish K. Sarangi, d. Rabiul Islam, Chiranjib Chakraborty, Kuldeep Dhama
884 [GO] 2022―Feb―03 SARS-CoV-2 Omicron variant is spreading in different parts of the world in three different trends Perumal Arumugam Desingu, K. Nagarajan
885 [GO] 2022―Feb―03 Comparison of immune responses induced by two or three doses of an alum-adjuvanted inactivated SARS-CoV-2 vaccine in mice Ning Luan, Yunfei Wang, Han Cao, Kangyang Lin, Cunbao Liu
886 [GO] 2022―Feb―03 Escaping from COVID-19 emergency accounting on previously infected subjects? Salvatore Chirumbolo, Sergio Pandolfi
887 [GO] 2022―Feb―03 Genomic, immunological and clinical analysis of COVID-19 vaccine breakthrough infections in Beijing, China Di Tian, Yang Song, Man Zhang, Yang Pan, Ziruo Ge, Yao Zhang, et al. (+7)
888 [GO] 2022―Feb―03 An exploratory study on the propagation of SARS-CoV-2 variants: Omicron is the most predominant variant Muthusami R, Saritha K
889 [GO] 2022―Feb―02 Immunogenicity and safety of the BNT162b2 COVID-19 mRNA vaccine in PLWH: a monocentric study in Bari, Italy E. Milano, A. Ricciardi, R. Casciaro, E. Pallara, E. De Vita, D.F. Bavaro, et al. (+4)
890 [GO] 2022―Feb―02 SARS-CoV-2 breakthrough infection and viral load among health care workers after COVID-19 vaccines Gabriela Barbosa, Ana Paula Cunha Chaves, Luciano Kleber de Souza Luna, Nancy Bellei
891 [GO] 2022―Feb―01 Detection of Zika virus disease in Thiruvananthapuram, Kerala, India 2021 during second wave of COVID-19 pandemic Pragya D. Yadav, Vettakkara Kandy Muhammed Niyas, Rajalakshmi Arjun, Rima R. Sahay, Anita M. Shete, Gajanan N. Sapkal, et al. (+4)
892 [GO] 2022―Jan―31 The SARS-CoV-2 omicron wave is indicating the end of pandemic phase but the COVID-19 will continue Sohel Daria, Rabiul Islam
893 [GO] 2022―Jan―31 Global case fatality rate of coronavirus disease 2019 (COVID-19) by continents and national income: a meta-analysis Ramy Abou Ghayda, Keum Hwa Lee, Young Joo Han, Seohyun Ryu, Sung Hwi Hong, Sojung Yoon, et al. (+84)
894 [GO] 2022―Jan―29 Comparing studies of SARS-CoV-2 viral loads requires caution Severino Jefferson Ribeiro da Silva
895 [GO] 2022―Jan―29 COVID-19: a new risk factor or just a new imitator of preeclampsia? NLRP3 activation: a possible commom mechanism Priscila Rezeck Nunes, Mariana Romao-Veiga, Vanessa Rocha Ribeiro, José Carlos Peraçoli, Maria Terezinha Serrao Peracoli, Leandro De Oliveira
896 [GO] 2022―Jan―28 The mechanism of multiple organ dyfunction syndrome in patients with COVID-19 Wenbin Zhao, Hanmeng Li, Jianghua Li, Bin Xu, Jian Xu
897 [GO] 2022―Jan―28 The impact of neutralizing monoclonal antibodies on the outcomes of COVID-19 outpatients: A systematic review and meta-analysis of randomized controlled trials Wei-Ting Lin, Shun-Hsing Hung, Chih-Cheng Lai, Cheng-Yi Wang, Chao-Hsien Chen
898 [GO] 2022―Jan―27 Emerging evidence on Omicron (B.1.1.529) SARS-CoV-2 variant Vineet Sharma, Himanshu Rai, Dev Nath Singh Gautam, Pradeep Kumar Prajapati, Rohit Sharma
899 [GO] 2022―Jan―27 One year follow-up of 18 women who infected COVID-19 while pregnant Yunyan Xianyu, Mengmei Wang, Fang Yue, Xiaoyu Xu, Haizhen Yang, Dong Zhao, Ke Hu
900 [GO] 2022―Jan―26 Recent advances and clinical application in point-of-care testing of SARS-CoV-2 Qing Ye, Dezhao Lu, Ting Zhang, Jianhua Mao, Shiqiang Shang
901 [GO] 2022―Jan―26 Brilacidin, a COVID-19 Drug Candidate, demonstrates broad-spectrum antiviral activity against human coronaviruses OC43, 229E and NL63 through targeting both the virus and the host cell Yanmei Hu, Hyunil Jo, William F. DeGrado, Jun Wang
902 [GO] 2022―Jan―25 Correlation between vaccine coverage and the COVID-19 pandemic throughout the world: based on real-world data Chao Huang, Lijun Yang, Jia Pan, Xiaomei Xu, Rong Peng
903 [GO] 2022―Jan―25 Role of Genetic Variants and Host Polymorphisms on COVID-19: From Viral Entrance Mechanisms to Immunological Reactions Abolfazl Adli, Mandana Rahimi, Reza Khodaie, Niloofar Hashemzaei, Sayed Mostafa Hosseini
904 [GO] 2022―Jan―24 Effects of the Enhanced Public Health Intervention during the COVID-19 Epidemic on Respiratory and Gastrointestinal Infectious Diseases in China Lan Wang, Xiangyu Guo, Na Zhao, Yanyan Ouyang, Binghui Du, Wangli Xu, et al. (+3)
905 [GO] 2022―Jan―22 Seroepidemiology of SARS-CoV-2 in pediatric population during a 16-month period prior to vaccination Filippos Filippatos, Elizabeth-Barbara Tatsi, Charilaos Dellis, Vasiliki Efthymiou, Alexandra Margeli, Ioannis Papassotiriou, et al. (+2)
906 [GO] 2022―Jan―22 Immunological and virological aspects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and hepatitis C virus Fabiola Justina Fumero León, Lucas Lima da Silva, Alanna Calheiros Santos, Vanessa Duarte da Costa, Juliana Custódio Miguel, Julia Trece Marques, et al. (+5)
907 [GO] 2022―Jan―21 Oxidative stress status and vitamin D levels of asymptomatic to mild symptomatic COVID-19 infections during the third trimester of pregnancy: A retrospective study in Metz, France Guillaume Schmitt, Sary Labdouni, Rachid Soulimani, Catherine Delamare, Jaouad Bouayed
908 [GO] 2022―Jan―21 SARS-CoV-2 intralineage variation and temporal patterns of COVID-19 risk factors in three cities of Southeastern Brazil: age, sex, and race André Eterovic, Márcia Aparecida Sperança, Ivana Barros de Campos, Daniela Rodrigues Colpas, Itatiana Ferreira Rodart, Andréia Moreira dos Santos Carmo, et al. (+3)
909 [GO] 2022―Jan―21 Characteristics of the first 1,119 SARS-CoV-2 Omicron variant cases, in Marseille, France, November-December 2021. Linda Houhamdi, Philippe Gautret, Van Thuan Hoang, Pierre-Edouard Fournier, Philippe Colson, Didier Raoult
910 [GO] 2022―Jan―20 Red Blood Cell Distribution Width: a severity indicator in patients with COVID-19 Zhong-hua Wang, Bing-qi Fu, Ying-wen Lin, Xue-biao Wei, Heng Geng, Wei-xin Guo, et al. (+5)
911 [GO] 2022―Jan―20 Transmission dynamics and mutational prevalence of the novel SARS-CoV-2 Omicron Variant of Concern Shailendra K. Saxena, Swatantra Kumar, Saniya Ansari, Janusz T. Paweska, Vimal K. Maurya, Anil K. Tripathi, Ahmed S. Abdel-Moneim
912 [GO] 2022―Jan―19 Remdesivir significantly reduces SARS-CoV-2 viral load on nasopharyngeal swabs in hospitalized patients with COVID-19: a retrospective case-control study. Annalucia Biancofiore, Antonio Mirijello, Maria Alessandra Puteo, Maria Pia Di Viesti, Maria Labonia, Massimiliano Copetti, et al. (+2)
913 [GO] 2022―Jan―15 Efficacy of Melatonin in the Treatment of Patients With COVID-19: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Shao-Huan Lan, Hong-Zin Lee, Chien-Ming Chao, Shen-Peng Chang, Li-Chin Lu, Chih-Cheng Lai
914 [GO] 2022―Jan―15 N protein-based ultrasensitive SARS-CoV-2 antibody detection in seconds via 3D nanoprinted, microarchitected array electrodes Md. Azahar Ali, Chunshan Hu, Fei Zhang, Sanjida Jahan, Bin Yuan, Mohammad S. Saleh, et al. (+2)
915 [GO] 2022―Jan―15 Aggregation of high-frequency RBD mutations of SARS-CoV-2 with three VOCs did not cause significant antigenic drift Tao Li, Zhimin Cui, Yunfei Jia, Ziteng Liang, Jianhui Nie, Li Zhang, et al. (+15)
916 [GO] 2022―Jan―15 Post-sequelae symptoms and comorbidities after COVID-19 Priya Duggal, Tristan Penson, Hannah N. Manley, Candelaria Vergara, Rebecca M. Munday, Dylan Duchen, et al. (+5)
917 [GO] 2022―Jan―15 Case fatality, mortality, socio-demographic, and screening of COVID-19 in the elderly population: A population-based registry study in Iran Elham Davtalab Esmaeili, Ali Fakhari, Behrouz Naghili, Farzad Khodamoradi, Hosein Azizi
918 [GO] 2022―Jan―14 Angiotensin II Infusion in COVID-19: An International, Multicenter, Registry-based Study Ary Serpa Neto, Giovanni Landoni, Marlies Ostermann, Nuttha Lumlertgul, Lui Forni, Lucas Alvarez-Belon, et al. (+6)
919 [GO] 2022―Jan―13 Comparison of the pediatric hospitalizations due to COVID-19 and H1N1pdm09 virus infections during the pandemic period. İlker Devrim, Elif Böncüoğlu, Elif Kıymet, Şahika Şahinkaya, Miray Yılmaz Çelebi, Ela Cem, et al. (+6)
920 [GO] 2022―Jan―13 Omicron variant of SARS-CoV-2: Genomics, transmissibility, and responses to current COVID-19 vaccines Yusha Araf, Fariya Akter, Yan-dong Tang, Rabeya Fatemi, Sorwer Alam Parvez, Chunfu Zheng, Golzar Hossain
921 [GO] 2022―Jan―12 Evaluation of childhood hospitalization rates and degree of severity of SARS-CoV-2 variants including of the B.1.1.7 (Alpha), B.1.315/P.1 (Beta/Gamma), and B.1.617.2 (Delta) Miray Yılmaz Çelebi, Elif Kıymet, Elif Böncüoğlu, Şahika Şahinkaya, Ela Cem, Mine Düzgöl, et al. (+4)
922 [GO] 2022―Jan―11 Twin combination of Omicron and Delta variant triggering a Tsunami wave of ever high surges in COVID-19 cases: a challenging global threat with a special focus on Indian sub-continent Ranjan K. Mohapatra, Ruchi Tiwari, Ashish K. Sarangi, Sanjay K. Sharma, Rekha Khandia, G Saikumar, Kuldeep Dhama
923 [GO] 2022―Jan―10 Distinct mutations and lineages of SARS-CoV-2 virus in the early phase of COVID-19 pandemic and subsequent one-year global expansion Yan Chen, Shiyong Li, Wei Wu, Shuaipeng Geng, Mao Mao
924 [GO] 2022―Jan―10 Evaluation of 3-month follow-up of patients with post-acute COVID-19 syndrome Buğra Kerget, Eda Çelik, Ferhan Kerget, Alperen Aksakal, Elif Yılmazel Uçar, Ömer Araz, Metin Akgün
925 [GO] 2022―Jan―08 COMPARISON OF COVID-19 LABORATORY DIAGNOSIS BY COMMERCIAL KITS: EFFECTIVITY OF RT-PCR TO THE RT-LAMP Yakup Artik, Alp Bahadır Coşğun, Nevra Pelin Cesur, Nedret Hızel, Yavuz Uyar, Haydar Sur, Alp Ayan
926 [GO] 2022―Jan―08 INDUCTION OF HUMORAL AND CELLULAR IMMUNE RESPONSES TO COVID-19 mRNA AND VECTOR VACCINES: A PROSPECTIVE COHORT STUDY IN BULGARIAN HEALTHCARE WORKERS Maria Nikolova, Yana Todorova, Radoslava Emilova, Iva Trifonova, Teodora Gladnishka, Nina Petrova-Yancheva, et al. (+4)
927 [GO] 2022―Jan―08 Arrhythmia May Contribute to Neuropsychiatric Symptoms in COVID-19 Patients Shu Yuan, Si-Cong Jiang, Zhong-Wei Zhang, Yu-Fan Fu, Zi-Lin Li, Jing Hu
928 [GO] 2022―Jan―06 Nasopharyngeal virome analysis of COVID-19 patients during three different waves in Campania Region of Italy Carlo Ferravante, Giuseppina Sanna, Viola Melone, Aurore Fromentier, Teresa Rocco, Ylenia D'Agostino, et al. (+11)
929 [GO] 2022―Jan―06 Neutralizing potency of COVID-19 vaccines against the SARS-CoV-2 Omicron (B.1.1.529) variant Giuseppe Lippi, Camilla Mattiuzzi, Brandon M. Henry
930 [GO] 2022―Jan―06 The SARS-CoV-2 Omicron (B.1.1.529) variant and effectiveness of existing vaccines: What we know so far Md. Sohan, Md. Jamal Hossain, Md. Rabiul Islam
931 [GO] 2022―Jan―05 Monoclonal antibodies as a trick or treat for COVID-19? The example of abciximab Kyriacos Evangelou, Sofia Rozani, Christos Tsagkaris
932 [GO] 2022―Jan―04 Viral Fever of unknown Origin during COVID-19 and Dengue Outbreaks in Pakistan; Is Media spreading panic during pandemic? Yusra Habib Khan, Muhammad Salman, Muhammad Hammad Butt, Tauqeer Hussain Mallhi
933 [GO] 2022―Jan―04 Epidemiological changes of common respiratory viruses in children during the COVID-19 pandemic Qing Ye, Dongjie Wang
934 [GO] 2022―Jan―03 The effectiveness of mRNA-1273 vaccine against COVID-19 caused by delta variant: A systematic review and meta-analysis Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan
935 [GO] 2022―Jan―03 Transient depletion of T cells during COVID-19 and seasonal influenza in people living with HIV Eisuke Adachi, Makoto Saito, Hiroyuki Nagai, Kazuhiko Ikeuchi, Michiko Koga, Takeya Tsutsumi, Hiroshi Yotsuyanagi
936 [GO] 2022―Jan―03 From Alpha to Omicron SARS-CoV-2 variants: what their evolutionary signatures can tell us? Robert Andreata-Santos, Luiz Mário Ramos Janini, Ricardo Durães-Carvalho
937 [GO] 2021―Dec―31 Non-significant Trends in COVID-19 Trials: Is There a Significance? Mostafa Yakoot
938 [GO] 2021―Dec―30 Hyperglycemia and blood glucose deterioration are risk factors for severe COVID-19 with diabetes: a two-center cohort study Fen Xiao, Yingchu Zhou, Meibiao Zhang, Dong Chen, Shaolin Peng, Haoneng Tang, et al. (+5)
939 [GO] 2021―Dec―30 The endogenous factors affecting the detection of serum SARS-CoV-2 IgG/IgM antibodies by ELISA Weiping Liu, Xia Long, Kexing Wan, Minggang Yin, Yi Yin, Bo Zhang, et al. (+2)
940 [GO] 2021―Dec―30 The changing dynamics of neutralizing antibody response within ten months of SARS-CoV-2 infections Aliye Bastug, Hurrem Bodur, Omer Aydos, Nazlican Filazi, Ergun Oksuz, Aykut Ozkul
941 [GO] 2021―Dec―30 Relative Instantaneous Reproduction Number of Omicron SARS-CoV-2 variant with respect to the Delta variant in Denmark Kimihito Ito, Chayada Piantham, Hiroshi Nishiura
942 [GO] 2021―Dec―29 Omicron and S-Gene Target Failure Cases in the Highest COVID-19 Case Rate Region in Canada - December 2021 Anthony Li, Allison Maier, Megan Carter, T. Hugh Guan
943 [GO] 2021―Dec―29 Epidemiology of influenza under the coronavirus disease 2019 pandemic in Nanjing, China Kangjun Wu, Xiaoqing Wu, Weixiang Wang, Lei Hong
944 [GO] 2021―Dec―29 Omicron (B.1.1.529 variant of SARS-CoV-2); an emerging threat: current global scenario Ranjan K. Mohapatra, Ashish K. Sarangi, Venkataramana Kandi, Mohammad Azam, Ruchi Tiwari, Kuldeep Dhama
945 [GO] 2021―Dec―27 Effect of montelukast therapy on clinical course, pulmonary function, and mortality in patients with COVID-19 Buğra Kerget, Ferhan Kerget, Murat Aydın, Ömer Karaşahin
946 [GO] 2021―Dec―27 A large scale meta-analytic atlas of mental health problems prevalence during the COVID-19 early pandemic Elena Dragioti, Han Li, George Tsitsas, Keum Hwa Lee, Jiwoo Choi, Jiwon Kim, et al. (+16)
947 [GO] 2021―Dec―25 TYPING OF ALPHA AND BETA CORONAVIRUSES BY DNA BAR CODING OF NSP12 GENE Waleed A. Nemr, Nashwa K. Radwan
948 [GO] 2021―Dec―25 Antibody Responses of the First Wave of Survivors infected with SARS-CoV-2 One Year Ago Lu He, Cheng Zeng, Yuyang Zeng, Wanzhou Xu, Ying Li, Xiaojie Xie, et al. (+6)
949 [GO] 2021―Dec―24 The Prevalence of Early- and Late-Onset Bacterial, Viral and Fungal Respiratory Superinfections in Invasively Ventilated COVID-19 Patients. Maria Paparoupa, Razaz Aldemyati, Hannes Roggenkamp, Benjamin Berinson, Dominik Nörz, Flaminia Olearo, et al. (+4)
950 [GO] 2021―Dec―23 Genomic characterization of the dominating Beta variant carrying vaccinated (Oxford-AstraZeneca) and non-vaccinated COVID-19 patient samples in Bangladesh: A metagenomics and whole genome approach Md. Mizanur Rahaman, Md. Murshed Hasan Sarkar, M. Shaminur Rahman, M. Rafiul Islam, Israt Islam, Otun Saha, et al. (+8)
951 [GO] 2021―Dec―22 In the age of Omicron variant: Paxlovid raises new hopes of COVID-19 recovery Zhonglei Wang, Liyan Yang
952 [GO] 2021―Dec―22 Bamlanivimab plus etesevimab treatment have a better outcome against COVID-19: A meta-analysis Huai-rong Xiang, Bei He, Yun Li, Xuan Cheng, Qi-zhi Zhang, Wen-xing Peng
953 [GO] 2021―Dec―22 Roles of the polybasic furin cleavage site of spike protein in SARS-CoV-2 replication, pathogenesis, and host immune responses and vaccination Golzar Hossain, Yan-dong Tang, Sharmin Akter, Chunfu Zheng
954 [GO] 2021―Dec―22 OMICRON (B.1.1.529): A new SARS-CoV-2 Variant of Concern mounting worldwide fear Vikram Thakur, Radha Kanta Ratho
955 [GO] 2021―Dec―21 Influence of the COVID-19 pandemic on the incidence and exacerbation of childhood allergic diseases Qing Ye, Bili Wang, Huihui Liu
956 [GO] 2021―Dec―21 Follow-up CT of “Reversed Halo Sign” in SARS-CoV-2 Delta VOC pneumonia: A report of two cases Jing Wu, Jie Tang, Tao Zhang, Yu-Chen Chen, Chao Du
957 [GO] 2021―Dec―20 SARS-CoV-2 Omicron Variant: Could it be Another Threat? Balamurugan Shanmugaraj, Ashwini Malla, Narach Khorattanakulchai, Waranyoo Phoolcharoen
958 [GO] 2021―Dec―18 Antibody responses to COVID-19 vaccines in older adults Rabia Bag Soytas, Mahir Cengiz, Mehmet Sami Islamoglu, Betul Borku Uysal, Serap Yavuzer, Hakan Yavuzer
959 [GO] 2021―Dec―16 Omicron and Delta Variant of SARS-CoV-2: A Comparative Computational Study of Spike Protein Suresh Kumar, Thiviya S. Thambiraja, Kalimuthu Karuppanan, Gunasekaran Subramaniam
960 [GO] 2021―Dec―16 ON THE SEVERITY OF COVID-19 INFECTIONS IN 2021 IN ITALY Fabio Divino, Antonello Maruotti, Alessio Farcomeni, Giovanna Jona Lasinio, Gianfranco Lovison, Massimo Ciccozzi
961 [GO] 2021―Dec―15 Rare case of drug-induced bradycardia associated with the just low dose use of methylprednisolone in a child with COVID-19 Ping Jiang, Shuang-hua Wu, Ting Zhu, Yuan Guo, Yi He
962 [GO] 2021―Dec―14 Preparation of highly specific monoclonal antibodies against SARS-CoV-2 nucleocapsid protein and the preliminary development of antigen detection test strips Chengzuo Xie, Haojie Ding, Jianzu Ding, Yangji Xue, Shaohong Lu, Hangjun Lv
963 [GO] 2021―Dec―14 Mucormycosis in COVID-19 recovered patients Anoop Kumar
964 [GO] 2021―Dec―14 Characterization of the novel SARS-CoV-2 Omicron (B.1.1.529) Variant of Concern and its global perspective Shailendra K. Saxena, Swatantra Kumar, Saniya Ansari, Janusz T. Paweska, Vimal K. Maurya, Anil K. Tripathi, Ahmed S. Abdel-Moneim
965 [GO] 2021―Dec―13 Bilateral Intermediate Uveitis in A Healthy Teenager with Multisystem Inflammatory Syndrome in Children (MIS-C) Secondary to COVID-19 Infection Alex Yee Chau Sim, Ainal Adlin Naffi, Tang Seng Fai, Najma Kori, Wan Asyraf Wan Zaidi, Petrick Periyasamy, et al. (+3)
966 [GO] 2021―Dec―13 The unresolved question on Covid-19 virus origin: the three cards game? Alessandra Borsetti, Fabio Scarpa, Antonello Maruotti, Fabio Divino, Giancarlo Ceccarelli, Marta Giovanetti, Massimo Ciccozzi
967 [GO] 2021―Dec―13 Sequential dynamics of virological and serological changes in the serum of SARS-CoV-2 infected patients Serge Ouoba, Mafumi Okimoto, Shintaro Nagashima, Yoshihiro Kitahara, Kei Miwata, Ko Ko, et al. (+6)
968 [GO] 2021―Dec―13 Sequence analysis of the Emerging Sars-CoV-2 Variant Omicron in South Africa Lulan Wang, Genhong Cheng
969 [GO] 2021―Dec―09 Efficacy and safety of current treatment interventions for patients with severe COVID-19 infection: a network meta-analysis of randomised controlled trials Gang Zhao, Qinglin Cheng, Junfang Chen, Qingjun Jia, Zijian Fang
970 [GO] 2021―Dec―09 The variants of SARS-CoV-2 and the challenges of vaccines Xiucui Han, Qing Ye
971 [GO] 2021―Dec―08 Robust clinical detection of SARS-CoV-2 variants by RT-PCR/MALDI-TOF multi-target approach Matthew M. Hernandez, Radhika Banu, Ana S. Gonzalez-Reiche, Adriana Guchte, Zenab Khan, Paras Shrestha, et al. (+20)
972 [GO] 2021―Dec―08 Modelling and Forecasting the Total Number of Cases and Deaths Due to Pandemic Nasrullah Khan, Asma Arshad, Muhammad Azam, Ali Hussein AL-Marshadi, Muhammad Aslam
973 [GO] 2021―Dec―07 What is the true place of the SARS-CoV-2 rapid point-of-care antigen test in the hospital setting? Lessons learned from real life. Steven Roger, Caroline Lefeuvre, Adeline Pivert, Alexandra Ducancelle, Dominique Savary, Élise Bouthry, Hélène Le Guillou-Guillemette
974 [GO] 2021―Dec―04 Total antioxidant capacity (TAC) as a marker of severity of COVID-19 infection; possible prognostic and therapeutic clinical application Neda Yaghoubi, Masoud Youssefi, Farahzad Jabbari Azad, Faramarz Farzad, Zahra Yavari, Farnaz Zahedi Avval
975 [GO] 2021―Dec―04 Spatiotemporal evolution, pattern of diffusion and influencing factors of the COVID-19 epidemic in Hainan Province, China Xing Gao, Gang Li, Jiaobei Wang, Tingting Xu
976 [GO] 2021―Dec―04 Clinical characteristics and prognostic factors of myocarditis associated with the mRNA COVID-19 vaccine Wongi Woo, Ah Young Kim, Dong Keon Yon, Seung Won Lee, Jimin Hwang, Louis Jacob, et al. (+10)
977 [GO] 2021―Dec―04 Detection of highly muted coronavirus variant Omicron (B.1.1.529) is triggering the alarm for South Asian countries: Associated risk factors and preventive actions Sohel Daria, Mohiuddin Ahmed Bhuiyan, Md. Rabiul Islam
978 [GO] 2021―Dec―04 Genomic evidence of SARS-CoV-2 reinfection in the Republic of Korea Ae Kyung Park, Jee Eun Rhee, Il-Hwan Kim, Heui Man Kim, Hyeokjin Lee, Jeong-Ah Kim, et al. (+13)
979 [GO] 2021―Dec―02 Advances in laboratory detection methods and technology application of SARS-CoV-2 Xiucai Zhang, Hanyan Meng, Huihui Liu, Qing Ye
980 [GO] 2021―Dec―01 Combination therapy of tocilizumab and steroid for COVID-19 patients: A meta-analysis Mahmood Moosazadeh, Tahoora Mousavi
981 [GO] 2021―Dec―01 Comparing Reliability of ICD-10-Based COVID-19 Comorbidity Data to Manual Chart Review, a Retrospective Cross-Sectional Study Joseph W. Schaefer, Joshua M. Riley, Michael Li, Dianna R. Cheney-Peters, Chantel M. Venkataraman, Chris J. Li, et al. (+13)
982 [GO] 2021―Dec―01 Public screening for COVID-19 in Wuhan, China and beware of the antibody positive in women and tumor patients Yufeng Shang, Yuxing Liang, Tao Liu, Jingfeng Li, Fuling Zhou
983 [GO] 2021―Dec―01 Omicron variant (B.1.1.529) of SARS-CoV-2, a global urgent public health alert! Shou-Jiang Gao, Haitao Guo, Guangxiang Luo
984 [GO] 2021―Nov―30 Clinical efficacy and adverse events of baricitinib treatment for coronavirus disease-2019 (COVID-19): A systematic review and meta-analysis Zhiwei Lin, Jianyi Niu, Yifan Xu, Lijie Qin, Jiabin Ding, Luqian Zhou
985 [GO] 2021―Nov―30 Prognostic factors and combined use of tocilizumab and corticosteroids in a Spanish cohort of elderly COVID-19 patients. Miguel Angel Duarte Millán, Nieves Mesa Plaza, Marta Guerrero Santillán, Alejandro Morales Ortega, David Bernal Bello, Ana Isabel Farfán Sedano, et al. (+23)
986 [GO] 2021―Nov―30 COVID-19 vaccinations: The unknowns, challenges, and hopes Kawthar Mohamed, Piotr Rzymski, Md Shahidul Islam, Rangarirai Makuku, Ayesha Mushtaq, Amjad Khan, et al. (+15)
987 [GO] 2021―Nov―30 SARS-CoV-2 antibody kinetics in blood donors with a previously positive SARS-CoV-2 antibody test within a seroprevalence survey Mette Bøegh Levring, Dorte Kinggaard Holm, Anna Christine Nilsson, Joschka Martin Bauer, Iben Skov Jensen, Jesper Rømhild Davidsen, et al. (+3)
988 [GO] 2021―Nov―27 Meta-analysis of arbidol versuslopinavir/ritonavir in the treatment of coronavirus disease 2019 Miao Yu, Deng-Chao Wang, Sheng Li, Yue-Hua Lei, Jian Wei, Li-Yan Huang
989 [GO] 2021―Nov―26 Study of the Effects of Interferon β-1a on Hospitalized Patients with COVID-19; SBMU Taskforce on the COVIFERON Study Mohammad Fallahzadeh, Mohamad Amin Pourhoseingholi, Masoud Ghanbari Boroujeni, Sajad Besharati, Masoud Mardani, Minoosh Shabani, et al. (+9)
990 [GO] 2021―Nov―26 Viral loads and profile of the patients infected with SARS-CoV-2 Delta, Alpha or R.1 variants in Tokyo Chihiro Tani-Sassa, Yumi Iwasaki, Naoya Ichimura, Katsutoshi Nagano, Yuna Takatsuki, Sonoka Yuasa, et al. (+9)
991 [GO] 2021―Nov―25 Association of polymorphisms in tumor necrosis factors with SARS-CoV-2 infection and mortality rate: a case-control study and in silico analyses Milad Heidari Nia, Mohsen Rokni, Shekoufeh Mirinejad, Maryam Kargar, Sara Rahdar, Saman Sargazi, et al. (+2)
992 [GO] 2021―Nov―25 Establish reference sequences for each clade of SARS-CoV-2 to provide a basis for virus variation and function research Jian Yu, Shanshan Sun, Qianqian Tang, Chengzhuo Wang, Liangchen Yu, Lulu Ren, et al. (+2)
993 [GO] 2021―Nov―23 Emerging SARS-CoV-2 variants can potentially break set epidemiological barriers in COVID-19 Ashutosh Kumar, Rakesh Parashar, Sujeet Kumar, Muneeb A Faiq, Chiman Kumari, Maheswari Kulandhasamy, et al. (+6)
994 [GO] 2021―Nov―23 A study of the evolution of the third COVID-19 pandemic wave in the Athens metropolitan area, Greece, through two cross-sectional seroepidemiological surveys: March, June 2021 Helena C. Maltezou, Bettina Krumbholz, Maria Mavrouli, Maria Tseroni, Maria N. Gamaletsou, Evanthia Botsa, et al. (+16)
995 [GO] 2021―Nov―23 Effectiveness and Safety of Ivermectin in COVID-19 Patients: A Prospective Study at A Safety-Net Hospital Muhammet Ozer, Suleyman Yasin Goksu, Reena Conception, Esad Ulker, Rodolfo Magallanes Balderas, Mohammed Mahdi, et al. (+6)
996 [GO] 2021―Nov―23 Severe neonatal COVID-19: challenges in management and therapeutic approach Concetta Marsico, Maria Grazia Capretti, Arianna Aceti, Caterina Vocale, Filomena Carfagnini, Carla Serra, et al. (+3)
997 [GO] 2021―Nov―23 Dynamics of spreading of SARS-CoV-2 in a Belgian hemodialysis facility: the importance of the analysis of viral strains Laura Labriola, Jean Ruelle, Anaïs Scohy, François Seghers, Quentin Perlot, Julien De Greef, et al. (+6)
998 [GO] 2021―Nov―20 Profiling serum levels of glutathione reductase and interleukin-10 in positive and negative-PCR COVID-19 outpatients: a comparative study from southwestern Iran Mahshid Naghashpour, Hamid Ghiassian, Sara Mobarak, Maryam Adelipour, Maghsud Piri, Maryam Seyedtabib, Sahar Golabi
999 [GO] 2021―Nov―19 COVID-19 vaccines Mix-and-Match: The Concept, the Efficacy and the Doubts Ronak Rashedi, Noosha Samieefar, Niloofar Masoumi, Sahar Mohseni, Nima Rezaei
1000 [GO] 2021―Nov―17 Evaluation of human coronavirus OC43 and SARS-COV-2 in children with respiratory tract infection during the COVID-19 pandemic Nasrin Keshavarz Valian, Babak Pourakbari, Kosar Asna Ashari, Reihaneh Hosseinpour Sadeghi, Shima Mahmoudi
1001 [GO] 2021―Nov―17 Usefulness of SARS-CoV-2 Antigen Test Sample as input for SARS-CoV-2 RT-PCR analysis Cristina García-Salguero, Esther Culebras, Paloma Merino, Elvira Baos, Alberto Delgado-Iribarren García-Campero
1002 [GO] 2021―Nov―17 Variants of Concern responsible for SARS-CoV-2 vaccine breakthrough infections from India Urvashi B Singh, Mercy Rophina, Rama Chaudhry, Vigneshwar Senthivel, Kiran Bala, Rahul C. Bhoyar, et al. (+15)
1003 [GO] 2021―Nov―16 Safety and immunogenicity of inactivated COVID-19 vaccine in health care workers Saovanee Benjamanukul, Sasiwimon Traiyan, Ritthideach Yorsaeng, Preeyaporn Vichaiwattana, Natthinee Sudhinaraset, Nasamon Wanlapakorn, Yong Poovorawan
1004 [GO] 2021―Nov―16 Postvaccination SARS-CoV-2 infection among healthcare workers - A Systematic Review and meta-analysis Saurabh Chandan, Shahab R. Khan, Smit Deliwala, Babu P. Mohan, Daryl Ramai, Ojasvini C. Chandan, Antonio Facciorusso
1005 [GO] 2021―Nov―16 Anti-oxidants associated with NSAIDs might even exacerbate the progress of SARS-CoV2 disease Salvatore Chirumbolo
1006 [GO] 2021―Nov―12 Analysis of long-term antibody response in COVID-19 patients by symptoms grade, gender, age, BMI, and medication Tuba Ozgocer, Şeyda Nur Dagli, Mehmet Reşat Ceylan, Faruk Disli, Cihat Ucar, Sedat Yildiz
1007 [GO] 2021―Nov―12 SARS-CoV-2 AY.4.2 variant circulating in Italy: genomic preliminary insight Silvia Angeletti, Marta Giovanetti, Marta Fogolari, Eleonora Cella, Lucia De Florio, Carla Lintas, et al. (+11)
1008 [GO] 2021―Nov―12 Clinical features and independent predictors for recurrence of positive SARS-CoV-2 RNA: a propensity score-matched analysis Ke Liu, Xiuli Yang, Chen Feng, Mei Chen, Chuantao Zhang, Yuelian Wang
1009 [GO] 2021―Nov―11 First wave of COVID-19 in Venezuela: Epidemiological, clinical and paraclinical characteristics of first cases David A. Forero-Peña, Fhabián S. Carrión-Nessi, Daniela L. Mendoza-Millán, Óscar D. Omaña-Ávila, Mario D. Mejía-Bernard, Natasha A. Camejo-Ávila, et al. (+17)
1010 [GO] 2021―Nov―10 ANALYSIS BY REAL-TIME PCR OF FIVE TRANSPORT AND CONSERVATION MEDIUM OF NASOPHARYNGEAL SWAB SAMPLES TO COVID-19 DIAGNOSIS IN SANTIAGO OF CHILE Carlos Barrera-Avalos, Roberto Luraschi, Eva Vallejos-Vidal, Maximiliano Figueroa, Esteban Arenillas, Daniela Barría, et al. (+23)
1011 [GO] 2021―Nov―10 Evolution of spike mutations following antibody treatment in two immunocompromised patients with persistent COVID-19 infection Yotam Bronstein, Amos Adler, Haytham Katash, Ora Halutz, Yair Herishanu, Katia Levytskyi
1012 [GO] 2021―Nov―10 Remitting Neuropsychiatric Symptoms in COVID-19 Patients: Viral Cause or Drug Effect? David A. Forero-Peña, Matthew M. Hernandez, Iriana Paola Mozo Herrera, Iván Bolívar Collado Espinal, Joselyn Páez Paz, Carlos Ferro, et al. (+10)
1013 [GO] 2021―Nov―10 Impact of ABO and Rhesus Blood Groups on COVID-19 Susceptibility and Severity: A Case-control Study Anthony Kerbage, Sara Haddad, Lewis Nasr, Albert Riachy, Elio Mekhael, Nabil Nassim, et al. (+4)
1014 [GO] 2021―Nov―10 Changing predominant SARS-CoV-2 lineages drive successive COVID-19 waves in Malaysia, February 2020 to March 2021 I-Ching Sam, Yoong Min Chong, Azwani Abdullah, Jolene Yin Ling Fu, M. Shahnaz Hasan, Fadhil Hadi Jamaluddin, et al. (+10)
1015 [GO] 2021―Nov―10 Factors associated with mechanical ventilation in SARS-CoV-2 patients treated with high flow nasal cannula oxygen and outcomes. Xavier Leroux, Maud Schock, Olivier Augereau, Henry Lessire, Charles Bouterra, Lounis Belilita, et al. (+4)
1016 [GO] 2021―Nov―09 ∆ALB level and COVID-19Dynamic change of serum albumin level can predict the prognosis of COVID-19 patients with hypoalbuminemia Ruirui Feng, Bing Wang, Zhuang Ma, Xiaozhong Guo, Hongyu Li, Yufu Tang, et al. (+12)
1017 [GO] 2021―Nov―09 Precautionary measures for more transmissible C.1.2 covid-19 variant: a caution for qatar and rest of the world. Soha Shawqi Albayat, Sohaib Arshad, Muhammad Asharib Arshad, Abdul Jabbar, Irfan Ullah
1018 [GO] 2021―Nov―05 Associations of heart failure with susceptibility and severe complications of COVID-19: A nationwide cohort study Hyung Jun Kim, Moo-Suk Park, Jae Il Shin, Jin Park, Dong-Hyeok Kim, Jimin Jeon, et al. (+2)
1019 [GO] 2021―Nov―02 Genomic surveillance reveals the detection of SARS-CoV-2 Delta, Beta and Gamma VOCs during the third wave in Pakistan Massab Umair, Aamer Ikram, Muhammad Salman, Syed Adnan Haider, Nazish Badar, Zaira Rehman, et al. (+3)
1020 [GO] 2021―Oct―30 Development and Validation of clinical prediction model to estimate the risk of critical patients with COVID-19 Wenyu Chen, Ming Yao, Lin Hu, Ye Zhang, Qinghe Zhou, Hongwei Ren, et al. (+3)
1021 [GO] 2021―Oct―30 Humoral response to SARS-CoV-2 and seasonal coronaviruses in COVID-19 patients Ortwin Adams, Marcel Andrée, Denise Rabl, Philipp N. Ostermann, Heiner Schaal, Erik Lehnert, et al. (+3)
1022 [GO] 2021―Oct―29 Norovirus Outbreak amid COVID-19 in the United Kingdom; Priorities for Achieving Control Yasmin Farah, Ali Syed Hasan, Ullah Irfan
1023 [GO] 2021―Oct―29 Management of Pregnant Women with COVID-19: A Tertiary Pandemic Center Experience on 1416 Cases Dilek Sahin, Atakan Tanacan, Seyit Ahmet Erol, Fatma Didem Yucel Yetiskin, Berhan Besimoglu, Eda Ozden Tokalioglu, et al. (+11)
1024 [GO] 2021―Oct―29 Vaccine development and technology for SARS-CoV-2: current insights Luigi Cattel, Susanna Giordano, Sara Traina, Tommaso Lupia, Silvia Corcione, Lorenzo Angelone, et al. (+3)
1025 [GO] 2021―Oct―28 Prolonged corticosteroid therapy and cytomegalovirus infection in patients with severe COVID-19 Yuji Yamamoto, Takayuki Shiroyama, Haruhiko Hirata, Tomoki Kuge, Kinnosuke Matsumoto, Midori Yoneda, et al. (+4)
1026 [GO] 2021―Oct―28 Comparative safety of mRNA COVID-19 vaccines to influenza vaccines: a pharmacovigilance analysis of WHO international database Min Seo Kim, Se Yong Jung, Jong Gyun Ahn, Se Jin Park, Yehuda Shoenfeld, Andreas Kronbichler, et al. (+21)
1027 [GO] 2021―Oct―28 “Angiotensin-Converting-Enzyme Insertion/Deletion ( I/D ) polymorphism, ACE activity and COVID-19: a rather controversial hypothesis. A case - control study” Anna Papadopoulou, Paraskevi C. Fragkou, Eirini Maratou, Dimitra Dimopoulou, Antonis Kominakis, Ioanna Kokkinopoulou, et al. (+10)
1028 [GO] 2021―Oct―27 EVALUATION OF ANTIBODY RESPONSE AFTER COVID-19 VACCINATION OF HEALTHCARE WORKERS Elif Bilge Uysal, Sibel Gümüş, Bayhan Bektöre, Hale Bozkurt, Ayşegül Gözalan
1029 [GO] 2021―Oct―26 SARS-CoV-2 variant with mutations in N gene affecting detection by widely used PCR primers Pia Laine, Hanna Nihtilä, Ella Mustanoja, Annina Lyyski, Anne Ylinen, Jukka Hurme, et al. (+4)
1030 [GO] 2021―Oct―22 Performance evaluation of Elecsys SARS-CoV-2 Antigen immunoassay for diagnostic of COVID-19 María C. Montalvo Villalba, Elena Sosa Glaria, Licel de los A. Rodriguez Lay, Odalys Valdés Ramirez, Dayana Vallina García, Amely Arencibia Garcia, et al. (+5)
1031 [GO] 2021―Oct―22 Is the course of COVID-19 associated with tuberculin skin test diameter? A retrospective study Tugba Arslan Gulen, Muhammet Bayraktar, Nese Yaksi, Uner Kayabas
1032 [GO] 2021―Oct―22 Short-term functional changes after hospital discharge by COVID-19 through teleconsultation at a reference service in Northeast Brazil: a cross-sectional study Bárbara R.A.F Barros-Leite, Marcela Raquel de Oliveira Lima, Marina Caminha, Kaliandra Santos, Cristiano Berardo Carneiro da Cunha, Lívia Barboza de Andrade
1033 [GO] 2021―Oct―22 The COVID-19 Yorkshire Rehabilitation Scale (C19-YRS): application and psychometric analysis in a post-COVID-19 syndrome cohort Rory J O’Connor, Nick Preston, Amy Parkin, Sophie Makower, Denise Ross, Jeremy Gee, et al. (+3)
1034 [GO] 2021―Oct―22 THE EVALUATION POTENTIAL GLOBAL IMPACT OF THE N501Y MUTATION IN SARS-COV-2 POSITIVE PATIENTS Selen Zeliha Mart Komurcu, Yakup Artik, Nevra Pelin Cesur, Arzu Tanriverdi, Derya Cakir Erdogan, Sule Celik, Elif Yilmaz Gulec
1035 [GO] 2021―Oct―21 Role of Toll-like receptors in modulation of cytokine storm signaling in SARS-CoV-2-induced COVID-19 Moumita Manik, Rakesh Kumar Singh
1036 [GO] 2021―Oct―21 Concerns on the multiple nomenclature systems for SARS-CoV-2 Xingguang Li
1037 [GO] 2021―Oct―21 Natural spring water gargle samples as an alternative to nasopharyngeal swabs for SARS-CoV-2 detection using a laboratory-developed test Sarah Gobeille Paré, Julie Bestman-Smith, Judith Fafard, Florence Doualla-Bell, Mariève Jacob-Wagner, Christian Lavallée, et al. (+11)
1038 [GO] 2021―Oct―21 Long COVID syndrome-associated brain fog Ali A. Asadi-Pooya, Ali Akbari, Amir Emami, Mehrzad Lotfi, Mahtab Rostamihosseinkhani, Hamid Nemati, et al. (+10)
1039 [GO] 2021―Oct―20 Duration from onset to discharge is longer in COVID-19 patients with low blood regulatory T-cell counts Hiroyasu Kaya, Daisuke Usuda
1040 [GO] 2021―Oct―19 COVID-19 SEQUELAE IN WORKING AGE PATIENTS. A SYSTEMATIC REVIEW. Gabriele d'Ettorre, Elio Gentilini Cacciola, Letizia Santinelli, Gabriella De Girolamo, Ornella Spagnolello, Alessandro Russo, et al. (+5)
1041 [GO] 2021―Oct―19 Introduction of SARS-CoV-2 C.37 (WHO VOI lambda) in the Sao Paulo State, Southeast Brazil Simone Kashima, Svetoslav N. Slavov, Marta Giovanetti, Evandra S. Rodrigues, José S. L. Patané, Vincent L. Viala, et al. (+34)
1042 [GO] 2021―Oct―16 Association between molecular markers of COVID-19 and Alzheimer's disease André Quincozes-Santos, Rafael Lopes da Rosa, Larissa Daniele Bobermin, Emanuela Fernanda Tureta, Lucélia Santi, Walter Orlando Beys-da-Silva
1043 [GO] 2021―Oct―16 Presence and clinical impact of human Herpesvirus-6 infection in patients with moderate to critical Coronavirus disease-19 Katia Lino, Lilian Santos Alves, Jessica Vasques Raposo, Thalia Medeiros, Cintia Fernandes Souza, Andrea Alice da Silva, et al. (+2)
1044 [GO] 2021―Oct―16 The level of Ig anti-RBD SARS-CoV-2 after two doses of CoronaVac vaccine Zulvikar Syambani Ulhaq, Gita Vita Soraya, Kristin Indriana, Rizky Devitasari, I Putu Yupindra Pradiptha, Dilloniar Bahny Zulfikar, et al. (+3)
1045 [GO] 2021―Oct―16 Postvaccination SARS-CoV-2 Alpha (B.1.1.7) Lineage Infection among Healthcare Workers on the Background of IgG Antibodies Ivailo Alexiev, Ivan Ivanov, Ivva Philipova, Nelly Korsun, Ivan Stoykov, Reneta Dimitrova, et al. (+9)
1046 [GO] 2021―Oct―16 Inhibition of Receptor-Binding Domain - ACE2 interaction after two doses of Sinovac's CoronaVac or AstraZeneca/Oxford's AZD1222 SARS-CoV-2 vaccines. Valéria Oliveira Silva, Rosemeire Yamashiro, Cintia Mayumi Ahagon, Ivana Barros de Campos, Isabela Penteriche de Oliveira, Elaine Lopes de Oliveira, et al. (+4)
1047 [GO] 2021―Oct―14 The occurrence of COVID-19 is associated with air quality and relative humidity Ling Tong, Lu Ji, Dan Li, Huihui Xu
1048 [GO] 2021―Oct―14 Prediction of in-hospital mortality with machine learning for COVID-19 patients treated with steroid and Remdesivir Toshiki Kuno, Yuki Sahashi, Shinpei Kawahito, Mai Takahashi, Masao Iwagami, Natalia N. Egorova
1049 [GO] 2021―Oct―11 Discrepancy between frequent occurrence of COVID-19-like symptoms and low seroconversion rates among healthcare workers Dorothea Dehnen, Katja Dehnen, Mirko Trilling, Melanie Fiedler, Julia Drexler, Marcel Goralski, et al. (+4)
1050 [GO] 2021―Oct―09 Breakthrough SARS-CoV-2 infections among BBV-152 (COVAXIN®) and AZD1222 (COVISHIELDT M ) recipients: Report from eastern state of India Girish Chandra Dash, Subhra Subhadra, Jyotirmayee Turuk, Debaprasad Parai, Sonalika Rath, Jyotsnamayee Sabat, et al. (+7)
1051 [GO] 2021―Oct―08 Modulation of Covid-19 cytokine storm by Tocilizumab Alberto Boretti, Bimal Banik
1052 [GO] 2021―Oct―08 Acute SARS-CoV-2 Alpha variant infection leading to placental insufficiency and fetal distress Sander Dumont, Jonas Balduyck, Marijke Reynders, Lieve Vanwalleghem, Barbara Lebbe
1053 [GO] 2021―Oct―08 SARS-CoV-2 rapid antigen test in comparison to RT-PCR targeting different genes: a real-life evaluation among unselected patients in a regional hospital of Italy Davide Treggiari, Chiara Piubelli, Sara Caldrer, Manuela Mistretta, Andrea Ragusa, Pierantonio Orza, et al. (+7)
1054 [GO] 2021―Oct―07 The association between famotidine and in-hospital mortality of patients with COVID-19 Toshiki Kuno, Matsuo So, Mai Takahashi, Natalia N. Egorova
1055 [GO] 2021―Oct―07 The global epidemic of SARS-CoV-2 variants and their mutational immune escape Dandan Tian, YanHong Sun, JianMing Zhou, Qing Ye
1056 [GO] 2021―Oct―01 SARS-CoV-2 Delta Variant infects ACE2 low primary human bronchial epithelial cells more efficiently than other variants Hongmei Li, Ting Liu, Liping Wang, Minghui Wang, Shaoqing Wang
1057 [GO] 2021―Oct―01 Temporal spread and evolution of SARS-CoV-2 in the second pandemic wave in Brazil Jonas Michel Wolf, Diéssy Kipper, Gabriela Ribeiro Borges, André Felipe Streck, Vagner Ricardo Lunge
1058 [GO] 2021―Oct―01 Surveillance genome sequencing reveal multiple SARS-CoV-2 variants circulating in the central Texas, USA with a predominance of Delta variant and review of vaccine breakthrough cases. Manohar B. Mutnal, Shelby Johnson, Nada Mohamed, Rasha Abddelgader, Linden Morales, Marcus Volz, et al. (+3)
1059 [GO] 2021―Sep―30 Assessing influenza vaccination success to inform COVID-19 vaccination campaign Ashley Moreland, Christina Gillezeau, Naomi Alpert, Emanuela Taioli
1060 [GO] 2021―Sep―30 Evaluation of rapid antigen detection test for individuals at risk of SARS-CoV-2 under quarantine Gannon C.K. Mak, Shermen S.M. Au, Mick C.W. Yeung, Dominic M.W. Lau, Kinson K.S. Lau, Ken H.L. Ng, et al. (+3)
1061 [GO] 2021―Sep―29 Increased incidence of COVID-19 in younger patients (May-July 2021) - an argument for extending vaccination? Paul W Bird, Roger Riff, Andrew Folwell, Christopher W Holmes, Julian W Tang
1062 [GO] 2021―Sep―29 Association of race/ethnicity and socioeconomic status with COVID-19 30-day mortality at a Philadelphia medical center using a retrospective cohort study Dianna R. Cheney-Peters, Shuji Mitsuhashi, Dina S. Zaret, Joshua M. Riley, Chantel M. Venkataraman, Joseph W. Schaefer, et al. (+13)
1063 [GO] 2021―Sep―29 Atypical Pityriasis Rosea Associated with mRNA Covid-19 Vaccine Ecem Bostan, Adam Jarbou
1064 [GO] 2021―Sep―29 Can Caspase-3 Gene Expression Levels Show the Degree of Injury in Cells in SARS-CoV-2 Infection? Pinar Yildiz Gulhan, Recep Eroz, Ozlem Ataoglu, Nevin İnce, Fatih Davran, Cihadiye Elif Öztürk, Oner Abidin Balbay
1065 [GO] 2021―Sep―28 Secondary Organizing Pneumonia After Recovery of Mild COVID-19 Infection Evgeny Golbets, Alon Kaplan, Tali Shafat, Yael Yagel, Alan Jotkowitz, Jenan Awesat, Leonid Barski
1066 [GO] 2021―Sep―28 SARS-CoV-2 Delta VOC pneumonia with CT follow-ups: a case report Jing Wu, Jie Tang, Tao Zhang, Yu-Chen Chen, Chao Du
1067 [GO] 2021―Sep―27 A systematic review on SARS-CoV-2 Associated Fungal Co-Infections Shringika Soni, Ramesh N Pudake, Utkarsh Jain, Nidhi Chauhan
1068 [GO] 2021―Sep―24 Do High Dose Corticosteroids Improve Outcomes in Hospitalized COVID-19 Patients? Gagan Kumar, Dhaval Patel, Martin Hererra, David Jefferies, Ankit Sakhuja, Mark Meersman CPA, et al. (+3)
1069 [GO] 2021―Sep―21 SARS-CoV-2 and blood donations in Portugal, June-July 2020 João R. Mesquita, Patrícia Barradas, Priscilla Gomes da Silva, Ana Sofia Ferreira, Eliane Silva, Isabel M. Matas, et al. (+6)
1070 [GO] 2021―Sep―21 Coinfection between SARS-CoV-2 and vector-borne diseases in Luanda, Angola Cruz S. Sebastião, Celestina Gaston, Joana Paula Paixão, Euclides N.M. Sacomboio, Zoraima Neto, Jocelyne Neto de Vasconcelos, Joana Morais
1071 [GO] 2021―Sep―20 Using Different Machine Learning Models to Classify Patients with Mild and Severe Cases of COVID-19 Based on Multivariate Blood Testing Rui-kun Zhang, Qi Xiao, Sheng-lang Zhu, Hai-yan Lin, Ming Tang
1072 [GO] 2021―Sep―20 COMPARISON OF PULSE-DOSE AND HIGH-DOSE CORTICOSTEROIDS WITH NO CORTICOSTEROID TREATMENT FOR COVID-19 PNEUMONIA IN THE INTENSIVE CARE UNIT Hamid Yaqoob, Daniel Greenberg, Frank Hwang, Curtis Lee, David Vernik, Ravi Manglani, et al. (+4)
1073 [GO] 2021―Sep―18 SARS-CoV-2 specific antibody responses after third CoronaVac or BNT162b2 vaccine following two-dose CoronaVac vaccine regimen Ali Umit Keskin, Sibel Bolukcu, Pinar Ciragil, Aynur Eren Topkaya
1074 [GO] 2021―Sep―16 Palmitoylation of SARS-CoV-2 S protein is critical for S mediated syncytia formation and virus entry Daoqun Li, Yihan Liu, Yue Lu, Shan Gao, Leiliang Zhang
1075 [GO] 2021―Sep―15 Should the world collaborate imminently to develop neglected live attenuated vaccines for COVID-19? Ji-Ming Chen
1076 [GO] 2021―Sep―15 Assessment of two-pool multiplex long-amplicon nanopore sequencing of SARS-CoV-2 Hongjie Liu, Jinhui Li, Yanfeng Lin, Xiaochen Bo, Hongbin Song, Kuibiao Li, et al. (+2)
1077 [GO] 2021―Sep―15 Evaluation of the correlation between the Access SARS-CoV-2 IgM and IgG II antibody tests with the SARS-CoV-2 surrogate virus neutralization test Yutaro Kitagawa, Kazuo Imai, Masaru Matsuoka, Ai Fukada, Katsumi Kubota, Momoko Sato, et al. (+6)
1078 [GO] 2021―Sep―13 Effect of Mortality from COVID-19 on Inpatient Outcomes Matthew C. Phillips, Laura Sarff, Josh Banerjee, Chase Coffey, Paul Holtom, Steve Meurer, et al. (+2)
1079 [GO] 2021―Sep―13 The first Italian outbreak of SARS-CoV-2 B.1.1.7 lineage in Corzano, Lombardy Serena Messali, Giovanni Campisi, Marta Giovanetti, Massimo Ciccozzi, Arnaldo Caruso, Francesca Caccuri
1080 [GO] 2021―Sep―13 A third booster dose may be necessary to mitigate neutralizing antibody fading after inoculation with two doses of an inactivated SARS-CoV-2 vaccine Lei Yue, Tianhong Xie, Ting Yang, Jian Zhou, Hongbo chen, Hailian Zhu, et al. (+8)
1081 [GO] 2021―Sep―10 Viral hepatitis amidst COVID-19 in Africa: Implications and Recommendations Syeda Kanza Kazmi, Fatima Muhammad Asad Khan, Valentino Natoli, Reem Hunain, Zarmina Islam, Ana Carla dos Santos Costa, et al. (+2)
1082 [GO] 2021―Sep―10 Molecular evolutionary characteristics of SARS-CoV-2 emerging in the United States Shihang Wang, Xuanyu Xu, Cai Wei, Sicong Li, Jingying Zhao, Yin Zheng, et al. (+4)
1083 [GO] 2021―Sep―09 Emergence of SARS-CoV-2 lineage B.1.617.2 in the local community of Hong Kong Alan K.L. Tsang, Gannon C.K. Mak, Patricia K.L. Leung, Peter K.C. Cheng, Peter C.W. Yip, Edman T.K. Lam, et al. (+2)
1084 [GO] 2021―Sep―09 Tracking down B.1.351 SARS-CoV-2 variant in Pakistan through genomic surveillance Massab Umair, Aamer Ikram, Nazish Badar, Syed Adnan Haider, Zaira Rehman, Muhammad Ammar, et al. (+4)
1085 [GO] 2021―Sep―08 Unreliable predictions about COVID-19 infections and hospitalizations make people worry: the case of Italy. Fabio Divino, Massimo Ciccozzi, Alessio Farcomeni, Giovanna Jona Lasinio, Gianfranco Lovison, Antonello Maruotti
1086 [GO] 2021―Sep―07 Occurrence of COVID-19 in priority groups receiving ChAdOx1 nCoV-19 coronavirus vaccine (recombinant): a preliminary analysis from north India Upinder Kaur, Sapna Bala, Bisweswar Ojha MBBS, Sumit Jaiswal MBBS, Sangeeta Kansal, Sankha Shubhra Chakrabarti
1087 [GO] 2021―Sep―07 Fewer non-Covid-19 respiratory tract infections and gastro-intestinal infections during the Covid-19 pandemic Christian Tanislav, Karel Kostev
1088 [GO] 2021―Sep―07 On reaching herd immunity during COVID-19 pandemic and further issues Sergio Pandolfi, Salvatore Chirumbolo
1089 [GO] 2021―Sep―07 Comparison of demographic and clinical characteristics of hospitalized COVID-19 patients with severe/critical illness in the first wave vs the second wave. Elif Sargin Altunok, Celal Satici, Veysel Dinc, Sadettin Kamat, Mustafa Alkan, Mustafa Asim Demirkol, et al. (+4)
1090 [GO] 2021―Sep―07 Atypical bacterial co-infections among patients with COVID-19: a study from India Rama Chaudhry, K Sreenath, Priyam Batra, EV Vinayaraj, Nisha Rathor, KVP Saikiran, et al. (+8)
1091 [GO] 2021―Sep―01 The Role of Type I Interferon in the Treatment of COVID-19 Fatemeh Sodeifian, Mahsa Nikfarjam, Naghmeh Kian, Kawthar Mohamed, Nima Rezaei
1092 [GO] 2021―Sep―01 COVID-19 Disease in Hospitalised Young Adults in India and China: Evaluation of Risk Factors Predicting Progression Across Two Major Ethnic Groups Smriti Panda, Sankanika Roy, Rohit K Garg, Gan Hui, Jack Gorard, Mayank Bhutada, et al. (+5)
1093 [GO] 2021―Sep―01 Immunogenicity After Two Doses of Inactivated Virus Vaccine in Healthcare Workers with and without Previous COVID-19 Infection: Prospective Observational Study Tuğba Yanık Yalçın, Deniz İlhan Topçu, Özlem Doğan, Saliha Aydın, Nuran Sarı, Çiğdem Erol, et al. (+4)
1094 [GO] 2021―Sep―01 Guillain-Barré syndrome is immunogenic in SARS-CoV-2 infected Josef Finsterer, Talal Almas
1095 [GO] 2021―Aug―31 Post-acute COVID-19 syndrome (PCS) and Health related Quality of life (HRQoL)- A systematic review and Meta-analysis. Preeti Malik, Karan Patel, Candida Pinto, Richa Jaiswal, Raghavendra Tirupathi, Shreejith Pillai, Urvish Patel
1096 [GO] 2021―Aug―30 Features of capsule endoscopy in COVID-19 patients with a six-month follow up: a prospective observational study Xiao-Ping Xie, Li-Ping Sheng, Chao-Qun Han, Yu Jin, Tao Bai, Xiao-Hua Hou, et al. (+2)
1097 [GO] 2021―Aug―30 Elements of Th1 / Th2 response and disease severity in COVID-19 patients: A short report Karolina Akinosoglou, Anne-Lise Delastic, Vasilina Dimakopoulou, Markos Marangos, Charalambos Gogos
1098 [GO] 2021―Aug―30 Melatonin effects on sleep quality and outcomes of COVID-19 patients: An open-label, Randomized, Controlled Trial Seyed Abbas Mousavi, Keyvan Heydari, Hossein Mehravaran, Majid Saeedi, Reza Alizadeh-Navaei, Akbar Hedayatizadeh-Omran, Amir Shamshirian
1099 [GO] 2021―Aug―30 High proportion of low cycle threshold value as an early indicator of COVID-19 surge Baijayantimala Mishra, Jai Ranjan, Prashanth Purushotham, Swarnatrisha Saha, Poesy Payal, Punyatoya Kar, et al. (+2)
1100 [GO] 2021―Aug―30 Neutralization of Alpha, Gamma, and D614G SARS-CoV-2 variants by CoronaVac vaccine-induced antibodies. Jorge Fernández, Nicole Bruneau, Rodrigo Fasce, Héctor San Martín, Monserrat Balanda, Patricia Bustos, et al. (+3)
1101 [GO] 2021―Aug―28 The impact of the COVID-19 pandemic on impending cancer deaths due to delays in diagnosis in the UK Umaima Wasim, Muhammad Junaid Tahir, Ahsun Rizwan Siddiqi, Abdul Jabbar, Irfan Ullah
1102 [GO] 2021―Aug―27 Prevalence and clinical outcomes of pleural effusion in COVID-19 patients: A systematic review and meta-analysis Sawai Singh Rathore, Nabeel Hussain, Ade Harrison Manju, Qingqing Wen, Sohaib Tousif, Camilo Andrés Avendaño-Capriles, et al. (+8)
1103 [GO] 2021―Aug―27 SARS-CoV-2 N-antigenemia in critically ill adult COVID-19 patients: frequency and association with inflammatory and tissue-damage biomarkers Beatriz Olea, Eliseo Albert, Ignacio Torres, Roberto Gozalbo-Rovira, Nieves Carbonell, José Ferreres, et al. (+6)
1104 [GO] 2021―Aug―26 Can rapid antibody tests and chest computed tomography really substitute real-time polymerase chain reaction in COVID-19? Giulio Cabrelle, Chiara Zanon, Filippo Crimì, Emilio Quaia
1105 [GO] 2021―Aug―26 Impact of the COVID-19 pandemic on the incidence of dengue fever in Peru Rubí Plasencia-Dueñas, Virgilio E. Failoc-Rojas, Alfonso J. Rodriguez-Morales
1106 [GO] 2021―Aug―26 Corticosteroids for COVID-19 symptoms and quality of life at 1 year from admission Ignacio Pérez Catalán, Celia Roig Martí, Daniela Palomo de la Sota, Alejandro Cardenal Álvarez, Maria José Esteve Gimeno, Sergio Fabra Juana, et al. (+5)
1107 [GO] 2021―Aug―26 Role of platelet-to-lymphocyte count ratio (PLR), as a prognostic indicator in COVID-19: A systematic review and meta-analysis Soumya Sarkar, Sundara Kannan, Puneet Khanna, Akhil Kant Singh
1108 [GO] 2021―Aug―24 Analysis of serum cytokine and protective vitamin D levels in severe cases of COVID-19 Nihayet Bayraktar, Hamdiye Turan, Mehmet Bayraktar, Ali Ozturk, Hamze Erdoğdu
1109 [GO] 2021―Aug―24 Autoimmune Complications of COVID-19 Niloufar Yazdanpanah, Nima Rezaei
1110 [GO] 2021―Aug―24 Effect of mutation and vaccination on spread, severity, and mortality of COVID-19 disease Hossam M. Zawbaa, Hasnaa Osama, Ahmed El-Gendy, Haitham Saeed, Hadeer S. Harb, Yasmin M. Madney, et al. (+7)
1111 [GO] 2021―Aug―24 Incomplete IgG avidity maturation after seasonal coronavirus infections Friedhelm Struck, Patrick Schreiner, Eva Staschik, Karin Wochinz-Richter, Sarah Schulz, Erwin Soutschek, et al. (+2)
1112 [GO] 2021―Aug―24 Humoral response to Spike S1 and S2 and Nucleocapsid Proteins on microarray after SARS-CoV-2 infection Amanda Izeli Portilho, Valéria Oliveira Silva, Cintia Mayumi Ahagon, Elaine Monteiro Matsuda, Elaine Lopes de Oliveira, Edilene Peres Real da Silveira, et al. (+6)
1113 [GO] 2021―Aug―24 The Effectiveness of Inactivated SARS-CoV-2 Vaccine (CoronaVac) on Antibody Response in Participants Aged 65 Years and Older Karamese Murat, Tutuncu Emin Ediz
1114 [GO] 2021―Aug―20 Re-activation or Re-infection of COVID-19 disease? Öner Özdemir
1115 [GO] 2021―Aug―20 Evolution of viral variants in remdesivir treated and untreated SARS-CoV-2 infected paediatrics patients Florencia A.T. Boshier, Juanita Pang, Justin Penner, Matthew Parker, Nele Alders, Alasdair Bamford, et al. (+14)
1116 [GO] 2021―Aug―19 SARS-CoV-2 RNAemia with a higher nasopharyngeal viral load is strongly associated with disease severity and mortality in patients with COVID-19 Hitoshi Kawasuji, Yoshitomo Morinaga, Hideki Tani, Yoshihiro Yoshida, Yusuke Taekgoshi, Makito Kaneda, et al. (+9)
1117 [GO] 2021―Aug―19 Epidemiologic characteristics of cases with re-infection, recurrence and hospital readmission due to COVID-19: a systematic review and meta-analysis Sahar Sotoodeh Ghorbani, Niloufar Taherpour, Sahar Bayat, Hadis Ghajari, Parisa Mohseni, Seyed Saeed Hashemi Nazari
1118 [GO] 2021―Aug―18 Evaluation of the Relationship Between Serum levels of Zinc, Vitamin B12, Vitamin D and Clinical outcomes in Patients with COVID-19 Habibesadat Shakeri, Amir Azimian, Hamed Ghasemzadeh-Moghaddam, Mohammadreza Safdari, Mehdi Haresabadi, Tahereh Daneshmand, Hasan Namdar Ahmadabad
1119 [GO] 2021―Aug―18 Elevated Inflammatory Markers Are Associated With Poor Outcomes in COVID-19 Patients Treated With Remdesivir Kate Stoeckle, Britta Witting, Shashi Kapadia, Anjile An, Kristen Marks
1120 [GO] 2021―Aug―18 Hemophagocytic lymphohistiocytosis following ChAdOx1 nCov-19 vaccination Sylvia Ai, Alexander Awford, Fernando Roncolato
1121 [GO] 2021―Aug―17 Anti-SARS-CoV-2 IgG levels in relation to disease severity of COVID-19 Xiquan Yan, Guoqiang Chen, Zhaoxia Jin, Zhongwei Zhang, Bing Zhang, Jiangming He, et al. (+8)
1122 [GO] 2021―Aug―17 A nomogram prediction of outcome in patients with COVID-19 based on individual characteristics incorporating immune response-related indicators Fang Tang, Xiaoshuai Zhang, Bicheng Zhang, Bo Zhu, Jun Wang
1123 [GO] 2021―Aug―17 Challenges of HIV amidst COVID-19 in Africa: Can we conquer them? Mohammad Mehedi Hasan, Parvathy Mohanan, Nzeribe Emmanuella, Ana Carla dos Santos Costa, Shoaib Ahmad, Sayed Hamid Mousavi, Mohammad Yasir Essar
1124 [GO] 2021―Aug―17 Evaluating the efficacy of extracted squalene from seed oil in the form of microemulsion for the treatment of COVID-19: A clinical study Mahmoud Ebrahimi, Nafiseh Farhadian, Ali Reza Amiri, Fatemeh Hataminia, Sara Saffar Soflaei, Mohammad Karimi
1125 [GO] 2021―Aug―13 ASSESSMENT OF CLINICAL OUTCOMES IN RENAL TRANSPLANT RECIPIENTS WITH COVID-19 Gulay Yilmaz, Ozdemir Ebru, Berber Ibrahim, Cakir Ulkem
1126 [GO] 2021―Aug―13 Impact of COVID-19 on the mental health in a cohort of Italian Rehabilitation health care workers Giacomo Farì, Alessandro Sire, Vincenzo Giorgio, Laura Rizzo, Antonella Bruni, Francesco Paolo Bianchi, et al. (+7)
1127 [GO] 2021―Aug―13 Letter to the editor in response to “Safety and Effectiveness of SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis” Jiawen Deng, Kiyan Heybati, Fangwen Zhou
1128 [GO] 2021―Aug―13 Vaccination versus infection with SARS-CoV-2: Establishment of a high avidity IgG response versus incomplete avidity maturation Friedhelm Struck, Patrick Schreiner, Eva Staschik, Karin Wochinz-Richter, Sarah Schulz, Erwin Soutschek, et al. (+2)
1129 [GO] 2021―Aug―11 fficacy and safety of Sofosbuvir plus Daclatasvir or Ravidasvir in patients with COVID-19, A Randomized Controlled Trial. Sherif abbass, Mohsen Salama, Tary Salman, Alyaa Sabry, Wael Abdel-Razek, Ehab Kamal, et al. (+15)
1130 [GO] 2021―Aug―10 Antibody response to SARS-CoV-2 vaccination, previous SARS-CoV-2 infection and change to single dose vaccination Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
1131 [GO] 2021―Aug―10 While we are discussing…the SARS-CoV-2 virus laughs Massimo Ciccozzi, Antonello Maruotti, Giancarlo Ceccarelli, Fabio Divino, Michele Guarino, Silvia Angeletti
1132 [GO] 2021―Aug―09 The association of COVID-19 antibody with in-hospital outcomes in COVID-19 infected patients Toshiki Kuno, Matsuo So, Yoshihisa Miyamoto, Masao Iwagami, Mai Takahashi, Natalia N. Egorova
1133 [GO] 2021―Aug―09 Effect of Azithromycin and Hydroxychloroquine in Patients Hospitalized with COVID-19: Network Meta-Analysis of Randomized Controlled Trials Gerald Chi, Sahar Memar Montazerin, Jane J. Lee, Syed Hassan A. Kazmi, Fahimehalsadat Shojaei, C. Michael Gibson
1134 [GO] 2021―Aug―09 Genomic analysis reveals a rapid spread and predominance of Lambda (C.37) SARS-COV-2 lineage in Peru despite circulation of variants of concern Carlos Padilla-Rojas, Victor Jimenez-Vasquez, Veronica Hurtado, Orson Mestanza, Iris Silva Molina, Luis Barcena, et al. (+11)
1135 [GO] 2021―Aug―05 Therapeutic interventions of remdesivir in diabetic and non-diabetic COVID-19 patients: A prospective observational study conducted on Pakistani population Qiadat Hasnain Qureshi, Taimoor Ashraf, Kanwal Rehman, Muhammad Kaleem Khosa, Muhammad Sajid Hamid Akash
1136 [GO] 2021―Aug―05 The rampant use of cow-dung to treat COVID-19: Is India at the brink of a zoonotic disease outbreak? Mohammad Yasir Essar, Syeda Kanza Kazmi, Mohammad Mehedi Hasan, Ana Carla dos Santos Costa, Shoaib Ahmad
1137 [GO] 2021―Aug―04 ABDULAHPrevalence and correlates of COVID-19 vaccine hesitancy in general public in Iraqi Kurdistan: A cross-sectional study Deldar Morad Abdulah
1138 [GO] 2021―Aug―04 Prolonged Symptom Onset to Admission Time is Associated with Severe Coronavirus Disease: A Meta combined Propensity-adjusted Analysis Yingchao Guan, Chaojin Chen, Anping Guo, Jingru Wei, Jiahui Cai, Hua Han, et al. (+3)
1139 [GO] 2021―Jul―31 Development and Validation of a Simplified Risk Score for the Prediction of Critical COVID-19 Illness in Newly Diagnosed Patients Stanislas Werfel, Carolin E. M. Jakob, Stefan Borgmann, Jochen Schneider, Christoph Spinner, Maximilian Schons, et al. (+11)
1140 [GO] 2021―Jul―31 Evaluation of a SARS-CoV-2 antigen-detecting rapid diagnostic test as a self-test: diagnostic performance and usability Nino Guy Cassuto, Anne Gravier, Mathilda Colin, Aurelie Theillay, Daniela Pires-Roteira, Sandra Pallay, et al. (+3)
1141 [GO] 2021―Jul―31 Comparison of Nasopharyngeal Swab and Nasopharyngeal Aspiration in Adults for SARS-CoV-2 Identification Using Reverse Transcription Polymerase Chain Reaction Selin ÜNSALER, Ayşe OKAN, Süda TEKİN, Ayşenur MERIÇ HAFIZ, Ozan GÖKLER, Ozan ALTUNTAŞ
1142 [GO] 2021―Jul―31 Performance assessment of seven SARS-CoV-2 IgG enzyme linked immunosorbent assays Ketki Deshpande, Ullas PT, Ojas Kaduskar, Neetu Vijay, Aparna Rakhe, Shankar Vidhate, et al. (+14)
1143 [GO] 2021―Jul―30 A cluster of the new SARS-CoV-2 B.1.621 lineage in Italy and sensitivity of the viral isolate to the BNT162b2 vaccine Serena Messali, Anna Bertelli, Giovanni Campisi, Alberto Zani, Massimo Ciccozzi, Arnaldo Caruso, Francesca Caccuri
1144 [GO] 2021―Jul―29 Arboviral Diseases and COVID-19 Coincidence: Challenges for Pakistan's Derelict Healthcare System Muhammad Hammad Butt, Aqsa Safdar, Attiya Amir, Muhammad Zaman, Abrar Ahmad, Rana Talha Saleem, et al. (+3)
1145 [GO] 2021―Jul―29 Statistical analysis of the Hungarian COVID-19 victims Elnaz Gholipour, Béla Vizvári, Tareq Babaqi, Szabolcs Takács
1146 [GO] 2021―Jul―29 Comparison of SARS-CoV-2 detection with the cobas® 6800/8800 system on gargle samples using two sample processing methods with combined oropharyngeal/nasopharyngeal swab Patrick Benoit, Annie-Claude Labbé, Linda Lalancette, Simon Gagnon, Eric Bonneau, Christian Lavallée, et al. (+5)
1147 [GO] 2021―Jul―29 SARS-CoV-2 pseudovirus infectivity and expression of viral entry-related factors ACE2, TMPRSS2, Kim-1 and NRP-1 in human cells from respiratory, urinary, digestive, reproductive and immune systems Fei Zhang, Wan Li, Jian Feng, Suzane Ramos da Silva, Enguo Ju, Hu Zhang, et al. (+4)
1148 [GO] 2021―Jul―27 Rapid antigen detection alone may not be sufficient for early diagnosis and/or mass screening of COVID-19 Zhenzhou Wan, Yongjuan Zhao, Renfei Lu, Yajuan Dong, Chiyu Zhang
1149 [GO] 2021―Jul―27 Evaluation of the relationship between pentraxin 3 (PTX3) rs2305619 (281A/G) and rs1840680 (1449A/G) polymorphisms and the clinical course of COVID-19 Ferhan Kerget, Buğra Kerget, Çiğdem Yüce Kahraman, Ömer Araz, Metin Akgün, Elif Yılmazel Uçar, Leyla Sağlam
1150 [GO] 2021―Jul―27 Sequencing on an imported case in China of COVID-19 Delta variant emerging from India in a cargo ship in Zhoushan, China Bing Wu, Hui Zhang, Yu-chao Wang, An Tang, Ke-feng Li, Peng Li, et al. (+3)
1151 [GO] 2021―Jul―27 Evaluation of predictors of severe-moderate COVID-19 infections at children: a review of 292 children. Aybüke Akaslan Kara, Elif Böncüoğlu, Elif Kıymet, Kamile Ötiken Arıkan, Şahika Şahinkaya, Mine Düzgöl, et al. (+6)
1152 [GO] 2021―Jul―27 Critical roles of cytokine storm and secondary bacterial infection in acute kidney injury development in COVID-19: A multi-center retrospective cohort study Xia-Qing Li, Han Liu, Hai-Yan Yin, Wen-Yong Gao, Xiao Yang, Dian-Shuang Xu, et al. (+6)
1153 [GO] 2021―Jul―27 Tobacco smoking and severity of COVID-19: Experience from a hospital-based prospective cohort study in Lyon-France Mitra Saadatian-Elahi, Sélilah Amour, Christelle Elias, Laetitia Henaff, Cédric Dananché, Philippe Vanhems
1154 [GO] 2021―Jul―27 The dynamics of quantitative SARS-CoV-2 anti-spike IgG response to BNT162b2 vaccination Shun Kaneko, Masayuki Kurosaki, Toru Sugiyama, Yuka Takahashi, Yoshimi Yamaguchi, Masayuki Nagasawa, Namiki Izumi
1155 [GO] 2021―Jul―27 Introduction of SARS-COV-2 C.37 (WHO VOI lambda) from Peru to Italy Andreina Baj, Federica Novazzi, Francesca Drago Ferrante, Angelo Genoni, Gianluca Cassani, Martina Prestia, et al. (+11)
1156 [GO] 2021―Jul―27 Acute Cerebellitis following SARS-CoV-2 infection: A Case Report and Review of Literature Maria C Moreno-Escobar, Parissa Feizi, Sanjiti Podury, Medha Tandon, Badria Munir, Muhammad Alvi, et al. (+2)
1157 [GO] 2021―Jul―27 SARS-CoV-2 R.1 lineage variants prevailed in Tokyo in March 2021 Katsutoshi Nagano, Chihiro Tani-Sassa, Yumi Iwasaki, Yuna Takatsuki, Sonoka Yuasa, Yuta Takahashi, et al. (+9)
1158 [GO] 2021―Jul―24 Epidemiological characteristics and incubation period of SARS-CoV-2 during the 2020-2021 winter pandemic wave in north China: an observational study Tiantian Liu, Zijian Chen, Jin Xu
1159 [GO] 2021―Jul―23 Repeat virological and serological profiles in hospitalized patients initially tested by nasopharyngeal RT-PCR for SARS-CoV-2 Noah Reich, Christopher F. Lowe, David Puddicombe, Nancy Matic, Jesse Greiner, Janet Simons, et al. (+11)
1160 [GO] 2021―Jul―23 SARS-CoV2-triggered acute arthritis: viral arthritis rather than reactive arthritis Shigeto Kobayashi, Yoshinori Taniguchi, Issei Kida, Naoto Tamura
1161 [GO] 2021―Jul―22 Evolution Trace of SARS-CoV-2 from January 19 to March 12, 2020 in the United States Ziying Lin, Hua Qing, Rui Li, Lei Zheng, Huipeng Yao
1162 [GO] 2021―Jul―21 Evaluation of a rapid antigen detection test (Panbio™ COVID-19 Ag Rapid Test Device) as a point-of-care diagnostic tool for COVID-19 in a Pediatric Emergency Department Silvia Carbonell-Sahuquillo, María Isabel Lázaro-Carreño, Jorge Camacho, Ana Barrés-Fernández, Eliseo Albert, Ignacio Torres, et al. (+3)
1163 [GO] 2021―Jul―21 Comparison Of Clinical And Biochemical Features Of Hospitalized COVID-19 And Influenza Pneumonia Patients Didem Görgün Hattatoğlu, Birsen Pınar Yıldız
1164 [GO] 2021―Jul―21 Post COVID-19 Complications: Multi-Systemic Approach Tarun Kumar Suvvari, LV Simhachalam Kutikuppala, Christos Tsagkaris, Anna Chiara Corriero, Venkataramana Kandi
1165 [GO] 2021―Jul―21 Lassa fever amidst the COVID-19 Pandemic in Africa: A rising concern, Efforts, Challenges and Future recommendations Olivier UWISHEMA, Baha Aldeen Abdalaziz Alshareif, Mohamed Yousif Elamin Yousif, Mohammed Eltahier Abdalla Omer, Alfredo Lorenzo Recio Sablay, Rabeet Tariq, et al. (+3)
1166 [GO] 2021―Jul―21 Seroprevalence of SARS-CoV-2 Antibodies Among Rural Healthcare Workers Jordan Z. Neises, Md Saddam Hossain, Rifat Sultana, Kevin N. Wanniarachchi, Jared W. Wollman, Eric Nelson, et al. (+4)
1167 [GO] 2021―Jul―21 Previous SARS-CoV-2 infection is linked to lower vaccination intentions Philipp Sprengholz, Cornelia Betsch
1168 [GO] 2021―Jul―17 Dexamethasone treatment may mitigate adverse effects of vitamin D deficiency in hospitalised Covid-19 patients Charlotte Wenban, Randeep S Heer, Vadir Baktash, Pirabakaran Kandiah, Theodora Katsanouli, Asmita Pandey, et al. (+5)
1169 [GO] 2021―Jul―16 SAFETY OF COVID-19 VACCINES Qutaiba Ahmed Al Khames Aga, Waseem Hashim Alkhaffaf, Tagreed Hamood Hatem, Kawthar F Nassir, Yazan Batineh, Abdullah Tahseen Dahham, et al. (+4)
1170 [GO] 2021―Jul―16 Comparison of clinical characteristics of a patient with Epstein-Barr virus-associated seizure and patients with COVID-19-associated seizure Larry Nichols, Merritt Thompson, Gretchen L. Bentz
1171 [GO] 2021―Jul―15 Cycle threshold values in RT-PCR to determine dynamics of SARS-CoV-2 viral load: An approach to reduce isolation period for COVID-19 patients Clara Aranha, Vainav Patel, Vikrant Bhor, Dimpu Gogoi
1172 [GO] 2021―Jul―15 Safety and Effectiveness of SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis Yunzhi Ling, Jiaying Zhong, Jiaru Luo
1173 [GO] 2021―Jul―14 The association between biochemically confirmed thyroid gland disorder and morbidity and mortality in patients with COVID-19 Anis Abobaker, Milad Darrat
1174 [GO] 2021―Jul―14 Probable viremia and positive placental swabs for SARS-CoV-2 in a preterm pregnant woman with mild COVID-19 Yesim Akdemir, Demet Haciseyitoglu, Guven Celebi, Cumhur Aydemir, Burak Bahadır, Anil Turhan Cakir, et al. (+2)
1175 [GO] 2021―Jul―14 Viral infections amidst COVID-19 in Africa: Implications and recommendations Olivier Uwishema, Irem Adanur, Abdulhammed Opeyemi Babatunde, Mohammad Mehedi Hasan, Osman Kamal Osman Elmahi, Kolawole Barakat Olajumoke, et al. (+5)
1176 [GO] 2021―Jul―14 Mucormycosis or black fungus infection is a new scare in South Asian countries during the COVID-19 pandemic: Associated risk factors and preventive measures Fahad I. Rahman, Md. Rabiul Islam, Mohiuddin A. Bhuiyan
1177 [GO] 2021―Jul―14 Evaluation of Rapid Antibody Test and Chest Computed Tomography Results of COVID-19 Patients: A Retrospective Study Ali Ozturk, Taylan Bozok, Tugce Simsek Bozok
1178 [GO] 2021―Jul―14 Effect of Different Storage Conditions on Covid-19 RT-PCR Results Elif Yilmaz Gulec, Nevra Pelin Cesur, Gonca Yeşilyurt Fazlioğlu, Cemal Kazezoğlu
1179 [GO] 2021―Jul―14 SARS-CoV-2 B.1.617 Indian variants: are electrostatic potential changes responsible for a higher transmission rate? Stefano Pascarella, Massimo Ciccozzi, Davide Zella, Martina Bianchi, Francesca Benetti, Domenico Benvenuto, et al. (+6)
1180 [GO] 2021―Jul―14 SARS-CoV-2 reinfection in a cancer patient with a defective neutralizing humoral response Cinzia Borgogna, Marco De Andrea, Gloria Griffante, Alessia Lai, Annalisa Bergna, Massimo Galli, et al. (+7)
1181 [GO] 2021―Jul―13 Post-covid Syndrome: A Single-Center Questionnaire Study On 1007 Participants Recovered from COVID-19 Bircan Kayaaslan, Fatma Eser, Ayse Kaya Kalem, Gamze Kaya, Betül Kaplan, Duygu Kacar, et al. (+3)
1182 [GO] 2021―Jul―13 Comparing the effectiveness of Atazanavir/Ritonavir/Dolutegravir/Hydroxychloroquine and Lopinavir/Ritonavir/Hydroxychloroquine treatment regimens in COVID-19 patients Saeed Kalantari, Soheil Rahmani Fard, Donya Maleki, Mahshid Talebi Taher, Zeynab Yasin, Yousef Alimohamadi, Sara Minaeian
1183 [GO] 2021―Jul―13 Public awareness about coronavirus vaccine, vaccine acceptance, and hesitancy Marwa O. Elgendy, Mohamed E. A. Abdelrahim
1184 [GO] 2021―Jul―13 Rapid immunoassay and clinical evaluation of the SARS-CoV-2 antibody assay on the Real Express-6 analyzer Shun Zhang, Yingjun Ning, Yejing Rong, Yaxing Nie, Zi Xiong, Rui Li, et al. (+2)
1185 [GO] 2021―Jul―12 Relapse of microscopic polyangiitis after vaccination against COVID-19: a case report Edoardo Conticini, Miriana D'Alessandro, Laura Bergantini, Elena Bargagli, Francesco Gentili, Maria Antonietta Mazzei, et al. (+2)
1186 [GO] 2021―Jul―10 Updated SARS-CoV-2 Single Nucleotide Variants and Mortality Association Shuyi Fang, Sheng Liu, Jikui Shen, Alex Z Lu, Audrey Katherine Yu Wang, Yucheng Zhang, et al. (+5)
1187 [GO] 2021―Jul―09 Evaluation of the relationship between macrophage migration inhibitory factor level and clinical course in patients with COVID-19 pneumonia Alperen Aksakal, Buğra Kerget, Ferhan Kerget, Seda Aşkın
1188 [GO] 2021―Jul―09 Dermatological manifestations associated with COVID-19: A comprehensive review of the current knowledge Zeinab Mohseni Afshar, Arefeh Babazadeh, Amirhossein Hasanpour, Mohammad Barary, Babak Sayad, Alireza Janbakhsh, et al. (+2)
1189 [GO] 2021―Jul―09 GENOMIC MONITORING UNVEIL THE EARLY DETECTION OF THE SARS-COV-2 B.1.351 (BETA) VARIANT (20H/501Y.V2) IN BRAZIL Svetoslav Nanev Slavov, José Salvatore Leister Patané, Rafael dos Santos Bezerra, Marta Giovanetti, Vagner Fonseca, Antonio Jorge Martins, et al. (+19)
1190 [GO] 2021―Jul―09 Genomic Characterization of SARS-CoV-2 Isolates from Patients in Turkey Reveals the Presence of Novel Mutations in Spike and nsp12 Proteins Erdem Sahin, Gulendam Bozdayi, Selin Yigit, Hager Muftah, Murat Dizbay, Ozlem Guzel Tunccan, et al. (+2)
1191 [GO] 2021―Jul―09 Time scale performance of rapid antigen testing for SARS-COV-2: evaluation of ten rapid antigen assays Zakarya Abusrewil, Inas M Alhudiri, Hamza Hussein Kaal, Salah Edin El Meshri, Fawzi O. Ebrahim, Tarek Dalyoum, et al. (+5)
1192 [GO] 2021―Jul―07 Remdesivir might induce changes in electrocardiogram beyond bradycardia in patients with Coronavirus disease 2019 (COVID-19) - the pilot study Petra Bistrovic, Marko Lucijanic
1193 [GO] 2021―Jul―07 Emergence of a young case infected with avian influenza A (H5N6) in Anhui Province, East China during the COVID-19 pandemic Jun-Ling Yu, Sai Hou, Ya-Ting Feng, Ge Bu, Qing-Qing Chen, Zhao-Qian Meng, et al. (+13)
1194 [GO] 2021―Jul―07 SARS-CoV-2 Vaccine-Induced Prothrombotic Immune Thrombocytopenia (VIPIT): Promoting Awareness to Improve Patient-Doctor Trust Tarun Kumar Suvvari, Eshwar Rajesh, Reewen George D Silva, Anna Chiara Corriero, LV Simhachalam Kutikuppala
1195 [GO] 2021―Jul―07 The Role of Angiopoietin-2 and Surfactant Protein-D Levels in SARS-CoV-2-related lung injury: A prospective, observational, cohort study Handan Alay, Esra Laloglu
1196 [GO] 2021―Jul―06 Rhinovirus spread in children during the COVID-19 pandemic despite social restrictions-a nationwide register study in Finland Ilari Kuitunen, Miia Artama, Marjut Haapanen, Marjo Renko
1197 [GO] 2021―Jul―06 Clinical Features and Outcome of COVID-19 positive children from a tertiary healthcare Hospital in Karachi Saba Shahid, Mohammad Raza, Samina Junejo, Sidra Maqsood
1198 [GO] 2021―Jul―06 Investigation of plasma exchange and hemoperfusion effects and complications for the treatment of patients with severe COVID-19 (SARS-CoV-2) disease: a systematic scoping review Razieh Sadat Mousavi-Roknabadi, Fatemeh Haddad, Aylar Fazlzadeh, Dorna Kheirabadi, Hamidreza Dehghan, Mohammad Rezaeisadrabadi
1199 [GO] 2021―Jul―05 What does COVID-19 Testing Results Really Say? The Real Statistics Concealed Behind the Accessible Data A. Rashki, A. Hoseinpour Dehkordi, R. Nemati, P. Tavousi
1200 [GO] 2021―Jul―02 Derangements of Biochemical Markers and Thyroid Function Analysis Among COVID-19 Positive Patients: A Developing Country Single-Center Experience Muhammad Sohaib Asghar, Farah Yasmin, Kartik Dapke, Rachana Phadke, Syed Muhammad Ismail Shah, Muhammad Daim Bin Zafar
1201 [GO] 2021―Jul―02 Lack of correlation between the SARS-CoV-2 cycle threshold ( C t ) value and clinical outcomes in patients with COVID-19 Jose F. Camargo, Rick Y. Lin, Krishna V. Komanduri
1202 [GO] 2021―Jul―02 Association between cycle threshold ( C t ) values and clinical and laboratory data in inpatients with COVID-19 and asymptomatic health workers Juan Pablo Ramirez-Hinojosa, Yunuen Rodriguez-Sanchez, Angel Kaleb Romero-Gonzalez, Marisol Chavez-Gutierrez, Nelly Raquel Gonzalez-Arenas, Aurora Ibarra-Arce, et al. (+14)
1203 [GO] 2021―Jul―02 Immunostimulation with interferon-γ in protracted SARS-CoV-2 pneumonia Anne-Claire Lukaszewicz, Fabienne Venet, Alexandre Faure, Emmanuelle Vignot, Guillaume Monneret
1204 [GO] 2021―Jul―01 Lassa fever and COVID-19 in Africa: A double crisis on the fragile health system Mohammad Mehedi Hasan, Ana Carla dos Santos Costa, Eleni Xenophontos, Parvathy Mohanan, Esther Edet Bassey, Shoaib Ahmad, Mohammad Yasir Essar
1205 [GO] 2021―Jun―29 Unrecognized introduction of SARS-CoV-2 variants of concern to Central Africa: Import and local transmission of B.1.1.7 in Gabon in the very early stage of the variant spread to the African continent Haruka Abe, Yuri Ushijima, Rodrigue Bikangui, Samira Zoa-Assoumou, Georgelin Nguema Ondo, Gédéon Prince Manouana, et al. (+9)
1206 [GO] 2021―Jun―29 Long-term monitoring of the development and extinction of IgA and IgG responses to SARS-CoV-2 infection Andrei Ivanov, Elena Semenova
1207 [GO] 2021―Jun―29 Phylogenomics reveals multiple introductions and early spread of SARS-CoV-2 into Peru Eduardo Juscamayta-López, Dennis Carhuaricra, David Tarazona, Faviola Valdivia, Nancy Rojas, Lenin Maturrano, Ronnie Gavilán
1208 [GO] 2021―Jun―28 Measles crisis in Africa amidst the COVID-19 pandemic: Delayed measles vaccine administration may cause a measles outbreak in Africa Olivier Uwishema, Lubanga F. Adriano, Tania Torbati, Helen Onyeaka
1209 [GO] 2021―Jun―26 Retrospective SARS-CoV-2 IgG screening during the first wave (March-June 2020) of the COVID-19 pandemic in the UK Paul William Bird, Kyran Sandhu, Oliver Fletcher, Billy Ames, Oliver Toovey, Julian Wei-Tze Tang
1210 [GO] 2021―Jun―25 Over one-year duration and age difference of SARS-CoV-2 antibody in convalescent COVID-19 patients Fanfan Zeng, Mengjun Wu, Jinbiao Wang, Jianyu Li, Guoyun Hu, Lin Wang
1211 [GO] 2021―Jun―25 Paracetamol in the home treatment of early COVID-19 symptoms: a possible foe rather than a friend for elderly patients? Sergio Pandolfi, Vincenzo Simonetti, Giovanni Ricevuti, Salvatore Chirumbolo
1212 [GO] 2021―Jun―25 COVID-19-associated Guillain Barre syndrome: Post-infectious alone or neuroinvasive too? Farman Khan, Praveen Sharma, Saurabh Pandey, Deepak Sharma, Vijayavarman V, Neeraj Kumar, et al. (+5)
1213 [GO] 2021―Jun―25 Evaluation of a chemiluminescent enzyme immunoassay-based high-throughput SARS-CoV-2 antigen assay for the diagnosis of COVID-19: The VITROS ® SARS-CoV-2 Antigen Test Nanako Matsuzaki, Yuta Orihara, Masahiro Kodana, Yutaro Kitagawa, Masaru Matsuoka, Rieko Kawamura, et al. (+5)
1214 [GO] 2021―Jun―25 Polymorphisms of ACE (I/D) and ACE2 Receptor Gene (Rs2106809, Rs2285666) are not Related to the Clinical Course of COVID-19; A Case Study Sevim KARAKAŞ ÇELİK, Güneş ÇAKMAK GENÇ, Nihal PİŞKİN, Bilgehan AÇIKGÖZ, Bülent ALTINSOY, Başak KURUCU İŞSİZ, Ahmet DURSUN
1215 [GO] 2021―Jun―25 Specific allelic discrimination of N501Y and other SARS-CoV-2 mutations by ddPCR detects B.1.1.7 lineage in Washington State Garrett A. Perchetti, Haiying Zhu, Margaret G. Mills, Lasata Shrestha, Cassia Wagner, Shah Mohamed Bakhash, et al. (+8)
1216 [GO] 2021―Jun―25 Reinfection with two genetically distinct SARS-CoV-2 viruses within 19 days Cynthia Y. Tang, Yang Wang, Jane A. McElroy, Tao Li, Richard Hammer, Detlef Ritter, et al. (+4)
1217 [GO] 2021―Jun―22 Real-life evaluation of a COVID-19 rapid antigen detection test in hospitalized children Irini Eleftheriou, Foteini Dasoula, Dimitra Dimopoulou, Evangelia Lebessi, Eftihia Serafi, Nikos Spyridis, Maria Tsolia
1218 [GO] 2021―Jun―21 COVID-19 sniffer dog experimental training: Which protocol and which implications for reliable sidentification? Silvia Angeletti, Francesco Travaglino, Silvia Spoto, Maria Chiara Pascarella, Giorgia Mansi, Marina De Cesaris, et al. (+7)
1219 [GO] 2021―Jun―18 Antiretrovirals shortage in Kenya amid COVID-19 Irfan Ullah, Wardah Hassan, Muhammad Junaid Tahir, Ali Ahmed
1220 [GO] 2021―Jun―17 Infectivity Assay for Detection of SARS-CoV-2 in Samples from Patients with COVID-19 Satoshi Hiroi, Ritsuko Kubota-Koketsu, Tadahiro Sasaki, Saeko Morikawa, Kazushi Motomura, Emi E. Nakayama, et al. (+2)
1221 [GO] 2021―Jun―17 Soluble angiotensin-converting enzyme 2 is transiently elevated in COVID-19 and correlates with specific inflammatory and endothelial markers Annika Lundström, Louise Ziegler, Sebastian Havervall, Ann-Sofie Rudberg, Fien Meijenfeldt, Prof Ton Lisman, et al. (+3)
1222 [GO] 2021―Jun―17 Measles returns to Democratic Republic of Congo: A New Predicament amid the COVID-19 Crisis Anmol Mohan, Rabiu Aishat Temitope, Sude Çavdaroğlu, Mohammad Mehedi Hasan, Ana Carla dos Santos Costa, Shoaib Ahmad, Mohammad Yasir Essar
1223 [GO] 2021―Jun―17 Predicting the development trend of the second wave of COVID-19 in five European countries Jiali Lei, Mengyuan Li, Xiaosheng Wang
1224 [GO] 2021―Jun―17 Medium-term serostatus in Spanish case series recovered from SARS-CoV-2 infection. Oscar Moreno-Pérez, Jose Manuel Ramos, Adelina Gimeno, Juan Carlos Rodríguez, Mariano Andres, Jose-Manuel Leon-Ramirez, et al. (+5)
1225 [GO] 2021―Jun―17 High-resolution melting curve FRET-PCR rapidly identifies SARS-CoV-2 mutations Subarna Barua, Monirul Hoque, Patrick John Kelly, Jianfa Bai, Gregg Hanzlicek, Lance Noll, et al. (+4)
1226 [GO] 2021―Jun―17 Laboratory Parameters related to Severe Disease and Death in SARS-CoV-2 Pneumonia: Retrospective Analysis G. Picchi, M. Di Norcia, V. Cofini, G. Sinatti, B. Cosimini, P. Vertolli, et al. (+5)
1227 [GO] 2021―Jun―14 Molecular biology of the SARs-CoV-2 spike protein: A review of current knowledge Chaogeng Zhu, Guiyun He, Qinqin Yin, Lin Zeng, Xiangli Ye, Yongzhong Shi, Wei Xu
1228 [GO] 2021―Jun―09 Detecting SARS-CoV-2 RNA in fecal specimens: The practical challenges Kok-Siong Poon, Nancy Wen-Sim Tee
1229 [GO] 2021―Jun―09 Interferon-alpha position in combating with COVID-19: A systematic review Ailar Nakhlband, Ali Fakhari, Hosein Azizi
1230 [GO] 2021―Jun―08 In-hospital Mortality in SARS-CoV-2 stratified by serum 25-Hydroxy-Vitamin D levels: A Retrospective Study Mohammed Al-Jarallah, Rajesh Rajan, Raja Dashti, Ahmad Al Saber, Jiazhu Pan, Kobalava D. Zhanna, et al. (+14)
1231 [GO] 2021―Jun―08 PREVALENCE OF IgG ANTIBODIES INDUCED BY THE SARS-COV-2 VIRUS IN ASYMPTOMATIC ADULTS IN NUEVO LEON, MEXICO. Edgar P. Rodríguez-Vidales, Denise Garza-Carrillo, José J. Pérez-Trujillo, Olivia A. Robles-Rodríguez, Ana María Salinas-Martínez, Roberto Montes Oca-Luna, et al. (+2)
1232 [GO] 2021―Jun―03 Biphasic anaphylaxis after exposure to the first dose of Pfizer-BioNTech COVID-19 mRNA vaccine Christophe Abi Zeid Daou, Mohammad Ali Natout, Nadine El Hadi
1233 [GO] 2021―Jun―03 Bird Flu Outbreak Amidst COVID-19 Pandemic in South Africa: Efforts and Challenges at Hand Olivier Uwishema, Lubanga Focus Adriano, Elie Chalhoub, Helen Onyeaka, Melissa Mhanna, Success Chekwube David, et al. (+3)
1234 [GO] 2021―Jun―03 The Demographic Characteristic, Prognosis and the Relationship with Cancer Subtypes of Hospitalised Covid-19 Patients with Malignancy: A Single-Center Experience Ezgi Değerli, Sümeyra Derin, Kerem Oruç, Nilay Şengül Samancı, Şahin Bedir, Emir Çelik, et al. (+4)
1235 [GO] 2021―Jun―03 COVID-19 PNEUMONIA IN KIDNEY TRANSPLANT RECIPIENTS: A PROMISING TREATMENT ALGORITHM IN THE ABSENCE OF A DISEASE-SPECIFIC DRUG Murat Karatas, Erhan Tatar, Cenk Simsek, Ali Murat Yıldırım, Alpay Ari, Baha Zengel, Adam Uslu
1236 [GO] 2021―Jun―03 Correlation between Interleukin Gene Polymorphisms with The Current Prevalence of and Mortality Rates due to The Novel Coronavirus Disease 2019 (COVID-2019) among 23 Countries Lutfiye Karcioglu Batur, Nezih Hekim
1237 [GO] 2021―Jun―03 Diagnose SARS-CoV-2 associated Guillain-Barre syndrome upon appropriate criteria and after exclusion of differentials Josef Finsterer
1238 [GO] 2021―Jun―03 Vertical Transmission of SARS-CoV-2: a prospective cross-sectional study from a tertiary center Selcan Sinaci, Doga Fatma Ocal, Banu Seven, Ali Taner Anuk, Berhan Besimoglu, Mehmet Can Keven, et al. (+8)
1239 [GO] 2021―Jun―03 Efficacy comparison of three rapid antigen tests for SARS-CoV-2 and how viral load impact their performance Laurent Blairon, Roberto Cupaiolo, Isabelle Thomas, Sébastien Piteüs, Alain Wilmet, Ingrid Beukinga, Marie Tré-Hardy
1240 [GO] 2021―Jun―02 Clinical Study Evaluating the Efficacy of Ivermectin in COVID-19 Treatment: A Randomized Controlled Study Sherief Abd-Elsalam, Rasha Abdel Noor, Rehab Badawi, Mai Khalaf, Eslam Saber Esmail, Shaimaa Soliman, et al. (+10)
1241 [GO] 2021―Jun―01 Relative expression of pro-inflammatory molecules in COVID-19 patients manifested disease severities Shireen Nigar, SM Tanjil Shah, Md. Ali Ahasan Setu, Sourav Dutta Dip, Habiba Ibnat, M Touhidul Islam, et al. (+3)
1242 [GO] 2021―Jun―01 An updated meta-analysis on the association between tuberculosis and COVID-19 severity and mortality Yadong Wang, Ruo Feng, Jie Xu, Hongjie Hou, Huifen Feng, Haiyan Yang
1243 [GO] 2021―Jun―01 Dengue and COVID-19: A risk of coepidemic in Ethiopia Anmol Mohan, Hajar Fakhor, Nirav Nimavat, Priyanka Mohan Lal, Ana Carla dos Santos Costa, Shoaib Ahmad, Mohammad Yasir Essar
1244 [GO] 2021―Jun―01 Inhibitory effect on SARS-CoV-2 infection of neferine by blocking Ca 2+ -dependent membrane fusion Yang Yang, Peng Yang, Cong Huang, Yuming Wu, Zhe Zhou, Xuejun Wang, Shengqi Wang
1245 [GO] 2021―Jun―01 Longitudinal detection of SARS-CoV-2-specific antibody responses with different serological methods Petra Emmerich, Ronald Possel, Christoph Josef Hemmer, Carlos Fritzsche, Hilte Geerdes-Fenge, Babett Menge, et al. (+4)
1246 [GO] 2021―May―31 European multicenter evaluation of Xpert® Xpress SARS-CoV-2/Flu/RSV test Femke Wolters, Maria Grünberg, Michael Huber, Harald H. Kessler, Florian Prüller, Lanja Saleh, et al. (+4)
1247 [GO] 2021―May―27 Prior immunosuppressive therapy is associated with mortality in COVID-19 patients: a retrospective study of 835 patients Elliot H Akama-Garren, Jonathan X Li
1248 [GO] 2021―May―27 Does the COVID-19 seroconversion in older adults resemble the young? Rabia Bag Soytas, Mahir Cengiz, Mehmet Sami Islamoglu, Betul Borku Uysal, Hande Ikitimur, Hakan Yavuzer, Serap Yavuzer
1249 [GO] 2021―May―27 Factors Associated with Hospital Readmissions among Patients with COVID-19: A Single Center Experience Geneva Guarin, Kevin Bryan Lo, Ruchika Bhargav, Grace Salacup, Ammaar Wattoo, Jean-Gabriel Coignet, et al. (+5)
1250 [GO] 2021―May―27 Genome-wide analysis of SARS-CoV-2 in VietnamGenome-wide analysis of SARS-CoV-2 strains circulating in Vietnam: understanding the nature of the epidemic and role of the D614G mutation Manh H Dao, Lan T Phan, Thang M Cao, Quang C Luong, Hang T. T. Pham, Nhung H. P. Vu, et al. (+16)
1251 [GO] 2021―May―25 Viral Co-infections in COVID-19 Parisa Shiri Aghbash, Narges Eslami, Milad Shirvaliloo, Hossein Bannazadeh Baghi
1252 [GO] 2021―May―25 EVALUATION of LONG TERM RADIOLOGICAL FINDINGS, PULMONARY FUNCTIONS AND HEALTH-RELATED QUALITY OF LIFE IN SURVIVORS OF SEVERE COVID-19 M.I. Bardakci, E.N. Ozturk, M.A. Ozkarafakili, H. Ozkurt, U. Yanc, D.Y. Sevgi
1253 [GO] 2021―May―21 Evaluation of the prognostic role of NLR, LMR, PLR and LCR ratio in COVID-19 patients Arife Erdogan, Fatma Ezgi Can, Hayriye Gönüllü
1254 [GO] 2021―May―21 Evaluation of the relationship between KIM-1 and suPAR levels and clinical severity in COVID-19 patients: A different perspective on suPAR Buğra Kerget, Ferhan Kerget, Alperen Aksakal, Seda Aşkın, Elif Yılmazel Uçar, Leyla Sağlam
1255 [GO] 2021―May―21 Quantitation of antibodies against SARS-CoV-2 spike protein after two doses of CoronaVac in health care workers Ayşen Bayram, Hadiye Demirbakan, Pınar Günel Karadeniz, Merve Erdoğan, Ipek Koçer
1256 [GO] 2021―May―19 Genome-wide screening of SARS-CoV-2 infection-related genes based on the blood leucocytes sequencing dataset of patients with COVID-19 Xin Gao, Yuan Liu, Shaohui Zou, Pengqin Liu, Jing Zhao, Changshun Yang, et al. (+2)
1257 [GO] 2021―May―19 Rapid COVID-19 antigenic tests: Usefulness of a modified method for diagnosis Soleimani Reza, Deckers Corentin, Huang Te-Din, Bogaerts Pierre, Evrard Stéphanie, Wallemme Isaline, et al. (+3)
1258 [GO] 2021―May―19 Assessment of salivary antibody response to BNT162b2 mRNA COVID-19 vaccination Ivana Lapić, Dragana Šegulja, Dunja Rogić
1259 [GO] 2021―May―19 Equal Access of COVID-19 Vaccine distribution in Africa: Challenges and Way Forward Abdullahi Tunde Aborode, Oluwatosin A. Olofinsao, Ekwebelem Osmond, Abiokpoyanam P. Batubo, Omowonuola Fayemiro, Onigbinde Sherifdeen, et al. (+4)
1260 [GO] 2021―May―18 Emergence of the SARS-CoV-2 B.1.1.7 variant observed at the Poitiers University Hospital Florent Hubert, Céline Chessa, Agnès Beby-Defaux, Anne Bourgoin, Laurence Boinot, Ursula Noury, et al. (+4)
1261 [GO] 2021―May―18 Comparative evaluation of Panbio and SD Biosensor antigen rapid diagnostic tests for COVID-19 diagnosis Felipe Pérez-García, Juan Romanyk, Helena Moya Gutiérrez, Andrea Labrador Ballestero, Inés Pérez Ranz, Javier González Arroyo, et al. (+4)
1262 [GO] 2021―May―18 COVID-19 vaccination in Ukraine: An update on the status of vaccination and the challenges at hand L. Matiashova, G. Isayeva, Aparajeya Shanker, Christos Tsagkaris, Abdullahi Tunde Aborode, Mohammad Yasir Essar, Shoaib Ahmad
1263 [GO] 2021―May―18 Evaluation of six different rapid methods for nucleic acid detection of SARS-COV-2 virus Sally A. Mahmoud, Subhashini Ganesan, Esra Ibrahim, Bhagyashree Thakre, Juliet George Teddy, Preeti Raheja, Walid Abbas Zaher
1264 [GO] 2021―May―15 Immunological aspects and gender bias during respiratory viral infections including novel Coronavirus disease-19 (COVID-19): a scoping review Sabitha Vadakedath, Venkataramana Kandi, Ranjan K. Mohapatra, Venkata Bharat Kumar Pinnelli, Richa Ramya Yegurla, Praveen R Shahapur, et al. (+7)
1265 [GO] 2021―May―15 COVID-19 encephalitis and Wernicke's encephalopathy Jason Kho, Amit K J Mandal, Ruth Geraldes, Hatice Tuzlali, Elena Boyd, Ross Nortley, Constantinos G Missouris
1266 [GO] 2021―May―15 The natural course of COVID-19 patients without clinical intervention Daxian Wu, Qunfang Rao, Wenfeng Zhang
1267 [GO] 2021―May―15 Association of GSTM1 and GSTT1 gene polymorphisms with COVID-19 susceptibility and its outcome Mohammad Abbas, Sushma Verma, Shrikant Verma, Sahabjada Siddiqui, Faizan Haider Khan, Syed Tasleem Raza, et al. (+3)
1268 [GO] 2021―May―15 Vitamin D and COVID-19: Role of ACE2, Age, Gender and Ethnicity Bruk Getachew, Yousef Tizabi
1269 [GO] 2021―May―15 Consider differentials before diagnosing SARS-CoV-2 associated Guillain-Barre syndrome Josef Finsterer, Fulvio A Scorza
1270 [GO] 2021―May―15 Genomic surveillance activities unveil the introduction of the SARS-CoV-2 B.1.525 variant of interest in Brazil: Case Report Felicidade Pereira, Stephane Tosta, Maricélia Maia Lima, Luciana Reboredo de Oliveira da Silva, Vanessa Brandão Nardy, Marcela Kelly Astete Gómez, et al. (+7)
1271 [GO] 2021―May―15 Multisystemic inflammatory syndrome in a young adult after SARS-CoV2 infection: case report. A. Viana-García, A. Pina-Belmonte, S. Salavert-Pamblanco, A. Atienza-Garcia
1272 [GO] 2021―May―11 SARS-CoV-2 prevalence, maternal and perinatal outcomes among pregnant women admitted for delivery: Experience from Covid-19 dedicated maternity hospital in Jammu, Jammu and Kashmir (India). Gupta Puneet, kumar Surender, Sharma Shashi Sudhan
1273 [GO] 2021―May―11 Complement levels at admission as a reflection of Coronavirus Disease 19 (COVID-19) severity state Brandon Michael Henry, Ivan Szergyuk, Maria Helena Santos de Oliveira, Giuseppe Lippi, Justin L. Benoit, Jens Vikse, Stefanie W. Benoit
1274 [GO] 2021―May―11 Comparative Analyses of ACE2 and TMPRSS2 gene: Implications for the Risk for Which Vertebrate Animals Are Susceptible to SARS-CoV-2 Chen Huang, Yu Jiang, Jie Yan
1275 [GO] 2021―May―10 Coronavirus Disease 2019 (COVID-19): A Systematic Review of 133 Children Presented with Kawasaki-like Multisystem Inflammatory Syndrome Pedram Keshavarz, Fereshteh Yazdanpanah, Sara Azhdari, Hadiseh Kavandi, Parisa Nikeghbal, Amir Bazyar, et al. (+4)
1276 [GO] 2021―May―10 SARS-CoV-2 B.1.1.7 REINFECTION AFTER PREVIOUS COVID-19 IN TWO IMMUNOCOMPETENT ITALIAN PATIENTS Federica Novazzi, Andreina Baj, Angelo Genoni, Pietro Giorgio Spezia, Alberto Colombo, Gianluca Cassani, et al. (+8)
1277 [GO] 2021―May―10 SARS-CoV-2 rapid antigen test: Fast-safe or dangerous? An analysis in the emergency department of an university hospital Carola Holzner, Dirk Pabst, Olympia Evdoxia Anastasiou, Ulf Dittmer, Randi Katrin Manegold, Joachim Risse, et al. (+3)
1278 [GO] 2021―May―10 SARS-CoV-2 RNAaemia in children: an Iranian referral hospital-based study Babak Pourakbari, Shima Mahmoudi, Yasmine Mahmoudieh, Hamid Eshaghi, Amene Navaeian, Maryam Rostamyan, Setareh Mamishi
1279 [GO] 2021―May―09 Cytokine Storm in Severe COVID-19 Pneumonia Bengül Gürsoy, Cemile Dilşah Sürmeli, Mustafa Alkan, Celal Satıcı, Sargın Altunok, Sadettin Kamat, et al. (+3)
1280 [GO] 2021―May―09 RT-PCR/MALDI-TOF mass spectrometry-based detection of SARS-CoV-2 in saliva specimens Matthew M. Hernandez, Radhika Banu, Paras Shrestha, Armi Patel, Feng Chen, Liyong Cao, et al. (+18)
1281 [GO] 2021―May―06 The surveillance of spike protein for patients with COVID-19 detected in Hong Kong in 2020 Gannon CK Mak, Angela WL Lau, Andy MY Chan, Edman TK Lam, Rickjason CW Chan, Dominic NC Tsang
1282 [GO] 2021―May―06 Maternal Selenium Status has Crucial Role on Clinical Outcomes Of Pregnant Women With COVID-19 Infection Seyit Ahmet Erol, Naci Polat, Sevginur Akdas, Pelin Aribal Ayral, Ali Taner Anuk, Eda Ozden Tokalioglu, et al. (+7)
1283 [GO] 2021―May―06 Cerebrospinal fluid and serum interleukins 6 and 8 during the acute and recovery phase in COVID-19 neuropathies patients Paolo Manganotti, Giulia Bellavita, Valentina Tommasini, Laura D'Acunto, Martina Fabris, Laura Cecotti, et al. (+5)
1284 [GO] 2021―May―06 Preliminary report on SARS-CoV-2 Spike mutation T478K Simone Di Giacomo, Daniele Mercatelli, Amir Rakhimov, Federico M. Giorgi
1285 [GO] 2021―May―04 Determinants of IgG antibodies kinetics after severe and critical COVID-19 Julien De Greef, Anaïs Scohy, Francis Zech, Aboubakar Frank, Charles Pilette, Ludovic Gerard, et al. (+4)
1286 [GO] 2021―May―04 Lymphopenia and lung complications in patients with coronavirus disease-2019 (COVID-19): A retrospective study based on clinical data Ehsan Zaboli, Hadi Majidi, Reza Alizadeh-Navaei, Akbar Hedayatizadeh-Omran, Hossein Asgarian-Omran, Laleh Vahedi Larijani, et al. (+2)
1287 [GO] 2021―May―04 The mystery of plummeting cases of measles during COVID-19 pandemic in Pakistan: Hidden impact of collateral damage Maria Tanveer, Ali Ahmed, Adeel Siddiqui, Sai Krishna Gudi
1288 [GO] 2021―May―04 Feasibility of convalescent plasma therapy in severe COVID-19 patients with persistent SARS-CoV-2 viremia Fabrice Camou, Claire Tinevez, Mathilde Beguet-Yachine, Pantxika Bellecave, Diana Ratiarison, Camille Tumiotto, et al. (+6)
1289 [GO] 2021―May―04 Unequal distribution of COVID-19 vaccine: A looming crisis Imaduddin Sawal, Shoaib Ahmad, Waleed Tariq, Muhammad Junaid Tahir, Mohammad Yasir Essar, Ali Ahmed
1290 [GO] 2021―May―04 Influenza season 2020-2021 did not begin in Finland despite the looser social restrictions during the second wave of COVID-19: A nationwide register study Ilari Kuitunen
1291 [GO] 2021―May―02 Betacoronaviruses genome analysis reveals evolution toward specific codons usage: implications for SARS-CoV-2 mitigation strategies Elisson Nogueira Lopes, Vagner Fonseca, Diego Frias, Stephane Tosta, Álvaro Salgado, Ricardo Assunção Vialle, et al. (+8)
1292 [GO] 2021―May―01 SARS-CoV-2 antibodies: IgA correlates with severity of disease in early COVID-19 infection Fainareti N. Zervou, Ping Louie, Anna Stachel, Ioannis M. Zacharioudakis, Yadira Ortiz-Mendez, Kristen Thomas, Maria E. Aguero-Rosenfeld
1293 [GO] 2021―May―01 Effect of The Coronavirus Pandemic on Tumor Markers Yunus Emre Purut, Burak Giray, Esra Gurbuz
1294 [GO] 2021―Apr―30 Optimal Uses of Pooled Testing for COVID-19 incorporating imperfect test performance and pool dilution effect: An Application to Congregate Settings in Los Angeles County Roch A. Nianogo, Prabhu Gounder, Vladimir Manuel, Nathaniel W. Anderson, Tony Kuo, Moira Inkelas, Onyebuchi A. Arah
1295 [GO] 2021―Apr―30 The breadth of concomitant virological features in a family cluster outbreak of COVID-19 pneumonia Guanglin Lei, Fanping Meng, Cheng Wang, Jin Yan, Fang Sun, Lei Shi, et al. (+4)
1296 [GO] 2021―Apr―29 Decreased In-Hospital Mortality Associated with Aspirin Administration in Hospitalized Patients Due to Severe COVID-19 Mohammad Haji Aghajani, Omid Moradi, Hossein Amini, Hamed Azhdari Tehrani, Elham Pourheidar, Mohammad Mahdi Rabiei, Mohammad Sistanizad
1297 [GO] 2021―Apr―29 Real-life evaluation of a rapid extraction-free SARS-CoV-2 RT-PCR assay (COVID-19 PCR Fast-L) for the diagnosis of COVID-19 Ignacio Torres, Jamal Qualai, Eliseo Albert, Felipe Bueno, Dixie Huntley, Sandrine Poujois, et al. (+2)
1298 [GO] 2021―Apr―29 Informing the Global COVID-19 Response by Estimating Excess Deaths in Italy During the COVID-19 and 1918 Influenza Pandemics Christina Gillezeau, Naomi Alpert, Marcantonio Caltabiano, Raja Flores, Emanuela Taioli
1299 [GO] 2021―Apr―29 Treatment Patterns in US Patients Hospitalized With